
<html lang="en"     class="pb-page"  data-request-id="e07be3a1-c83c-43a6-b99c-cd8c226fd1bc"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b00145;issue:issue:10.1021/jmcmar.2019.62.issue-13;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia" /></meta><meta name="dc.Creator" content="Nagore&#xA;I.  Marín-Ramos" /></meta><meta name="dc.Creator" content="Moisés  Balabasquer" /></meta><meta name="dc.Creator" content="Francisco J.  Ortega-Nogales" /></meta><meta name="dc.Creator" content="Iván R.  Torrecillas" /></meta><meta name="dc.Creator" content="Ana  Gil-Ordóñez" /></meta><meta name="dc.Creator" content="Beatriz  Marcos-Ramiro" /></meta><meta name="dc.Creator" content="Pedro  Aguilar-Garrido" /></meta><meta name="dc.Creator" content="Ian  Cushman" /></meta><meta name="dc.Creator" content="Antonio  Romero" /></meta><meta name="dc.Creator" content="Francisco J.  Medrano" /></meta><meta name="dc.Creator" content="Consuelo  Gajate" /></meta><meta name="dc.Creator" content="Faustino  Mollinedo" /></meta><meta name="dc.Creator" content="Mark R.  Philips" /></meta><meta name="dc.Creator" content="Mercedes  Campillo" /></meta><meta name="dc.Creator" content="Miguel  Gallardo" /></meta><meta name="dc.Creator" content="Mar  Martín-Fontecha" /></meta><meta name="dc.Creator" content="María L.  López-Rodríguez" /></meta><meta name="dc.Creator" content="Silvia  Ortega-Gutiérrez" /></meta><meta name="dc.Description" content="Blockade of Ras activity by inhibiting its post-translational methylation catalyzed by isoprenylcysteine carboxylmethyltransferase (ICMT) has been suggested as a promising antitumor strategy. Howev..." /></meta><meta name="Description" content="Blockade of Ras activity by inhibiting its post-translational methylation catalyzed by isoprenylcysteine carboxylmethyltransferase (ICMT) has been suggested as a promising antitumor strategy. Howev..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 10, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00145" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00145" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00145" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00145" /></link>
        
    
    

<title>A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00145" /></meta><meta property="og:title" content="A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0016.jpeg" /></meta><meta property="og:description" content="Blockade of Ras activity by inhibiting its post-translational methylation catalyzed by isoprenylcysteine carboxylmethyltransferase (ICMT) has been suggested as a promising antitumor strategy. However, the paucity of inhibitors has precluded the clinical validation of this approach. In this work we report a potent ICMT inhibitor, compound 3 [UCM-1336, IC50 = 2 μM], which is selective against the other enzymes involved in the post-translational modifications of Ras. Compound 3 significantly impairs the membrane association of the four Ras isoforms, leading to a decrease of Ras activity and to inhibition of Ras downstream signaling pathways. In addition, it induces cell death in a variety of Ras-mutated tumor cell lines and increases survival in an in vivo model of acute myeloid leukemia. Because ICMT inhibition impairs the activity of the four Ras isoforms regardless of its activating mutation, compound 3 surmounts many of the common limitations of available Ras inhibitors described so far. In addition, these results validate ICMT as a valuable target for the treatment of Ras-driven tumors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00145"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00145">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00145&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00145&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00145&amp;href=/doi/10.1021/acs.jmedchem.9b00145" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 6035-6046</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00021" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00173" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Nagore I. Marín-Ramos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nagore I. Marín-Ramos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div><div class="loa-info-affiliations-info">CEI Campus Moncloa, UCM-UPM and CSIC, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nagore%0AI.++Mar%C3%ADn-Ramos">Nagore I. Marín-Ramos</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Moisés Balabasquer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Moisés Balabasquer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mois%C3%A9s++Balabasquer">Moisés Balabasquer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Francisco J. Ortega-Nogales</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Francisco J. Ortega-Nogales</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Francisco+J.++Ortega-Nogales">Francisco J. Ortega-Nogales</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Iván R. Torrecillas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Iván R. Torrecillas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratori de Medicina Computacional, Unitat de Bioestadística, Facultat de Medicina, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Iv%C3%A1n+R.++Torrecillas">Iván R. Torrecillas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ana Gil-Ordóñez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ana Gil-Ordóñez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ana++Gil-Ord%C3%B3%C3%B1ez">Ana Gil-Ordóñez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Beatriz Marcos-Ramiro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Beatriz Marcos-Ramiro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Beatriz++Marcos-Ramiro">Beatriz Marcos-Ramiro</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pedro Aguilar-Garrido</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pedro Aguilar-Garrido</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">H12O-CNIO Haematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), E-28029 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pedro++Aguilar-Garrido">Pedro Aguilar-Garrido</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ian Cushman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ian Cushman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ian++Cushman">Ian Cushman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Antonio Romero</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonio Romero</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biológicas, CSIC, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Romero">Antonio Romero</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Francisco J. Medrano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Francisco J. Medrano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biológicas, CSIC, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Francisco+J.++Medrano">Francisco J. Medrano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Consuelo Gajate</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Consuelo Gajate</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biológicas, CSIC, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Consuelo++Gajate">Consuelo Gajate</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Faustino Mollinedo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Faustino Mollinedo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biológicas, CSIC, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Faustino++Mollinedo">Faustino Mollinedo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mark R. Philips</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark R. Philips</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Perlmutter Cancer Center, New York University School of Medicine, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark+R.++Philips">Mark R. Philips</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mercedes Campillo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mercedes Campillo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratori de Medicina Computacional, Unitat de Bioestadística, Facultat de Medicina, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mercedes++Campillo">Mercedes Campillo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Miguel Gallardo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Miguel Gallardo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">H12O-CNIO Haematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), E-28029 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Miguel++Gallardo">Miguel Gallardo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mar Martín-Fontecha</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mar Martín-Fontecha</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mar++Mart%C3%ADn-Fontecha">Mar Martín-Fontecha</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">María L. López-Rodríguez</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">María L. López-Rodríguez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>M.L.L.-R.: phone, 34-91-3944239; e-mail, <a href="/cdn-cgi/l/email-protection#8ae7e6fff0e6f8caffe9e7a4eff9"><span class="__cf_email__" data-cfemail="0e63627b74627c4e7b6d63206b7d">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+L.++L%C3%B3pez-Rodr%C3%ADguez">María L. López-Rodríguez</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Silvia Ortega-Gutiérrez</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Silvia Ortega-Gutiérrez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>S.O.-G.: phone, 34-91-3945244; e-mail: <a href="/cdn-cgi/l/email-protection#c7b4aea8b5b3a2a0a687b2a4aae9a2b4"><span class="__cf_email__" data-cfemail="c3b0aaacb1b7a6a4a283b6a0aeeda6b0">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Ortega-Guti%C3%A9rrez">Silvia Ortega-Gutiérrez</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0257-6754" title="Orcid link">http://orcid.org/0000-0002-0257-6754</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00145&amp;href=/doi/10.1021%2Facs.jmedchem.9b00145" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 6035–6046</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 10, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 January 2019</li><li><span class="item_label"><b>Published</b> online</span>10 June 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 July 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00145" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00145</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6035%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNagore%250AI.%2BMar%25C3%25ADn-Ramos%252C%2BMois%25C3%25A9s%2BBalabasquer%252C%2BFrancisco%2BJ.%2BOrtega-Nogales%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D13%26contentID%3Dacs.jmedchem.9b00145%26title%3DA%2BPotent%2BIsoprenylcysteine%2BCarboxylmethyltransferase%2B%2528ICMT%2529%2BInhibitor%2BImproves%2BSurvival%2Bin%2BRas-Driven%2BAcute%2BMyeloid%2BLeukemia%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6046%26publicationDate%3DJuly%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00145"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1304</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00145" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nagore\nI.&quot;,&quot;last_name&quot;:&quot;Marín-Ramos&quot;},{&quot;first_name&quot;:&quot;Moisés&quot;,&quot;last_name&quot;:&quot;Balabasquer&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;J. Ortega-Nogales&quot;},{&quot;first_name&quot;:&quot;Iván&quot;,&quot;last_name&quot;:&quot;R. Torrecillas&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Gil-Ordóñez&quot;},{&quot;first_name&quot;:&quot;Beatriz&quot;,&quot;last_name&quot;:&quot;Marcos-Ramiro&quot;},{&quot;first_name&quot;:&quot;Pedro&quot;,&quot;last_name&quot;:&quot;Aguilar-Garrido&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;Cushman&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Romero&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;J. Medrano&quot;},{&quot;first_name&quot;:&quot;Consuelo&quot;,&quot;last_name&quot;:&quot;Gajate&quot;},{&quot;first_name&quot;:&quot;Faustino&quot;,&quot;last_name&quot;:&quot;Mollinedo&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;R. Philips&quot;},{&quot;first_name&quot;:&quot;Mercedes&quot;,&quot;last_name&quot;:&quot;Campillo&quot;},{&quot;first_name&quot;:&quot;Miguel&quot;,&quot;last_name&quot;:&quot;Gallardo&quot;},{&quot;first_name&quot;:&quot;Mar&quot;,&quot;last_name&quot;:&quot;Martín-Fontecha&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;L. López-Rodríguez&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Ortega-Gutiérrez&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;6035-6046&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00145&quot;},&quot;abstract&quot;:&quot;Blockade of Ras activity by inhibiting its post-translational methylation catalyzed by isoprenylcysteine carboxylmethyltransferase (ICMT) has been suggested as a promising antitumor strategy. However, the paucity of inhibitors has precluded the clinical validation of this approach. In this work we report a potent ICMT inhibitor, compound 3 [UCM-1336, IC50 = 2 μM], which is selective against the other enzymes involved in the post-translational modifications of Ras. Compound 3 significantly impairs the membrane association of the four Ras isoforms, leading to a decrease of Ras activity and to inhibition of Ras downstream signaling pathways. In addition, it induces cell death in a variety of Ras-mutated tumor cell lines and increases survival in an in vivo model of acute myeloid leukemia. Because ICMT inhibition impairs the activity of the four Ras isoforms regardless of its activating mutation, compound 3 surmounts many of the common limitations of available Ras inhibitors described so far. In addition, these r&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00145&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00145" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00145&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00145" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00145&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00145" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00145&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00145&amp;href=/doi/10.1021/acs.jmedchem.9b00145" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00145" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00145" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00145%26sid%3Dliteratum%253Aachs%26pmid%3D31181882%26genre%3Darticle%26aulast%3DMar%25C3%25ADn-Ramos%26date%3D2019%26atitle%3DA%2BPotent%2BIsoprenylcysteine%2BCarboxylmethyltransferase%2B%2528ICMT%2529%2BInhibitor%2BImproves%2BSurvival%2Bin%2BRas-Driven%2BAcute%2BMyeloid%2BLeukemia%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D13%26spage%3D6035%26epage%3D6046%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/jmcmar.2019.62.issue-13/20190711/jmcmar.2019.62.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Blockade of Ras activity by inhibiting its post-translational methylation catalyzed by isoprenylcysteine carboxylmethyltransferase (ICMT) has been suggested as a promising antitumor strategy. However, the paucity of inhibitors has precluded the clinical validation of this approach. In this work we report a potent ICMT inhibitor, compound <b>3</b> [UCM-1336, IC<sub>50</sub> = 2 μM], which is selective against the other enzymes involved in the post-translational modifications of Ras. Compound <b>3</b> significantly impairs the membrane association of the four Ras isoforms, leading to a decrease of Ras activity and to inhibition of Ras downstream signaling pathways. In addition, it induces cell death in a variety of Ras-mutated tumor cell lines and increases survival in an in vivo model of acute myeloid leukemia. Because ICMT inhibition impairs the activity of the four Ras isoforms regardless of its activating mutation, compound <b>3</b> surmounts many of the common limitations of available Ras inhibitors described so far. In addition, these results validate ICMT as a valuable target for the treatment of Ras-driven tumors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18722" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18722" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Constitutively activated Ras is present in about one-third of the human cancers, including those among the most aggressive ones such as pancreatic, lung, or colon cancers or some leukemias. However, after several decades of continuous research efforts, Ras direct inhibition with small molecules still remains a current challenge.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7">(1−7)</a> Instead, interference with the enzymes involved in the post-translational modification of Ras could be an alternative, considering that in absence of any of its post-translational modifications Ras loses its capacity to promote tumor transformation.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Ras post-translational modification involves three consecutive steps: prenylation, catalyzed by farnesyltransferase (FTase) or geranylgeranyltransferase (GGTase), proteolysis, mediated by the endoprotease Ras-converting enzyme 1 (Rce1), and final methylation of the carboxy terminal amino acid by the enzyme isoprenylcysteine carboxylmethyltransferase (ICMT). Though FTase has been the target of a variety of drug discovery programs, its inhibitors failed to show satisfactory activity in clinical trials, probably because of the alternative prenylation by GGTase. Consequently, more recent efforts have been dedicated to target the postprenylation enzymes Rce1 and ICMT.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Whereas Rce1 inhibition has raised some toxicity concerns, ICMT blockade seems more promising given that its genetic inactivation blocks Ras proper localization and activity,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> ameliorates phenotypes of K-Ras-induced malignancies in vivo,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and is critical for malignant transformation and tumor maintenance by all Ras isoforms in humans.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> These findings provide a compelling rationale for the development of ICMT inhibitors as a promising approach to anticancer drug development for treating challenging Ras-driven tumors. However, its clinical validation has been hampered by the lack of synthetic inhibitors, and to date, only one inhibitor, cysmethynil<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A), has been thoroughly characterized. This compound effectively blocks the anchorage independent growth in a human colon cancer cell line<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and impairs tumor progress in mice.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> However, its advancement toward clinical phases has been hampered by its limited potency in vitro in some cancer cell lines<a onclick="showRef(event, 'ref14 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref16">(14,16)</a> and in vivo models, where doses between 100 and 200 mg/kg are usually required to observe inhibition of tumor growth.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Further efforts in the development of more efficacious ICMT inhibitors have led to the identification of several structural scaffolds able to inhibit to some extent ICMT,<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17−20)</a> including indole derivatives,<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> some of them structurally similar to cysmethynil but with improved cellular antiproliferative activities,<a onclick="showRef(event, 'ref16 ref23'); return false;" href="javascript:void(0);" class="ref ref16 ref23">(16,23)</a> farnesyl cysteine analogs,<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24−26)</a> and a series of tetrahydropyrane derivatives, one of these compounds being the most potent ICMT inhibitor described to date, with a IC<sub>50</sub> value of 1.3 nM. However, this excellent in vitro value led only to a modest reduction in cell viability in different tumor cell lines.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In this context, new compounds able to block ICMT activity would be highly desirable. In this work we describe a new potent and selective ICMT inhibitor, compound <b>3</b>, which significantly impairs the membrane association of the four Ras isoforms, leading to a remarkable reduction in Ras activity, to the inhibition of the mitogen-activated protein kinase (MAPK) signaling pathway, and finally to cell death by autophagy and apoptosis. In addition, compound <b>3</b> significantly reduces cell viability in a variety of Ras-mutated tumor cell lines and, importantly, shows in vivo activity, as it increases survival in the Ras-driven model of acute myeloid leukemia at a dose of 25 mg/kg without causing any toxic side effect.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Structures of cysmethynil, AFC, and compound <b>1</b>. (B) Tc-ICMT-derived homology model of h-ICMT in complex with cysmethynil (orange) and <i>S</i>-adenosylmethionine (SAM) cofactor (cyan). The indole ring is positioned in front of Trp216, the amide group is located between Arg274 and Asp122, and the octyl tail expands toward Tyr236. (C) Tc-ICMT-derived homology model of h-ICMT in complex with AFC (orange) and SAM cofactor (cyan). AFC positions the carboxyl group between conserved Arg174, His187, Arg247, Trp216 and the methyl group of SAM. The prenyl moiety expands between TM5 and TM8 helices toward Tyr236. Tc-ICMT PDB code is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V7P">5V7P</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25476" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25476" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Hit Identification</h3><div class="NLM_p">In order to identify new ICMT inhibitors, we carried out a screening of our in-house library that led to the identification of compound <b>1</b> as an initial hit (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). This compound blocked ICMT activity, albeit with moderate potency (25% inhibition of the ICMT activity at 50 μM), making necessary further optimization of the compound. As a first step in that direction, we decided to perform docking studies. For this, we built a homology model of the human enzyme (h-ICMT) using as templates the <i>Methanosarcina acetivorans</i> ICMT (Ma-ICMT),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> the only structure available when this work was started (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">Supporting Information Figure S1</a>), and the recently disclosed <i>Tribolium castaneum</i> enzyme (Tc-ICMT),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> the only eukaryotic ICMT described up to date (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">Supporting Information Figure S2</a>). Analysis of the complexes between the Ma-ICMT derived h-ICMT with <i>N</i>-acetyl-<i>S</i>-farnesyl-<span class="smallcaps smallerCapital">l</span>-cysteine (AFC), the minimal structural element recognized by ICMT (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">Supporting Information Figure S1, panel B</a>), or with the inhibitor cysmethynil (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">Supporting Information Figure S1, panel C</a>) showed the possibility of adding, in compound <b>1</b>, a hydrophobic tail to expand toward the membrane through the substrate tunnel, similar to the farnesyl moiety of AFC or the octyl chain of cysmethynil. An analogous situation was observed in the models of the h-ICMT derived from Tc-ICMT in complex with cysmethynil (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B) or with AFC (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C), a fact that prompted us to design and synthesize derivative <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). Remarkably, this compound displayed an enhanced capacity to inhibit ICMT activity (55% inhibition at 50 μM).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Tc-ICMT-derived homology models of h-ICMT in complex with compounds <b>2</b> and <b>3</b>. (A) Compound <b>2</b> (in orange) positions the octyl chain toward the membrane in a similar manner as the hydrophobic tail of cysmethynil and AFC. <i>S</i>-Adenosylmethionine (SAM) cofactor is shown in cyan. (B) Extracellular view of the homology model of the h-ICMT in complex with compound <b>3</b> (orange) and SAM (cyan). Tc ICMT PDB code is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V7P">5V7P</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A closer look at the interaction model between compound <b>2</b> and the protein (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A) highlighted the presence of a cluster of aromatic amino acids in the binding site formed by Trp216 of TM7 and Phe243 and Phe244 of TM8. Hence, it would be conceivable that the replacement of the methyl and cyclohexyl substituents of compound <b>2</b> by phenyl rings, able to establish π–π stacking interactions, allowed for an improvement of affinity toward the protein. Consequently, we designed compound <b>3</b>, which fitted perfectly in the model (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). One phenyl ring can fill the pocket formed by Arg174 of TM6, Tyr213 and Trp216 of TM7 and Phe243 and Phe244 of TM8. The amide group is hydrogen bonding Arg247 of TM8, and the octyl chain of the ligand fills the lipid site. The other phenyl group is placed between the TM5-TM8 crevice, while the adjacent amide group is able to establish a hydrogen bond with Ser129 on the top of TM5 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). It is worthy to mention that the h-ICMT model based on the Tc-ICMT structure, as well as all the mutagenesis data published to date, confirms the conserved interactions of ICMT ligands with Arg247 below the cofactor binding site. Hence, compound <b>3</b> was synthesized and tested for ICMT activity, showing, to our delight, an excellent 93% enzyme activity inhibition at 50 μM and an IC<sub>50</sub> value of 2 μM (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">Supporting Information Figure S3</a> for a representative dose–response curve).</div><div class="NLM_p">The importance of the structural elements suggested by the model was confirmed with the synthesis of several sets of compounds. In this regard, we verified that replacement of one or the two phenyl rings by nonaromatic moieties (compounds <b>4</b>–<b>10</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) led to a decrease in activity (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Also, we validated the importance of the <i>n</i>-octyl chain because its substitution by shorter or oxygen-containing chains (compounds <b>11</b>–<b>16</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) dramatically diminishes activity when compared to the 93% inhibition of compound <b>3</b>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Synthesized compounds <b>3</b>–<b>34</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of ICMT Activity of Synthesized Compounds <b>5</b>–<b>10</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0010.gif" alt="" id="GRAPHIC-d7e706-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0011.gif" alt="" id="gr4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The values are the mean ± standard error of the mean (SEM) from two to three independent experiments performed in triplicate. ICMT inhibition values were determined at 50 μM.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values for ICMT inhibition are shown in parentheses. Data correspond to the mean ± SEM from two independent experiments carried out in duplicate.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Compounds inhibiting less than 10% of the ICMT activity at 50 μM were considered inactive.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of ICMT Activity of Synthesized Compounds <b>11</b>–<b>16</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0012.gif" alt="" id="GRAPHIC-d7e738-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0013.gif" alt="" id="gr5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The values are the mean ± SEM from two to three independent experiments performed in triplicate. ICMT inhibition values were determined at 50 μM.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Compounds inhibiting less than 10% of the ICMT activity at 50 μM were considered inactive.</p></div></div><div></div></div><div class="NLM_p">In addition, the adequate distance between the two carbonyl groups was confirmed with the synthesis of derivatives <b>17</b> and <b>18</b>, which also showed a decrease in activity (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The exploration of different hydrogen acceptor groups such as <i>N</i>-methylamides and sulfonamides (compounds <b>19</b>–<b>24</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) did not yield any enhancement in activity. Finally, we also studied whether the inhibitory capacity of the compound could be improved by the introduction of different substituents in the phenyl ring (compounds <b>25</b>–<b>34</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The obtained results suggest that only the introduction of small substituents in the <i>para</i> position keeps the ability to inhibit ICMT (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), the <i>p</i>-fluoro derivative <b>27</b> with 84% inhibition at 50 μM and an IC<sub>50</sub> value of 3 μM being the best inhibitor within this series. Although none of the synthesized analogs were able to improve the activity of inhibitor <b>3</b>, compounds <b>5</b> and <b>27</b> showed comparable values to derivative <b>3</b> in terms of ICMT inhibitory potency (maximal inhibition values between 82% and 93% at 50 μM). Accordingly, they were evaluated for their IC<sub>50</sub> value at ICMT, for in vitro cellular activity, and for their ADME profile (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Taken together, these data showed that compound <b>3</b> not only exhibited the best value in terms of ICMT inhibition (93% of maximal activity and IC<sub>50</sub> value of 2 μM vs 82% of maximal activity and 12 μM of compound <b>5</b> and 84% and 3 μM of compound <b>27</b>) but also the lowest clogP (4.1 for compound <b>3</b> vs 5.1 and 4.5 for derivatives <b>5</b> and <b>27</b>, respectively) and the highest cellular activity (IC<sub>50</sub> value of 5 μM for compound <b>3</b>, whereas the IC<sub>50</sub> values for compounds <b>5</b> and <b>27</b> were 29.1 and 13.7 μM, respectively). These results, together with the higher permeability (68% for compound <b>3</b> vs 50% and 54% for compounds <b>5</b> and <b>27</b>, respectively), stability in mouse serum (171 min for compound <b>3</b> compared to 118 and 55 min for compounds <b>5</b> and <b>27</b>, respectively) and in human serum (>24 h), and the slightly lower human serum albumin (HSA) binding, prompted us to select compound <b>3</b> for an in-depth cellular and in vivo characterization aimed at validating ICMT as a target of interest for Ras inhibition. Toward this objective we sought to confirm that the inhibition of ICMT by compound <b>3</b> (i) delocalizes Ras from the membrane, (ii) inactivates Ras and its downstream signaling pathways, (iii) induces cell death in Ras-dependent tumor cell lines, and (iv) has in vivo efficacy in Ras-dependent tumors.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibition of ICMT Activity of Synthesized Compounds <b>17</b>–<b>24</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0014.gif" alt="" id="GRAPHIC-d7e907-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The values are the mean ± SEM from two to three independent experiments performed in triplicate. ICMT inhibition values were determined at 50 μM.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibition of ICMT Activity of Synthesized Compounds <b>25</b>–<b>34</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0015.gif" alt="" id="GRAPHIC-d7e925-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">ICMT inhibition (%)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">ICMT inhibition (%)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left"><i>o</i>-F</td><td class="colsep0 rowsep0" align="left">23 ± 5</td><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">63 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-F</td><td class="colsep0 rowsep0" align="left">23 ± 4</td><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-NHCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">40 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-F</td><td class="colsep0 rowsep0" align="left">84 ± 7 (3 ± 1)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-CN</td><td class="colsep0 rowsep0" align="left">68 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left"><i>o</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">30 ± 6</td><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">53 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">35 ± 4</td><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-CON(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">47 ± 5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The values are the mean ± SEM from two to three independent experiments performed in triplicate. ICMT inhibition values were determined at 50 μM.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values for ICMT inhibition are shown between parentheses. Data correspond to the mean ± SEM from two independent experiments carried out in duplicate.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Selected Data for Compounds <b>3</b>, <b>5</b>, and <b>27</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">ICMT inhibition (%)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">clogP<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">cellular cytotoxicity (IC<sub>50</sub>, μM)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">permeability (%)<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">mouse serum <i>t</i><sub>1/2</sub>(min)<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">human serum <i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">HSA binding<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a><i>F</i><sub>b</sub> (<i>K</i><sub>d</sub>, μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">93 ± 4 (2 ± 1)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="left">5.0 ± 0.7</td><td class="colsep0 rowsep0" align="left">68 ± 9</td><td class="colsep0 rowsep0" align="left">171 ± 23</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">95.4 (28)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">82 ± 3 (12 ± 3)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">29.1 ± 0.6</td><td class="colsep0 rowsep0" align="left">50 ± 3</td><td class="colsep0 rowsep0" align="left">118 ± 17</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">99.5 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">84 ± 7 (3 ± 1)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">13.7 ± 0.1</td><td class="colsep0 rowsep0" align="left">54 ± 13</td><td class="colsep0 rowsep0" align="left">55 ± 24</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">98.7 (7.8)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">The values are the mean ± SEM from two to three independent experiments performed in triplicate. ICMT inhibition values were determined at 50 μM.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values for ICMT inhibition are shown in parentheses. Data correspond to the mean ± SEM from two independent experiments carried out in duplicate.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">clogP values were calculated with ACDLabs Percepta Software (ACDlogP classic algorithm, version 2018.1.1).</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Cellular viability was determined in MDA-MB-231 cells by the MTT assay. In all cases, the percentage of viable cells after treatment with 50 μM of the compound compared to vehicle was less than 5%. Data for IC<sub>50</sub> values correspond to the mean ± SEM from at least two independent experiments carried out in duplicate.</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">Permeability is expressed as the percentage of the compound that passes through a parallel artificial membrane. Data correspond to the mean ± SEM from at least two independent experiments carried out in duplicate.</p></div><div class="footnote" id="t5fn6"><sup><sup>f</sup></sup><p class="last">Data correspond to the mean ± SEM from two or three independent experiments carried out in duplicate.</p></div><div class="footnote" id="t5fn7"><sup><sup>g</sup></sup><p class="last">Binding to human serum albumin (HSA) is expressed as the bound fraction (<i>F</i><sub>b</sub>). Dissociation constants (<i>K</i><sub>d</sub>) are given between parentheses. Data represent the means from two independent experiments performed in duplicate. SEM is in all cases within 10% of the mean value.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compound <b>3</b> Induces Mislocalization of Endogenous Ras, Decreases Ras Activation, and Induces Cell Death by Autophagy and Apoptosis</h3><div class="NLM_p">First, we checked the ability of compound <b>3</b> to produce mislocalization of endogenous Ras in PC-3 cells, which were chosen because they have high levels of ICMT and they have been described to be cysmethynil-sensitive,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> although the direct effect of ICMT inhibition in endogenous Ras has not been ever studied. Remarkably, treatment of PC-3 cells with 5 μM compound <b>3</b> induced significant Ras mislocalization (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The observed effects were dose-dependent (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">Supporting Information Figure S4</a>) and higher than the ones induced by the same concentration of cysmethynil (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">Supporting Information Figure S4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>3</b> (5 μM) induces Ras mislocalization from the cellular membrane (left image, white arrows) to intracellular locations in PC-3 cells to higher extent than cysmethynil (Cysm) at the same concentration. Immunofluorescence images show Ras in green stained using an anti-Ras primary antibody followed by the appropriate secondary FITC-labeled antibody. Nuclei (in blue) were stained with Hoechst 33258. Images were obtained in a Leica confocal microscope under the same conditions and are representative of three to five independent experiments. Bars, 30 μm. The bar graphs represent the optical density of the membrane Ras signal quantified with ImageJ. White bar, DMSO; gray bar, compound <b>3</b> (5 μM); black bar, cysmethynil (Cysm, 5 μM). Data correspond to the average ± SEM of three independent experiments and have been analyzed with GraphPad Prism 5. ns, not significant; ∗∗, <i>P</i> < 0.01 vs DMSO (one-way ANOVA followed by the Dunnett’s multiple comparison test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Importantly, Ras mislocalization paralleled substantial decreases in active Ras (GTP-bound complex) and in the activity of its downstream MEK/ERK and PI3K/AKT signaling pathways (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). These effects led finally to cellular death by autophagy, as indicated by the increase of the levels of microtubule-associated protein 1A/1B light chain 3 (LC3), and apoptosis, as shown by the caspase-mediated cleavage of poly(ADP-ribose) polymerase (PARP) that leads to the appearance of the specific 89 kDa fragment and by the increase in the caspase 3 activity (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Again, compound <b>3</b> induced superior effects compared with cysmethynil even when used at a lower concentration (10 μM and 25 μM, respectively, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>3</b> significantly reduces the Ras-GTP (active form) levels and its downstream MEK/ERK and PI3K/AKT signaling pathways. (A) Ras-GTP complex from PC-3 cells treated with DMSO, cysmethynil (CYSM, 25 μM), or compound <b>3</b> (10 μM) were immunoprecipitated and visualized by Western blot. The bar graph shows the ratio Ras-GTP/total Ras, expressed as percentage relative to DMSO. (B) Representative Western blots of phosphorylated MEK1/2 (pMEK1/2), ERK1/2 (p-ERK1/2), and AKT (p-AKT) and the corresponding total kinases (T-MEK1/2, T-ERK1/2, and T-AKT). Lysates were obtained from PC-3 cells treated with DMSO, cysmethynil (CYSM, 25 μM), or compound <b>3</b> (10 μM). The bar graphs represent the optical density of the immunoreactive phosphorylated protein normalized to the total corresponding protein and expressed as the percentage relative to DMSO. White bars, DMSO; gray bars, cysmethynil (CYSM, 25 μM); black bars, compound <b>3</b> (10 μM). Data correspond to the average ± SEM of three to five independent experiments. ns, not significant; ∗, <i>P</i> < 0.05; ∗∗, <i>P</i> < 0.01 vs DMSO (Student’s <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>3</b> induces autophagy and apoptosis in PC-3 cells. Cells treated with DMSO, cysmethynil (CYSM, 25 μM), or compound <b>3</b> (10 μM) were lysed and stained for (A) LC-3 expression, (B) PARP levels, and (C) caspase 3 activity. Images are representative of at least three independent experiments, and data in (C) correspond to the average ± SEM of three independent experiments. ∗∗∗, <i>P</i> < 0.001 vs DMSO (Student’s <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Compound <b>3</b> Induces Mislocalization of the Four Ras Isoforms</h3><div class="NLM_p">The four Ras isoforms (H-Ras, K-Ras4A and -4B, and N-Ras) contribute in different extent to different tumors.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> For instance, K-Ras is the most frequently mutated isoform in the majority of cancers, with 90% of pancreatic or 35% of colon tumors harboring K-Ras mutations. Instead, N-Ras mutations have a higher presence in melanoma and hematopoietic tumors.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> Then, it is essential to assess whether a compound affects all the Ras isoforms. Notably, compound <b>3</b> induces the mislocalization of the four Ras isoforms (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), as shown when AD-293 cells were transfected with H-, N-, and K-Ras4A and -4B isoforms. These effects are especially significant in the case of H-Ras (most common isoform in cervix and urinary tract tumors) and K-Ras4A (necessary for lung tumor initiation),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> where compound <b>3</b> is clearly more efficacious than the same concentration of cysmethynil.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>3</b> impairs plasma localization of the four Ras isoforms. Confocal images of live AD-293 cells that had been transiently transfected with H-Ras, K-Ras4A, K-Ras4B, and N-Ras GFP fusion plasmids and treated overnight with vehicle (DMSO), cysmethynil (CYSM, 5 μM), or compound <b>3</b> (5 μM). Live cells were imaged with an inverted Zeiss LSM 510 Meta laser scanning confocal microscope. Similar results were obtained with three independent transfections performed in triplicate. Bars, 10 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to corroborate that the observed mislocalization of the Ras isoforms is caused by ICMT inhibition and not by other nonspecific mechanisms, we corrobated that Fyn, a protein which belongs to the Src family of tyrosine protein kinases that is located at the plasma membrane after myristoylation and palmitoylation processes, but which is not a substrate of ICMT, is not affected by compound <b>3</b> or cysmethynil (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">Supporting Information Figure S5</a>). We also confirmed that compound <b>3</b> did not affect geranylgeranylated proteins because AAX removal and subsequent methylation by ICMT take place only for formerly farnesylated Ras. The differential substrate recognition of FTase against GGTase I is dictated by the amino acid situated in the X position of the CAAX tetrapeptide: S and M define farnesylation, whereas L indicates geranylgeranylation.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Using a K-Ras4B protein tagged with GFP which contains a point mutation in the CAAX motif designed to replace farnesylation by geranylgeranylation, we determined the influence of compound <b>3</b>. Consistent with an ICMT-dependent effect, geranylgeranylated K-Ras4B (K-Ras4B-CVIL-GFP) was located in the plasma membrane with an identical pattern in the presence or in the absence of derivative <b>3</b>, while farnesylated K-Ras4B-GFP was mislocalized to the cytosol after the incubation with compound <b>3</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">Supporting Information Figure S6</a>). To further verify the specificity of the compound’s mechanism of action, we tested its effects on cells where ICMT expression has been blocked with a specific small interfering RNA as well as on the enzymes involved in the prenylation pathway (FTase, GGTase, and Rce1). Our results show that when ICMT expression is blocked with a specific small interfering RNA, compound <b>3</b> does not induce significant cytotoxicity, suggesting that the effects observed are mainly due to ICMT inhibition (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A). Moreover, this compound does not inhibit in a noticeable manner FTase, GGTase, or Rce1 enzymes, as supported by the fact that specific substrates of these enzymes remain unaffected in the presence of compound <b>3</b>. For example, protein HDJ2 is specifically farnesylated by FTase.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Accordingly, lonafarnib, a selective FTase inhibitor, impairs its farnesylation as revealed by the appearance of a nonfarnesylated HDJ2 band in the immunoblot (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B). Conversely, neither compound <b>3</b> nor a specific GGTase inhibitor (compound GGTI298) affects HDJ2 processing. In the case of Rap1A, a specific substrate of GGTase,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> neither compound <b>3</b> nor lonafarnib has any influence in the geranylgeranylation of this protein whereas the specific GGTase inhibitor GGTI298 clearly inhibits its prenylation, as indicated by the appearance of the corresponding upper band (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B). Similarly, compound <b>3</b> does not affect the hydrolysis by Rce1 of the specific peptide substrate KSKTKC(farnesyl)VI<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">Supporting Information Figure S7</a>).</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>3</b> does not induce cytotoxicity in ICMT-depleted cells nor inhibits FTase or GGTase enzymes. (A) Effect of siRNA-induced silencing of ICMT gene expression on cytotoxicity induced by compound <b>3</b>. Cytotoxicity of compound <b>3</b> at different concentrations is eliminated by siRNA-induced reduction of ICMT expression levels. PC-3 cells were transfected with siRNA-targeting ICMT for 72 h. Equal amounts of total protein from PC-3 cells transfected with siRNA-targeting ICMT or with the control were subjected to immunoblotting analyses with antibodies against ICMT or GADPH as loading control. Results shown in the lower panel are the average ± SEM of three different experiments. Shown gel is representative of those obtained in three independent experiments. ns, not significant; ∗∗∗, <i>p</i> < 0.001 (Student’s <i>t</i> test) vs ICMT expression in siRNA control-transfected cells. (B) Effect of compound <b>3</b> on the prenylation state of HDJ2 and Rap1A proteins. PC-3 cells were treated with vehicle, compound <b>3</b>, GGTase inhibitor GGTI298 (10 μM), or lonafarnib (1 μM), lysed and immunoblotted with antibodies against HDJ2, Rap1A or GADPH (used as loading control). Images are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Compound <b>3</b> Induces Cell Death in a Variety of Ras-Mutated Tumor Cell Lines</h3><div class="NLM_p">Taken together, all these data suggest that compound <b>3</b> should be able to significantly impair cell proliferation in Ras-mutated tumor cells of different origins and with distinct Ras mutations. To assess this, we have selected a panel of cells bearing the most frequently mutated Ras isoform in the majority of cancers (K-Ras) with the most abundant point mutations (G12C, G12D, G12V, and G13D) and two cell lines with mutated N-Ras, the most important isoform in acute myeloid leukemia (AML) and in melanoma.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The obtained data (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>)<named-content content-type="anchor" rid="fig8" type="simple"></named-content><named-content content-type="anchor" rid="fig9" type="simple"></named-content> show that compound <b>3</b> significantly reduces cell proliferation in all tested Ras mutant cell lines with IC<sub>50</sub> values in the low micromolar range and selectivity against nontumor fibroblasts. Although these results are consistent with a Ras-dependent cytotoxicity mediated by ICMT inhibition, the existence of genetic alterations and differences between cell lines can influence sensitivity to ICMT inhibitors, and of course only a careful delineation of all the oncogenic signaling pathways together with data on ICMT expression and activity will enable the complete understanding of the ICMT contribution to cancer.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Cytotoxicity of Compound <b>3</b> in a Panel of Ras-Mutated Cancer Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell</th><th class="colsep0 rowsep0" align="center">tissue origin</th><th class="colsep0 rowsep0" align="center">Ras isoform and status</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PANC-1</td><td class="colsep0 rowsep0" align="left">pancreas</td><td class="colsep0 rowsep0" align="left">K-Ras (G12D)</td><td class="colsep0 rowsep0" align="left">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MIA PaCa-2</td><td class="colsep0 rowsep0" align="left">pancreas</td><td class="colsep0 rowsep0" align="left">K-Ras (G12C)</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDA-MB-231</td><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">K-Ras (G13D)</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SW620</td><td class="colsep0 rowsep0" align="left">colon</td><td class="colsep0 rowsep0" align="left">K-Ras (G12V)</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SK-Mel-173</td><td class="colsep0 rowsep0" align="left">melanoma</td><td class="colsep0 rowsep0" align="left">N-Ras (Q61K)</td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HL60</td><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="left">N-Ras (Q61K)</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NIH3T3</td><td class="colsep0 rowsep0" align="left">fibroblast</td><td class="colsep0 rowsep0" align="left">nontumor</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">142BR</td><td class="colsep0 rowsep0" align="left">fibroblast</td><td class="colsep0 rowsep0" align="left">nontumor</td><td class="colsep0 rowsep0" align="left">>50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Cytotoxicity was evaluated by the MTT or the XTT assay. IC<sub>50</sub> values are the mean from two to three independent experiments performed in triplicate. In all cases, the SEM is within 10% of the mean value.</p></div></div></div><div class="NLM_p last">The dose–response analysis showed that compound <b>3</b> promoted cell death at 10 μM after 24 h treatment in MIA PaCa-2 and HuP-T4 as well as at 20 μM in the rather resistant PANC-1, PK9, and Capan-2 cell lines whereas a concentration of 50 μM was required to induce cell death with cysmethynil. Furthermore, pancreatic cancer Capan-2 cells were even resistant to this concentration of cysmethynil (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">Supporting Information Figure S8</a>). The analysis of the sub-G<sub>0</sub>/G<sub>1</sub> region of cell cycle confirmed that compound <b>3</b> induced an apoptosis-like cell death (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">Supporting Information Figure S9</a>).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Antitumor Effect of Compound <b>3</b></h3><div class="NLM_p">Finally, to evaluate the potential of the ICMT inhibitor in an in vivo setting, we performed a xenograft mice model by transplanting HL-60 N-Ras mutated AML cells into NSG mice. An initial pharmacokinetic profile was carried out in mice prior to the in vivo efficacy testing. In vitro, the compound showed a half-life in mouse serum of around 3 h and in human serum of more than 24 h. For in vivo pharmacokinetic studies, mice received a single intraperitoneal injection of 25 mg/kg of compound <b>3</b> and the plasma concentration of the compound was measured at different time points (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">Supporting Information Figure S10</a>). At this dose, concentration of compound reached a maximal concentration in serum of 1700 nM 1 h postinjection and remained around 480 nM up to 6 h postinjection, so we considered these values as satisfactory to allow the in vivo use of the compound using these conditions. Treatment of mice with compound <b>3</b> (25 mg/kg, intraperitoneally) for 15 days (3 cycles of 5 days of treatment followed by 2 days of rest) increased mice survival (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A, <i>p</i> = 0.0274) and reduced the tumor burden in the bone marrow compared with vehicle (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B,C). Before sacrifice, the serum levels of compound <b>3</b> were measured the last day of the treatment (2 h postinjection) and turned out to be 736 nM, in full consistency with the pharmacokinetic curve. These results demonstrate the in vivo efficacy of compound <b>3</b> against Ras-dependent malignancies.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0009.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Antitumor effect of compound <b>3</b> in the Ras-driven model of acute myeloid leukemia. (A) Kaplan–Meier curves indicating survival of HL-60 transplanted NSG mice treated with vehicle (<i>n</i> = 5) or with compound <b>3</b> (<i>n</i> = 9). Statistical significance was determined by the log rank test (<i>p</i> = 0.0274; HR, 6.211; 95% CI or ratio 1.225 to 31.48). Hematoxylin and eosin (H&E) and human HL-60 staining (hCD45) of paraffin-embedded bone marrow (BM) sections from wild-type HL-60 transplanted NSG mice treated with (B) vehicle or (C) compound <b>3</b>. Scale bar represents 125 μm (left images) and 50 μm (right images).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87511" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87511" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this work we describe a new potent ICMT inhibitor, compound <b>3</b>,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> that produces the mislocalization of the four Ras isoforms blocking their activation and their oncogenic signaling, leading to significant cell death in a broad panel of cell lines bearing mutated Ras and to an increased survival in the Ras-dependent cancer model of acute myeloid leukemia. These results provide strong support to the hypothesis that inhibition of the post-translational modification of Ras can be clinically relevant in Ras-driven cancers.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50412" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50412" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Compound Synthesis</h3><div class="NLM_p">Unless stated otherwise, starting materials, reagents, and solvents were purchased as high-grade commercial products from Abcr, Acros, Fluorochem, Scharlab, Sigma-Aldrich, Honeywell, Thermo Fisher Scientific and were used without further purification. Tetrahydrofuran (THF) and dichloromethane (DCM) were dried using a Pure Solv Micro 100 Liter solvent purification system. Triethylamine and pyridine were dried over KOH and distilled over CaH<sub>2</sub> before using.</div><div class="NLM_p">Reactions were monitored by analytical thin-layer chromatography (TLC) on plates supplied by Merck silica gel plates (Kieselgel 60 F-254) with detection by UV light (254 nm), ninhydrin solution, or 10% phosphomolybdic acid solution in EtOH. Flash chromatography was performed on a Varian 971-FP flash purification system using silica gel cartridges (Varian, particle size 50 μm). Melting points (mp) are uncorrected and were determined on a Stuart Scientific electrothermal apparatus. Infrared (IR) spectra were measured on a Bruker Tensor 27 instrument equipped with an attenuated total reflectance (ATR) Specac accessory with diamond crystal and a transmission range of 5200–650 cm<sup>–1</sup>; frequencies (υ) are expressed in cm<sup>–1</sup>. NMR spectra were recorded on a Bruker Avance 300-AM (<sup>1</sup>H, 300 MHz; <sup>13</sup>C, 75 MHz) at the NMR facilities of the Universidad Complutense of Madrid (UCM). Chemical shifts (δ) are expressed in parts per million relative to internal tetramethylsilane; coupling constants (<i>J</i>) are in hertz (Hz). The following abbreviations are used to describe peak patterns when appropriate: s (singlet), d (doublet), t (triplet), qt (quintet), m (multiplet), app (apparent), br (broad). NMR experiments (homonuclear correlation spectroscopy (H,H COSY), heteronuclear multiple quantum correlation (HMQC), and heteronuclear multiple bond correlation (HMBC)) of representative compounds were acquired to assign protons and carbons of new structures. High resolution mass spectrometry (HRMS) was carried out on a FTMS Bruker APEX Q IV spectrometer in electrospray ionization (ESI) mode at the UCM’s facilities. HPLC–MS analysis was performed using an Agilent 1200LC-MSD VL. LC separation was achieved with an Eclipse XDB-C18 column (5 μm, 4.6 mm × 150 mm) together with a guard column (5 μm, 4.6 mm × 12.5 mm). The gradient mobile phases consisted of A (95:5 water/methanol) and B (5:95 water/methanol) with 0.1% ammonium hydroxide and 0.1% formic acid as the solvent modifiers. MS analysis was performed with an ESI source. The capillary voltage was set to 3.0 kV, and the fragmentor voltage was set at 70 eV. The drying gas temperature was 350 °C, the drying gas flow was 10 L/min, and the nebulizer pressure was 20 psi. Spectra were acquired in positive and negative ionization mode from 100 to 1000 <i>m</i>/<i>z</i> and in UV-mode at four different wavelengths (210, 230, 254, and 280 nm).</div><div class="NLM_p last">Spectroscopic data of all described compounds were consistent with the proposed structures. Satisfactory chromatograms were obtained for all tested compounds, which confirmed a purity of at least 95%. The synthesis and structural characterization of derivative <b>3</b> are detailed below. Full details regarding the synthetic procedures and characterization data of all compounds are given in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis of <i>N</i><sup>3</sup>-(3-Anilino-3-oxopropyl)-<i>N</i><sup>3</sup>-octyl-<i>N</i><sup><i>1</i></sup>-phenyl-β-alaninamide (<b>3</b>)</h3><div class="NLM_p last">To a solution of <i>N</i>-phenylacrylamide (500 mg, 3.4 mmol) and octylamine (182 μL, 1.1 mmol) in dry acetonitrile (1 mL/mmol of amine), DBU (508 μL, 3.4 mmol) was added at rt and under an argon atmosphere. The reaction mixture was stirred at reflux for 16 h. The solvent was evaporated under reduced pressure and the residue was purified by column chromatography (hexane/EtOAc, 1:1) to yield compound <b>3</b> as an oil (387 mg) in 83% yield. <i>R</i><sub><i>f</i></sub> (EtOAc/MeOH, 9:1): 0.42. IR (ATR, ν): 3294 (NH), 1659, 1546 (CON), 1601, 1497 cm<sup>–1</sup> (Ar). <sup>1</sup>H NMR (CDCl<sub>3</sub>, δ): 0.85 (t, <i>J</i> = 6.7 Hz, 3H, CH<sub>3</sub>), 1.19–1.25 (m, 10H, (C<u class="uu">H</u><sub>2</sub>)<sub>5</sub>CH<sub>3</sub>), 1.53 (m, 2H, C<u class="uu">H</u><sub>2</sub>(CH<sub>2</sub>)<sub>5</sub>CH<sub>3</sub>), 2.53 (t, <i>J</i> = 6.3 Hz, 6H, 2CH<sub>2</sub>CO, (CH<sub>2</sub>)<sub>6</sub>C<u class="uu">H</u><sub>2</sub>N), 2.86 (t, <i>J</i> = 6.2 Hz, 4H, 2COCH<sub>2</sub>C<u class="uu">H</u><sub>2</sub>N), 7.03 (t, <i>J</i> = 7.3 Hz, 2H, 2H<sub>4</sub>), 7.20 (t, <i>J</i> = 7.8 Hz, 4H, 2H<sub>3</sub>, 2H<sub>5</sub>), 7.43 (d, <i>J</i> = 7.8 Hz, 4H, 2H<sub>2</sub>, 2H<sub>6</sub>), 8.91 ppm (br s, 2H, 2NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>, δ): 14.2 (CH<sub>3</sub>), 22.7, 26.9, 27.8, 29.4, 29.6, 31.9 ((<u class="uu">C</u>H<sub>2</sub>)<sub>6</sub>CH<sub>3</sub>), 34.6 (2<u class="uu">C</u>H<sub>2</sub>CO), 50.0 (2CH<sub>2</sub>N), 53.8 ((CH<sub>2</sub>)<sub>6</sub>C<u class="uu">H</u><sub>2</sub>N), 120.0 (2C<sub>2</sub>, 2C<sub>6</sub>), 124.1 (2C<sub>4</sub>), 129.0 (2C<sub>3</sub>, 2C<sub>5</sub>), 138.2 (2C<sub>1</sub>), 170.6 ppm (2CO). MS (ESI): 424.3 [(M + H)<sup>+</sup>]. HPLC-MS, <i>t</i><sub>r</sub> (min): 18.55. HRMS (ESI): calcd for C<sub>26</sub>H<sub>38</sub>N<sub>3</sub>O<sub>2</sub> [(M + H)<sup>+</sup>], 424.2958; found, 424.2958.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Determination of ICMT Activity</h3><div class="NLM_p last">Synthesized compounds were tested for their ability to inhibit human ICMT activity using Sf9 membranes containing the recombinantly expressed enzyme. In this assay, a mixture of biotin-farnesyl-<span class="smallcaps smallerCapital">l</span>-cysteine and tritiated S-adenosylmethionine in the presence or absence of the compound under study was prepared and the reaction was initiated by the addition of the Sf9 membrane homogenates. The inhibitory capacity of the compounds is expressed as percentage of inhibition of the methyl esterification step, in which the tritiated methyl group of the methyl donor <i>S</i>-adenosylmethionine is transferred to the substrate biotin-farnesyl-<span class="smallcaps smallerCapital">l</span>-cysteine as described previously<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and the radioactivity incorporated is quantified.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Cell Lines and Culture</h3><div class="NLM_p last">MDA-MB-231, MIA PaCa-2, PANC-1, SW620, Capan-2, and NIH3T3 cells from American Type Culture Collection (ATCC, Rockville, MD) and SK-Mel-173 from Memorial Sloan-Kettering Cancer Center (New York, USA) were grown in Dulbecco’s modified Eagle medium (DMEM, Invitrogen) supplemented with 10% heat-inactivated fetal bovine serum (FBS, HyClone), 1% <span class="smallcaps smallerCapital">l</span>-glutamine (Invitrogen), 1% sodium pyruvate (Invitrogen), 50 U/mL penicillin, and 50 μg/mL streptomycin (Invitrogen). Human fibroblasts 142BR were from Sigma and were cultured as indicated by the vendor. Human prostate cancer PC3 cells, obtained from ATCC, and human pancreatic PK-9 cells, kindly provided by Dr. Aimable Nahimana (Lausanne, Switzerland), were maintained in Roswell Park Memorial Institute medium (RPMI) supplemented with 10% heat-inactivated FBS, 1% <span class="smallcaps smallerCapital">l</span>-glutamine, 1% sodium pyruvate, 50 U/mL penicillin, and 50 μg/mL streptomycin. Cells were incubated at 37 °C in the presence of 5% of CO<sub>2</sub>. The epithelial human pancreatic adenocarcinoma cell line HuP-T4 was obtained from the European Collection of Cell Cultures (ECACC, U.K.) and were grown in minimum essential medium Eagle’s supplemented with 10% (v/v) FBS, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 1 mM sodium pyruvate, 1% nonessential amino acids (GIBCO-BRL), and antibiotics.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Cell Growth Inhibition Assay</h3><div class="NLM_p">The effect of the different compounds on the proliferation of human tumor cell lines (cytostatic activity) was determined through standard MTT or XTT assays.<a onclick="showRef(event, 'ref3 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref3 ref38 ref39">(3,38,39)</a> For MTT assay, cells were seeded in 96-well plates at a density of 5 or 10 × 10<sup>3</sup> cells per well in the corresponding medium with 10% FBS for 24 h prior to treatments. The medium was then replaced by fresh medium containing different concentrations of compounds tested or by medium containing the equivalent volume of dimethylsulfoxide (DMSO, vehicle control). Cells were treated for 48 h, and then medium was replaced by fresh medium with 2 mg/mL of MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide], Sigma-Aldrich) and cells were incubated for 4 h at 37 °C in the dark. Once supernatants were removed, formazan crystals previously formed by viable cells were dissolved in DMSO (100 μL/well) and absorbance was measured at 570 nm (OD 570-630) using an Asys UVM 340 (Biochrom Ltd., Cambridge, U.K.) microplate reader. Background absorbance from blank wells containing only media with compound or vehicle was subtracted from each test well. Results were reported as IC<sub>50</sub> ± SEM from three independent experiments.</div><div class="NLM_p last">XTT assay was carried out using the XTT (sodium 3′-[1-(phenylaminocarbonyl)-3,4-tetrazolium]bis(4-methoxy-6-nitro)benzenesulfonic acid hydrate) cell proliferation kit (Roche Molecular Biochemicals, Mannheim, Germany) according to the manufacturer’s instructions. Cells (0.9 × 10<sup>3</sup> MIA PaCa-2, 3 × 10<sup>3</sup> SW620, and 4 × 10<sub>3</sub> PANC-1 and MDA-MB-231 cells in 100 μL) were incubated in culture medium containing 10% heat-inactivated FBS in the absence and in the presence of compound <b>3</b> at different concentration ranges in 96-well flat-bottomed microtiter plates, and following 72 h of incubation at 37 °C in a humidified atmosphere of air/CO<sub>2</sub> (19/1), the XTT assay was performed. Measurements were performed in triplicate, and each experiment was repeated three times. The IC<sub>50</sub> (50% inhibitory concentration) value, defined as the drug concentration required to cause 50% inhibition in cellular proliferation with respect to the untreated controls, was determined. Nonlinear curves fitting the experimental data were carried out in each case.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Apoptosis Assay</h3><div class="NLM_p last">Quantitation of apoptotic cells was determined by flow cytometry as the percentage of cells in the sub-G<sub>0</sub>/G<sub>1</sub> region (hypodiploidy) in cell-cycle analysis as previously described.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Immunoblot Analysis</h3><div class="NLM_p last">Western blot analysis was carried out as described previously.<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42−44)</a> Briefly, PC3 cells were plated at a density of 2 × 10<sup>6</sup> cells in 15 cm dishes and allowed to grow overnight in RPMI medium with 10% FBS. The medium was then replaced by fresh medium containing 10 μM compound or 0.1% DMSO for vehicle control. Cells were incubated in the presence of the compounds for 24 and 1 h; before the lysis they were stimulated with FBS. Cells were washed with PBS and lysed with ice-cold RIPA buffer (50 mM Tris-HCl at pH 7.4, 150 mM NaCl, 1% Igepal) containing protease inhibitors (Roche) and phosphatase inhibitors (phosphatase inhibitor cocktail 2 and 3, Sigma-Aldrich). Lysates were clarified by centrifugation at 10 000<i>g</i> for 10 min at 4 °C and used straightaway or stored at −80 °C. Protein concentration was measured (DC protein assay kit, Bio-Rad), and samples with equal amounts of total protein were diluted into a Laemmli reducing sample buffer (Bio-Rad) and denatured at 95 °C for 5 min. Samples were then resolved on 4–20% SDS–PAGE gels (Bio-Rad) and proteins transferred to nitrocellulose membranes (GE Healthcare, Amersham). After 1 h of incubation in a blocking buffer (10 mM Tris-HCl at pH 8.0, 150 mM NaCl, 0.05% Tween-20 (TBS-T) with 1% BSA), Western immunoblotting was performed overnight at 4 °C with rabbit anti-phospho-Akt, rabbit anti-Akt, rabbit anti-phospho-ERK1/2, rabbit anti-ERK1/2, rabbit anti-phospho-MEK1/2, rabbit anti-MEK1/2, rabbit anti-α/β tubulin (1:1000, Cell Signaling), rabbit anti-ICMT (1:200, Santa Cruz) or mouse anti-Ras (1:1000, Millipore). Next day, after three 5 min washes with TBS-T, immunoblots were exposed for 1 h either to goat anti-mouse or to goat anti-rabbit IgG HRP conjugate (1:5000, Sigma-Aldrich). Protein bands were visualized using enhanced chemiluminescence detection reagents (GE Healthcare, Amersham) in a Fujifilm LAS-3000 developer (Tokyo, Japan) and quantified by densitometry using ImageJ software (NIH). Relative phosphorylation levels from three independent experiments were represented as mean ± SEM in bar graphs.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Intracellular Imaging of Ras</h3><div class="NLM_p last">PC3 cells were seeded at a density of 2 × 10<sup>4</sup> cells per well on 12 mm coverslips previously treated with poly-<span class="smallcaps smallerCapital">d</span>-lysine hydrobromide (Sigma-Aldrich) and grown for 24 h at 37 °C and 5% of CO<sub>2</sub> in RPMI medium with 10% FBS. After this time, it was replaced with fresh medium with indicated concentrations of compounds or an equivalent volume of DMSO and cells were incubated for 120 h, replacing the medium with compounds or DMSO after the first 48 h. Cells were washed twice with PBS, fixed with 4% paraformaldehyde, and permeabilized with PBS-T (PBS with 0.1% Triton X-100, Sigma-Aldrich). Incubation with primary antibody mouse anti-Ras (1:200, Thermo Scientific) in PBS with 4% normal goat serum (NGS) was performed at rt with gentle shaking for 2 h. Then cells were washed twice with PBS-T and incubated 1 h in darkness with fluorescent goat anti-mouse (1:1500, Alexa Fluor 488, Life Technologies) in PBS with 1% NGS. After this time, cells were washed again twice with PBS-T and incubated with a solution of 5 μg/mL Hoechst (Sigma-Aldrich) in PBS for 10 min at rt to visualize cell nuclei. Finally, cells were washed again thrice with PBS-T and coverslips were carefully mounted with Immumount (Thermo Scientific). Visualization was performed using an Olympus IX83 inverted confocal microscope fitted with the appropriate excitation and emission filters and a 60× oil immersion objective.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Ras-GTP Pull-Down Assay</h3><div class="NLM_p last">PC3 cells were plated at a density of 2 × 10<sup>6</sup> cells in 15 cm dishes and incubated in RPMI medium with 10% FBS at 37 °C and 5% of CO<sub>2</sub>. After 24 h, medium was replaced by fresh medium with indicated concentrations of compounds or an equivalent volume of DMSO for controls, and cells were incubated for 48 h at 37 °C and 5% of CO<sub>2</sub>. At this point, medium was replaced once again for fresh medium with compounds or DMSO, and the incubation was kept for another 72 h. For the analysis of active Ras (Ras-GTP), a glutathione <i>S</i>-transferase fusion of the Ras binding domain (RBD) of Raf1 along with glutathione (GSH) agarose resin was used (active Ras pull-down and detection kit, Thermo Scientific). After treatments, cells were washed with PBS and lysed with ice-cold lysis buffer supplied by manufacturer. Lysates were clarified by 15 min of centrifugation at 16 000<i>g</i>, and protein concentration was measured using bicinchoninic acid method (Pierce BCA protein assay kit, Thermo Scientific). Before performing the pull-down assay, an amount of 50 μL of each lysate was separated to analyze the total Ras expression. Equal amounts of protein from each condition were then used to carry out the pull-down assay, following the manufacturer’s instructions. The entire samples obtained after the pull-down assay were boiled 5 min and loaded onto 4–20% SDS–PAGE gels (Bio-Rad). Ras proteins were visualized by immunoblotting on nitrocellulose membranes using mouse anti-Ras provided by manufacturer. Blots were analyzed by densitometry using ImageJ software (NIH). Data were representative of three independent experiments ± SEM.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> RNA Interference-Mediated Silencing of the ICMT Gene</h3><div class="NLM_p last">PC-3 cells were transfected with an ICMT siRNA (h) or with a control siRNA commercially available from Santa Cruz Biotechnology (sc-88830 and sc-37007, respectively), using lipofectamine and following the manufacturer’s instructions. Inhibition of ICMT expression was checked by immunoblotting. To determine cytotoxicity in transfected cells, the MTT protocol indicated above was followed.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Inhibition of FTase, GGTase, and Rce1 Enzymes</h3><div class="NLM_p last">For FTase and GGTase, PC3 cells were treated with compound <b>3</b> or vehicle for 48 h and then lysed in Laemmli buffer (catalog number 161/0747, Biorad) containing protease inhibitors (protease inhibitor cocktail from Roche plus 1 mM PMSF) and phosphatase inhibitors (10 mM sodium fluoride, 0.3 μg/mL calyculin A, 1 mM sodium orthovanadate, and 10 mM β-glycerolphosphate). Lysates were subjected to SDS–PAGE using either 10% (for HDJ2) or 15% (for Rap1A) Tris-glycine gels and then immunoblotted using antibodies specific for HDJ2 (MA5-12748, Thermo Fisher), Rap1A (Ab sc-65; Santa Cruz Biotechnology, Santa Cruz, CA), or GADPH (2118, Cell Signaling). Blots were developed using the corresponding secondary antibody and analyzed as indicated above. For Rce1 inhibition, PC-3 cells were incubated in the presence or absence of compound <b>3</b> (10 μM) for 24 h. Cells were homogenized in 100 mM HEPES, pH = 7.5, 5 mM MgCl<sub>2</sub>, 0.5% NP-40 buffer and flash-frozen in liquid nitrogen and stored at −80 °C until use. Aliquots were thawed quickly at 37 °C and then kept on ice until dilution into buffer just before use. Reactions were performed by incubation of 0.2 mg of PC-3 homogenates in the presence of 250 μM of the Rce1 specific peptide substrate KSKTKC(f)VI (synthesized by GenScript Biotech, Netherlands BV) for 60 min at 37 °C. Then, reactions were stopped by adding an equal volume of ice-cold acetonitrile and kept at 4 °C until analysis by HPLC coupled to MS/MS in the UCM’s Mass Spectrometry CAI as detailed below following the signal corresponding to the M + 2/2 ion.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Xenograft Model and in Vivo Treatment</h3><div class="NLM_p">All scientific procedures with animals conformed to EU Directive 2010/63EU and Recommendation 2007/526/EC, enforced in Spanish law under Real Decreto 53/2013. Animal protocols were approved by the local ethics committees and the Animal Protection Area of the Comunidad Autónoma de Madrid (PROEX 022/17). Experiments were conducted on 8 weeks female mice from the CNIO animal facility. For pharmacokinetic studies, compound <b>3</b> was administered intraperitoneally (25 mg/kg) and blood was collected at the selected time points postdose (<i>n</i> = 3 per time point) by cardiac puncture. Blood was allowed to clot at room temperature for 30 min and centrifuged at 4 °C for 10 min at 16 000<i>g</i>. The supernatant was transferred to a clean polypropylene tube and stored at −80 °C until analysis. For analysis, a volume of cold acetonitrile was added to the serum. The sample was incubated in an ice bath for 10 min and centrifuged at 4 °C for 10 min at 16 000<i>g</i>. The resulting organic layer was filtered through a polytetrafluoroethylene filter (0.2 μm, 13 mm diameter, Fisher Scientific) and 20 μL of the sample analyzed by LC–MS/MS at the UCM’s Mass Spectrometry CAI. Separation was performed using a Phenomenex Gemini 5 μm C18 110A 150 mm × 2 mm column (run time 8 min; flow 0.5 mL/min; gradient 3.5 min 5% B to 5 min 100% B to 6 min 100% B to 8 min 5% B. Phase A: water with formic acid 0.1%. Phase B: acetonitrile). The entire LC eluent was directly introduced to an electrospray ionization (ESI) source operating in the positive ion mode for LC MS/MS analysis on a Shimadzu LCMS8030 triple quadrupole mass spectrometer coupled to UHPLC with an oven temperature of 31.5 °C. The mass spectrometer ion optics were set in the multiple reaction monitoring mode, and the transition selected for quantification was 423.50 > 289.05 (CE: −21v).</div><div class="NLM_p last">C57BL/6 HL-60 AML cells were obtained from DMSZ culture collection (Braunschweig, Germany) and were cultured in RPMI with 10% FBS. Five million cells were injected into the tail veins of female NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ (NSG) mice. One week post injection, mice were treated for 3 weeks with vehicle (DMSO) or 25 mg/kg of compound <b>3</b>. Moribund mice were sacrificed according to IACUC and CNIO guidelines under protocol PROEX 022/17.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Survival Analysis</h3><div class="NLM_p last">Survival analysis was performed using the Kaplan–Meier method. Differences between survival distributions were analyzed using the log rank test. Hazard ratio and confidence interval were obtained by Mantel–Haenszel analysis. Statistical computations were performed using GraphPad Prism 6.0.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Pathological Analysis and Immunohistochemistry</h3><div class="NLM_p last">Mice were euthanized and tissues were collected and fixed in 10% formalin followed by paraffin embedding. Tissue sections were processed and stained with hematoxylin and eosin, and pathology was evaluated. Immunohistochemistry was performed by deparaffinization followed by epitope exposure using steam and citric acid. Slides were incubated in H<sub>2</sub>O<sub>2</sub>, blocked for 20 min at rt, and then incubated with antibodies against hCD45 (ref 13917, Cell Signaling Technologies, Inc., Danvers, MA, USA), protein interactions were visualized by the signal detection with a peroxidase conjugated secondary antibody (EnVision + Dual Link, Agilent, Santa Clara, CA, 113 USA) and the DAB substrate kit (ab94665, Abcam, Cambridge, U.K.). Slides were counterstained with Carazzi’s hematoxylin solution (PanReac AppliChem, Ottoweg, 115 Darmstadt, Germany) before mounting in DPX Mountant (Sigma-Aldrich, St.Louis, MO, USA).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00145" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24234" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24234" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00145" class="ext-link">10.1021/acs.jmedchem.9b00145</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Ma- and Tc-ICMT derived homology models of h-ICMT (Figures S1 and S2), concentration–response curves for cysmethynil and compound <b>3</b> (Figure S3), effect of compound <b>3</b> on the membrane association of Ras (Figure S4) and Fyn (Figure S5) and of farnesylated and geranylgeranylated K-Ras (Figure S6) and on Rce1 enzyme (Figure S7), effect of compound <b>3</b> on the induction of apoptosis en human pancreatic cancer cells (Figures S8 and S9) and plasma concentration of compound <b>3</b> after ip injection (Figure S10), computational models, detailed synthetic procedures, characterization data of final compounds <b>1</b>, <b>2</b>, <b>4</b>–<b>34</b> and intermediates <b>35</b>–<b>55</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Homology models of human ICMT built using the crystal structure of Ma-ICMT (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A2N">4A2N</a>), as template (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Homology models of human ICMT built using the crystal structure of Tc-ICMT (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V7P">5V7P</a>), as template (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_004.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf">jm9b00145_si_001.pdf (1.31 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_002.csv">jm9b00145_si_002.csv (1.83 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_003.pdb">jm9b00145_si_003.pdb (241.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_004.pdb">jm9b00145_si_004.pdb (356.28 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00145" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12256" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12256" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María L. López-Rodríguez</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#771a1b020d1b053702141a591204"><span class="__cf_email__" data-cfemail="5a37362f2036281a2f3937743f29">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Ortega-Gutiérrez</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0257-6754" title="Orcid link">http://orcid.org/0000-0002-0257-6754</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d7a4beb8a5a3b2b0b697a2b4baf9b2a4"><span class="__cf_email__" data-cfemail="8dfee4e2fff9e8eaeccdf8eee0a3e8fe">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nagore
I. Marín-Ramos</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">CEI
Campus Moncloa, UCM-UPM and CSIC, E-28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Moisés Balabasquer</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco J. Ortega-Nogales</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Iván R. Torrecillas</span> - <span class="hlFld-Affiliation affiliation">Laboratori
de Medicina Computacional, Unitat de Bioestadística, Facultat
de Medicina, Universitat Autònoma
de Barcelona, E-08193 Bellaterra, Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Gil-Ordóñez</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beatriz Marcos-Ramiro</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pedro Aguilar-Garrido</span> - <span class="hlFld-Affiliation affiliation">H12O-CNIO
Haematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), E-28029 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian Cushman</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Cancer Biology, Duke
University Medical Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Romero</span> - <span class="hlFld-Affiliation affiliation">Centro de
Investigaciones Biológicas, CSIC, E-28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco J. Medrano</span> - <span class="hlFld-Affiliation affiliation">Centro de
Investigaciones Biológicas, CSIC, E-28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Consuelo Gajate</span> - <span class="hlFld-Affiliation affiliation">Centro de
Investigaciones Biológicas, CSIC, E-28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Faustino Mollinedo</span> - <span class="hlFld-Affiliation affiliation">Centro de
Investigaciones Biológicas, CSIC, E-28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark R. Philips</span> - <span class="hlFld-Affiliation affiliation">Perlmutter
Cancer Center, New York University School
of Medicine, New York, New York 10016, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mercedes Campillo</span> - <span class="hlFld-Affiliation affiliation">Laboratori
de Medicina Computacional, Unitat de Bioestadística, Facultat
de Medicina, Universitat Autònoma
de Barcelona, E-08193 Bellaterra, Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Miguel Gallardo</span> - <span class="hlFld-Affiliation affiliation">H12O-CNIO
Haematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), E-28029 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mar Martín-Fontecha</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>N.I.M.-R., M.B., and F.J.O.-N. contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants from the Spanish MINECO (Grants SAF2016-78792-R, SAF2017-89672-R) and predoctoral fellowships from CEI Moncloa (N.I.M.-R.), MINECO (M.B. and F.J.O.), and Fundación La Caixa (A.G.-O.). The authors thank Prof. P.J. Casey for advice in the determination of ICMT inhibition and thank UCM’s CAIs Cytometry and Fluorescence Microscopy and Mass Spectrometry for their assistance.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AFC</td><td class="NLM_def"><p class="first last"><i>N</i>-acetyl-<i>S</i>-farnesyl-<span class="smallcaps smallerCapital">l</span>-cysteine</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">FTase</td><td class="NLM_def"><p class="first last">farnesyltransferase</p></td></tr><tr><td class="NLM_term">GGTase</td><td class="NLM_def"><p class="first last">geranylgeranyltransferase</p></td></tr><tr><td class="NLM_term">h-ICMT</td><td class="NLM_def"><p class="first last">human ICMT</p></td></tr><tr><td class="NLM_term">HSA</td><td class="NLM_def"><p class="first last">human serum albumin</p></td></tr><tr><td class="NLM_term">ICMT</td><td class="NLM_def"><p class="first last">isoprenylcysteine carboxylmethyltransferase</p></td></tr><tr><td class="NLM_term">LC3</td><td class="NLM_def"><p class="first last">microtubule-associated protein 1A/1B light chain 3</p></td></tr><tr><td class="NLM_term">Ma-ICMT</td><td class="NLM_def"><p class="first last">ICMT from <i>Methanosarcina acetivorans</i></p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly(ADP-ribose) polymerase</p></td></tr><tr><td class="NLM_term">Rce1</td><td class="NLM_def"><p class="first last">endoprotease Ras-converting enzyme 1</p></td></tr><tr><td class="NLM_term">SAM</td><td class="NLM_def"><p class="first last"><i>S</i>-adenosylmethionine</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">Tc-ICMT</td><td class="NLM_def"><p class="first last">ICMT from <i>Tribolium castaneum</i></p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westover, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficarro, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacold, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janne, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of oncogenic K-Ras by a covalent catalytic site inhibitor</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1002/anie.201307387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1002%2Fanie.201307387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvValsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=199-204&author=S.+M.+Limauthor=K.+D.+Westoverauthor=S.+B.+Ficarroauthor=R.+A.+Harrisonauthor=H.+G.+Choiauthor=M.+E.+Pacoldauthor=M.+Carrascoauthor=J.+Hunterauthor=N.+D.+Kimauthor=T.+Xieauthor=T.+Simauthor=P.+A.+Janneauthor=M.+Meyersonauthor=J.+A.+Martoauthor=J.+R.+Engenauthor=N.+S.+Gray&title=Therapeutic+targeting+of+oncogenic+K-Ras+by+a+covalent+catalytic+site+inhibitor&doi=10.1002%2Fanie.201307387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Targeting of Oncogenic K-Ras by a Covalent Catalytic Site Inhibitor</span></div><div class="casAuthors">Lim, Sang Min; Westover, Kenneth D.; Ficarro, Scott B.; Harrison, Rane A.; Choi, Hwan Geun; Pacold, Michael E.; Carrasco, Martin; Hunter, John; Kim, Nam Doo; Xie, Ting; Sim, Taebo; Jaenne, Pasi A.; Meyerson, Matthew; Marto, Jarrod A.; Engen, John R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-204</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We report the synthesis of a GDP analog, SML-8-73-1, and a prodrug deriv., SML-10-70-1, which are selective, direct-acting covalent inhibitors of the K-Ras G12C mutant relative to wild-type Ras.  Biochem. and biophys. measurements suggest that modification of K-Ras with SML-8-73-1 renders the protein in an inactive state.  These first-in-class covalent K-Ras inhibitors demonstrate that irreversible targeting of the K-Ras guanine-nucleotide binding site is potentially a viable therapeutic strategy for inhibition of Ras signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfLlkUFFkg-7Vg90H21EOLACvtfcHk0ljPEbYZz7g8nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvValsrbN&md5=f99a8c9603d4139135606c964706a822</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fanie.201307387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201307387%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DS.%2BM.%26aulast%3DWestover%26aufirst%3DK.%2BD.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DHarrison%26aufirst%3DR.%2BA.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DPacold%26aufirst%3DM.%2BE.%26aulast%3DCarrasco%26aufirst%3DM.%26aulast%3DHunter%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DXie%26aufirst%3DT.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTherapeutic%2520targeting%2520of%2520oncogenic%2520K-Ras%2520by%2520a%2520covalent%2520catalytic%2520site%2520inhibitor%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D199%26epage%3D204%26doi%3D10.1002%2Fanie.201307387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marin-Ramos, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span> <span> </span><span class="NLM_article-title">Blocking Ras inhibition as an antitumor strategy</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.semcancer.2018.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.semcancer.2018.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=29409706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFKjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2019&pages=91-100&author=N.+I.+Marin-Ramosauthor=S.+Ortega-Gutierrezauthor=M.+L.+Lopez-Rodriguez&title=Blocking+Ras+inhibition+as+an+antitumor+strategy&doi=10.1016%2Fj.semcancer.2018.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Blocking Ras inhibition as an antitumor strategy</span></div><div class="casAuthors">Marin-Ramos, Nagore I.; Ortega-Gutierrez, Silvia; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">91-100</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ras proteins are among the most frequently mutated drivers in human cancer and remain an elusive pharmaceutical targeting.  Previous studies have improved the understanding of Ras structure, processing, and signaling pathways in cancer cells and have opened new possibilities for inhibiting Ras function.  In this review we discuss the most recent advances towards inhibiting Ras activity with small mols., highlighting the two approaches: (i) compds. that bind directly to Ras protein and (ii) inhibitors of the enzymes involved in the post-translational modifications of Ras.  In the former, we analyze the most recent contributions in each of the main classes of Ras direct binders, including the different types of nucleotide exchange inhibitors, allosteric compds., and mols. that interfere with the interaction between Ras and its effectors.  In the latter, we examine the compds. that inhibit Ras activation by blocking any of its post-translational modifications.  Also, a special focus is made on those mols. that have progressed the farthest from medicinal chem. and drug development points of view.  Finally, the current scene regarding the clin. trials of Ras inhibitors, together with the future promising avenues for further development of the challenging Ras field are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWw2RqFhpnErVg90H21EOLACvtfcHk0ljPEbYZz7g8nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFKjs74%253D&md5=721a62e21dddff7fc9d25732ec30040f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2018.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2018.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DMarin-Ramos%26aufirst%3DN.%2BI.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26atitle%3DBlocking%2520Ras%2520inhibition%2520as%2520an%2520antitumor%2520strategy%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2019%26volume%3D54%26spage%3D91%26epage%3D100%26doi%3D10.1016%2Fj.semcancer.2018.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marín-Ramos, N.
I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piñar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Villa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín-Fontecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canales, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Algar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Barbero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajate, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollinedo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutiérrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Rodríguez, M. L.</span></span> <span> </span><span class="NLM_article-title">Development of a nucleotide exchange inhibitor that impairs Ras oncogenic signaling</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1685</span>, <span class="refDoi"> DOI: 10.1002/chem.201604905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1002%2Fchem.201604905" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=27885731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGhsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=1676-1685&author=N.%0AI.+Mar%C3%ADn-Ramosauthor=C.+Pi%C3%B1arauthor=H.+V%C3%A1zquez-Villaauthor=M.+Mart%C3%ADn-Fontechaauthor=%C3%81.+Gonz%C3%A1lezauthor=%C3%81.+Canalesauthor=S.+Algarauthor=P.+P.+Mayoauthor=J.+Jim%C3%A9nez-Barberoauthor=C.+Gajateauthor=F.+Mollinedoauthor=L.+Pardoauthor=S.+Ortega-Guti%C3%A9rrezauthor=A.+Visoauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=Development+of+a+nucleotide+exchange+inhibitor+that+impairs+Ras+oncogenic+signaling&doi=10.1002%2Fchem.201604905"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Nucleotide Exchange Inhibitor That Impairs Ras Oncogenic Signaling</span></div><div class="casAuthors">Marin-Ramos, Nagore I.; Pinar, Carmen; Vazquez-Villa, Henar; Martin-Fontecha, Mar; Gonzalez, Angel; Canales, Angeles; Algar, Sergio; Mayo, Paloma P.; Jimenez-Barbero, Jesus; Gajate, Consuelo; Mollinedo, Faustino; Pardo, Leonardo; Ortega-Gutierrez, Silvia; Viso, Alma; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1676-1685</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Despite more than three decades of intense effort, no anti-Ras therapies have reached clin. application.  Contributing to this failure has been an underestimation of Ras complexity and a dearth of structural information.  In this regard, recent studies have revealed the highly dynamic character of the Ras surface and the existence of transient pockets suitable for small-mol. binding, opening up new possibilities for the development of Ras modulators.  Herein, a novel Ras inhibitor (compd. 12) is described that selectively impairs mutated Ras activity in a reversible manner without significantly affecting wild-type Ras, reduces the Ras-guanosine triphosphate (GTP) levels, inhibits the activation of the mitogen-activated protein kinase (MAPK) pathway, and exhibits remarkable cytotoxic activity in Ras-driven cellular models.  The use of mol. dynamics simulations and NMR spectroscopy expts. has enabled the mol. bases responsible for the interactions between compd. 12 and Ras protein to be explored.  The new Ras inhibitor binds partially to the GTP-binding region and extends into the adjacent hydrophobic pocket delimited by switch II.  Hence, Ras inhibitor 12 could represent a new compd. for the development of more efficacious drugs to target Ras-driven cancers; a currently unmet clin. need.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp58dPubMr9DbVg90H21EOLACvtfcHk0liJZy1F54FTkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGhsrjJ&md5=306d9a9b923f9b1fac12d3fd3ae93210</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fchem.201604905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201604905%26sid%3Dliteratum%253Aachs%26aulast%3DMar%25C3%25ADn-Ramos%26aufirst%3DN.%2BI.%26aulast%3DPi%25C3%25B1ar%26aufirst%3DC.%26aulast%3DV%25C3%25A1zquez-Villa%26aufirst%3DH.%26aulast%3DMart%25C3%25ADn-Fontecha%26aufirst%3DM.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3D%25C3%2581.%26aulast%3DCanales%26aufirst%3D%25C3%2581.%26aulast%3DAlgar%26aufirst%3DS.%26aulast%3DMayo%26aufirst%3DP.%2BP.%26aulast%3DJim%25C3%25A9nez-Barbero%26aufirst%3DJ.%26aulast%3DGajate%26aufirst%3DC.%26aulast%3DMollinedo%26aufirst%3DF.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DOrtega-Guti%25C3%25A9rrez%26aufirst%3DS.%26aulast%3DViso%26aufirst%3DA.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DDevelopment%2520of%2520a%2520nucleotide%2520exchange%2520inhibitor%2520that%2520impairs%2520Ras%2520oncogenic%2520signaling%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D1676%26epage%3D1685%26doi%3D10.1002%2Fchem.201604905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostrem, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Direct small-molecule inhibitors of KRas: from structural insights to mechanism-based design</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1038%2Fnrd.2016.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=27469033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=771-785&author=J.+M.+Ostremauthor=K.+M.+Shokat&title=Direct+small-molecule+inhibitors+of+KRas%3A+from+structural+insights+to+mechanism-based+design&doi=10.1038%2Fnrd.2016.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design</span></div><div class="casAuthors">Ostrem, Jonathan M. L.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">771-785</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">KRAS is the most frequently mutated oncogene in human cancer.  In addn. to holding this distinction, unsuccessful attempts to target this protein have led to the characterization of RAS as 'undruggable'.  However, recent advances in technol. and novel approaches to drug discovery have renewed hope that a direct KRAS inhibitor may be on the horizon.  In this Review, we provide an in-depth anal. of the structure, dynamics, mutational activation and inactivation, and signalling mechanisms of RAS.  From this perspective, we then consider potential mechanisms of action for effective RAS inhibitors.  Finally, we examine each of the many recent reports of direct RAS inhibitors and discuss promising avenues for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBobrhZLF3V7Vg90H21EOLACvtfcHk0liJZy1F54FTkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FK&md5=b0832c7ef45cc0555e11c59baccc5abd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.139%26sid%3Dliteratum%253Aachs%26aulast%3DOstrem%26aufirst%3DJ.%2BM.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DDirect%2520small-molecule%2520inhibitors%2520of%2520KRas%253A%2520from%2520structural%2520insights%2520to%2520mechanism-based%2520design%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D771%26epage%3D785%26doi%3D10.1038%2Fnrd.2016.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, R. B.</span></span> <span> </span><span class="NLM_article-title">Therapeutic strategies to target Ras-mutant cancers</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">709</span>– <span class="NLM_lpage">720</span>, <span class="refDoi"> DOI: 10.1038/s41571-018-0105-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1038%2Fs41571-018-0105-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=30275515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVeqs7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=709-720&author=M.+B.+Ryanauthor=R.+B.+Corcoran&title=Therapeutic+strategies+to+target+Ras-mutant+cancers&doi=10.1038%2Fs41571-018-0105-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic strategies to target RAS-mutant cancers</span></div><div class="casAuthors">Ryan, Meagan B.; Corcoran, Ryan B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">709-720</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  RAS genes are the most commonly mutated oncogenes in cancer, but effective therapeutic strategies to target RAS-mutant cancers have proved elusive.  A key aspect of this challenge is the fact that direct inhibition of RAS proteins has proved difficult, leading researchers to test numerous alternative strategies aimed at exploiting RAS-related vulnerabilities or targeting RAS effectors.  In the past few years, we have witnessed renewed efforts to target RAS directly, with several promising strategies being tested in clin. trials at different stages of completion.  Important advances have also been made in approaches designed to indirectly target RAS by improving inhibition of RAS effectors, exploiting synthetic lethal interactions or metabolic dependencies, using therapeutic combination strategies or harnessing the immune system.  In this Review, we describe historical and ongoing efforts to target RAS-mutant cancers and outline the current therapeutic landscape in the collective quest to overcome the effects of this crucial oncogene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojQcBt2xwv47Vg90H21EOLACvtfcHk0lj4afSJQWbjtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVeqs7bM&md5=44839eb1482998d710b74e9362f4e0ea</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fs41571-018-0105-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41571-018-0105-0%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DM.%2BB.%26aulast%3DCorcoran%26aufirst%3DR.%2BB.%26atitle%3DTherapeutic%2520strategies%2520to%2520target%2520Ras-mutant%2520cancers%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2018%26volume%3D15%26spage%3D709%26epage%3D720%26doi%3D10.1038%2Fs41571-018-0105-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sautier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nising, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, L.</span></span> <span> </span><span class="NLM_article-title">Latest advances towards Ras inhibition: a medicinal chemistry perspective</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">15982</span>– <span class="NLM_lpage">15988</span>, <span class="refDoi"> DOI: 10.1002/anie.201608270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1002%2Fanie.201608270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFahtL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=15982-15988&author=B.+Sautierauthor=C.+F.+Nisingauthor=L.+Wortmann&title=Latest+advances+towards+Ras+inhibition%3A+a+medicinal+chemistry+perspective&doi=10.1002%2Fanie.201608270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Latest Advances Towards Ras Inhibition: A Medicinal Chemistry Perspective</span></div><div class="casAuthors">Sautier, Brice; Nising, Carl F.; Wortmann, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">15982-15988</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Owing to their high occurrence rate across many human cancers and their lack of druggability so far, mutant forms of the signaling protein Ras are currently among the most attractive (and elusive) oncol. targets.  This strong appeal explains the sustained effort in the field, and the ensuing progress has rekindled optimism regarding the discovery of Ras inhibitors.  In this Minireview, the authors discuss the most recent advances towards irreversible inhibitors, and highlight approaches to inhibitors of Ras-effector interactions that have been overshadowed by the current focus on direct Ras inhibition.  At the same time, the authors provide a crit. assessment from a medicinal chem. perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFjaiRaV3EarVg90H21EOLACvtfcHk0lj4afSJQWbjtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFahtL7F&md5=9aead7b14a7534e188f4c2b721e11903</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fanie.201608270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201608270%26sid%3Dliteratum%253Aachs%26aulast%3DSautier%26aufirst%3DB.%26aulast%3DNising%26aufirst%3DC.%2BF.%26aulast%3DWortmann%26aufirst%3DL.%26atitle%3DLatest%2520advances%2520towards%2520Ras%2520inhibition%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D15982%26epage%3D15988%26doi%3D10.1002%2Fanie.201608270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frett, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. Y.</span></span> <span> </span><span class="NLM_article-title">Targeting mutant KRas for anticancer therapeutics: a review of novel small molecule modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5219</span>– <span class="NLM_lpage">5230</span>, <span class="refDoi"> DOI: 10.1021/jm3017706</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3017706" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsV2gsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5219-5230&author=Y.+Wangauthor=C.+E.+Kaiserauthor=B.+Frettauthor=H.+Y.+Li&title=Targeting+mutant+KRas+for+anticancer+therapeutics%3A+a+review+of+novel+small+molecule+modulators&doi=10.1021%2Fjm3017706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Mutant KRAS for Anticancer Therapeutics: A Review of Novel Small Molecule Modulators</span></div><div class="casAuthors">Wang, Yuanxiang; Kaiser, Christine E.; Frett, Brendan; Li, Hong-yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5219-5230</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The RAS proteins play a role in cell differentiation, proliferation, and survival.  Aberrant RAS signaling has been found to play a role in 30% of all cancers.  KRAS, a key member of the RAS protein family, is an attractive cancer target, as frequent point mutations in the KRAS gene render the protein constitutively active.  A no. of attempts have been made to target aberrant KRAS signaling by identifying small mol. compds. that (1) are synthetic lethal to mutant KRAS, (2) block KRAS/GEF interactions, (3) inhibit downstream KRAS effectors, or (4) inhibit the post-translational processing of RAS proteins.  In addn., inhibition of novel targets outside the main KRAS signaling pathway, specifically the cell cycle related kinase PLK1, has been shown have an effect in cells that harbor mutant KRAS.  Herein we review the use of various high-throughput screening assays utilized to identify new small-mol. compds. capable of targeting mutant KRAS-driven cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogrA1KFIgQuLVg90H21EOLACvtfcHk0liFDqCh7CMXQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsV2gsbc%253D&md5=83623863b372993bdb0171d93e1db205</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm3017706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3017706%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKaiser%26aufirst%3DC.%2BE.%26aulast%3DFrett%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DH.%2BY.%26atitle%3DTargeting%2520mutant%2520KRas%2520for%2520anticancer%2520therapeutics%253A%2520a%2520review%2520of%2520novel%2520small%2520molecule%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5219%26epage%3D5230%26doi%3D10.1021%2Fjm3017706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span> <span> </span><span class="NLM_article-title">Protein prenylation: unique fats make their mark on biology</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1038/nrm.2015.11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1038%2Fnrm.2015.11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=26790532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=110-122&author=M.+Wangauthor=P.+J.+Casey&title=Protein+prenylation%3A+unique+fats+make+their+mark+on+biology&doi=10.1038%2Fnrm.2015.11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Protein prenylation: unique fats make their mark on biology</span></div><div class="casAuthors">Wang, Mei; Casey, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">110-122</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The modification of eukaryotic proteins by isoprenoid lipids, which is known as prenylation, controls the localization and activity of a range of proteins that have crucial functions in biol. regulation.  The roles of prenylated proteins in cells are well conserved across species, underscoring the biol. and evolutionary importance of this lipid modification pathway.  Genetic suppression and pharmacol. inhibition of the protein prenylation machinery have provided insights into several cellular processes and into the etiol. of diseases in which prenylation is involved.  The functional dependence of prenylation substrates, such as RAS proteins, on this modification and the therapeutic potential of targeting the prenylation process in pathol. conditions accentuate the need to fully understand this form of post-translational modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr08TXPqy6XorVg90H21EOLACvtfcHk0liFDqCh7CMXQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOrsrk%253D&md5=b6694153ce758f85c4e01c499d8de74a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrm.2015.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm.2015.11%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26atitle%3DProtein%2520prenylation%253A%2520unique%2520fats%2520make%2520their%2520mark%2520on%2520biology%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2016%26volume%3D17%26spage%3D110%26epage%3D122%26doi%3D10.1038%2Fnrm.2015.11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Der, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philips, M. R.</span></span> <span> </span><span class="NLM_article-title">Targeting Ras membrane association: back to the future for anti-Ras drug discovery?</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1819</span>– <span class="NLM_lpage">1827</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-3214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1158%2F1078-0432.CCR-14-3214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=25878363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsl2gt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=1819-1827&author=A.+D.+Coxauthor=C.+J.+Derauthor=M.+R.+Philips&title=Targeting+Ras+membrane+association%3A+back+to+the+future+for+anti-Ras+drug+discovery%3F&doi=10.1158%2F1078-0432.CCR-14-3214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?</span></div><div class="casAuthors">Cox, Adrienne D.; Der, Channing J.; Philips, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1819-1827</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">RAS proteins require membrane assocn. for their biol. activity, making this assocn. a logical target for anti-RAS therapeutics.  Lipid modification of RAS proteins by a farnesyl isoprenoid is an obligate step in that assocn., and is an enzymic process.  Accordingly, farnesyltransferase inhibitors (FTI) were developed as potential anti-RAS drugs.  The lack of efficacy of FTIs as anticancer drugs was widely seen as indicating that blocking RAS membrane assocn. was a flawed approach to cancer treatment.  However, a deeper understanding of RAS modification and trafficking has revealed that this was an erroneous conclusion.  In the presence of FTIs, KRAS and NRAS, which are the RAS isoforms most frequently mutated in cancer, become substrates for alternative modification, can still assoc. with membranes, and can still function.  Thus, FTIs failed not because blocking RAS membrane assocn. is an ineffective approach, but because FTIs failed to accomplish that task.  Recent findings regarding RAS isoform trafficking and the regulation of RAS subcellular localization have rekindled interest in efforts to target these processes.  In particular, improved understanding of the palmitoylation/depalmitoylation cycle that regulates RAS interaction with the plasma membrane, endomembranes, and cytosol, and of the potential importance of RAS chaperones, have led to new approaches.  Efforts to validate and target other enzymically regulated posttranslational modifications are also ongoing.  In this review, we revisit lessons learned, describe the current state of the art, and highlight challenging but promising directions to achieve the goal of disrupting RAS membrane assocn. and subcellular localization for anti-RAS drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCImUyZbuCKrVg90H21EOLACvtfcHk0lhsthCg-ZUIlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsl2gt74%253D&md5=6f41ac23a7d14b90633755e374b6ffea</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-3214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-3214%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DA.%2BD.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26aulast%3DPhilips%26aufirst%3DM.%2BR.%26atitle%3DTargeting%2520Ras%2520membrane%2520association%253A%2520back%2520to%2520the%2520future%2520for%2520anti-Ras%2520drug%2520discovery%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D1819%26epage%3D1827%26doi%3D10.1158%2F1078-0432.CCR-14-3214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergo, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavino, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beigneux, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. G.</span></span> <span> </span><span class="NLM_article-title">Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1172/JCI200418829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1172%2FJCI200418829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=14966563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFKhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2004&pages=539-550&author=M.+O.+Bergoauthor=B.+J.+Gavinoauthor=C.+Hongauthor=A.+P.+Beigneuxauthor=M.+McMahonauthor=P.+J.+Caseyauthor=S.+G.+Young&title=Inactivation+of+Icmt+inhibits+transformation+by+oncogenic+K-Ras+and+B-Raf&doi=10.1172%2FJCI200418829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf</span></div><div class="casAuthors">Bergo, Martin O.; Gavino, Bryant J.; Hong, Christine; Beigneux, Anne P.; McMahon, Martin; Casey, Patrick J.; Young, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">539-550</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Isoprenylcysteine carboxyl methyltransferase (Icmt) methylates the carboxyl-terminal isoprenylcysteine of CAAX proteins (e.g., Ras and Rho proteins).  In the case of the Ras proteins, carboxyl methylation is important for targeting of the proteins to the plasma membrane.  We hypothesized that a knockout of Icmt would reduce the ability of cells to be transformed by K-Ras.  Fibroblasts harboring a floxed Icmt allele and expressing activated K-Ras (K-Ras-Icmtflx/flx) were treated with Cre-adenovirus, producing K-Ras-IcmtΔ/Δ fibroblasts.  Inactivation of Icmt inhibited cell growth and K-Ras-induced oncogenic transformation, both in soft agar assays and in a nude mice model.  The inactivation of Icmt did not affect growth factor-stimulated phosphorylation of Erk1/2 or Akt1.  However, levels of RhoA were greatly reduced as a consequence of accelerated protein turnover.  In addn., there was a large Ras/Erk1/2-dependent increase in p21Cip1, which was probably a consequence of the reduced levels of RhoA.  Deletion of p21Cip1 restored the ability of K-Ras-IcmtΔ/Δ fibroblasts to grow in soft agar.  The effect of inactivating Icmt was not limited to the inhibition of K-Ras-induced transformation: inactivation of Icmt blocked transformation by an oncogenic form of B-Raf (V599E).  These studies identify Icmt as a potential target for reducing the growth of K-Ras- and B-Raf-induced malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgtsUKYvB3B7Vg90H21EOLACvtfcHk0lhsthCg-ZUIlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFKhsb0%253D&md5=521e9d001c068e7aef840765d1f3d748</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1172%2FJCI200418829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI200418829%26sid%3Dliteratum%253Aachs%26aulast%3DBergo%26aufirst%3DM.%2BO.%26aulast%3DGavino%26aufirst%3DB.%2BJ.%26aulast%3DHong%26aufirst%3DC.%26aulast%3DBeigneux%26aufirst%3DA.%2BP.%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26atitle%3DInactivation%2520of%2520Icmt%2520inhibits%2520transformation%2520by%2520oncogenic%2520K-Ras%2520and%2520B-Raf%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2004%26volume%3D113%26spage%3D539%26epage%3D550%26doi%3D10.1172%2FJCI200418829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wahlstrom, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutts, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindskog, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjogren, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergo, M. O.</span></span> <span> </span><span class="NLM_article-title">Inactivating Icmt ameliorates K-Ras-induced myeloproliferative disease</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">1357</span>– <span class="NLM_lpage">1365</span>, <span class="refDoi"> DOI: 10.1182/blood-2007-06-094060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1182%2Fblood-2007-06-094060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=18502828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvVOktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=1357-1365&author=A.+M.+Wahlstromauthor=B.+A.+Cuttsauthor=M.+Liuauthor=A.+Lindskogauthor=C.+Karlssonauthor=A.+K.+Sjogrenauthor=K.+M.+Anderssonauthor=S.+G.+Youngauthor=M.+O.+Bergo&title=Inactivating+Icmt+ameliorates+K-Ras-induced+myeloproliferative+disease&doi=10.1182%2Fblood-2007-06-094060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivating Icmt ameliorates K-RAS-induced myeloproliferative disease</span></div><div class="casAuthors">Wahlstrom, Annika M.; Cutts, Briony A.; Liu, Meng; Lindskog, Annika; Karlsson, Christin; Sjogren, Anna-Karin M.; Andersson, Karin M. E.; Young, Stephen G.; Bergo, Martin O.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1357-1365</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Hyperactive signaling through the RAS proteins is involved in the pathogenesis of many forms of cancer.  The RAS proteins and many other intracellular signaling proteins are either farneslated or geranylgeranylated at a carboxylterminal cysteine.  That isoprenylcysteine is then carboxyl methylated by isoprenylcysteine carboxyl methyltransferase (ICMT).  We previously showed that inactivation of Icmt mislocalizes the RAS proteins away from the plasma membrane and blocks RAS transformation of mouse fibroblasts, suggesting that ICMT could be a therapeutic target.  However, nothing is known about the impact of inhibiting ICMT on the development of malignancies in vivo.  In the current study, we tested the hypothesis that inactivation of Icmt would inhibit the development or progression of a K-RAS-induced myeloproliferative disease in mice.  We found that inactivating Icmt reduced splenomegaly, the no. of immature myeloid cells in peripheral blood, and tissue infiltration by myeloid cells.  Moreover, in the absence of Icmt, the ability of K-RAS-expressing hematopoietic cells to form colonies in methylcellulose without exogenous growth factors was reduced dramatically.  Finally, inactivating Icmt reduced lung tumor development and myeloproliferation phenotypes in a mouse model of K-RAS-induced cancer.  We conclude that inactivation of Icmt ameliorates phenotypes of K-RAS-induced malignancies in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriOROOZKs_wbVg90H21EOLACvtfcHk0lhsthCg-ZUIlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvVOktLg%253D&md5=eaa0e2fa401c0823cba19480efc1b8a1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-06-094060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-06-094060%26sid%3Dliteratum%253Aachs%26aulast%3DWahlstrom%26aufirst%3DA.%2BM.%26aulast%3DCutts%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLindskog%26aufirst%3DA.%26aulast%3DKarlsson%26aufirst%3DC.%26aulast%3DSjogren%26aufirst%3DA.%2BK.%26aulast%3DAndersson%26aufirst%3DK.%2BM.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DBergo%26aufirst%3DM.%2BO.%26atitle%3DInactivating%2520Icmt%2520ameliorates%2520K-Ras-induced%2520myeloproliferative%2520disease%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D1357%26epage%3D1365%26doi%3D10.1182%2Fblood-2007-06-094060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span> <span> </span><span class="NLM_article-title">Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all Ras isoforms</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">3934</span>– <span class="NLM_lpage">3942</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1038%2Fonc.2016.508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=28192404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislGltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=3934-3942&author=H.+Y.+Lauauthor=J.+Tangauthor=P.+J.+Caseyauthor=M.+Wang&title=Isoprenylcysteine+carboxylmethyltransferase+is+critical+for+malignant+transformation+and+tumor+maintenance+by+all+Ras+isoforms&doi=10.1038%2Fonc.2016.508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms</span></div><div class="casAuthors">Lau, H. Y.; Tang, J.; Casey, P. J.; Wang, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3934-3942</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite extensive effort, there has been limited progress in the development of direct RAS inhibitors.  Targeting isoprenylcysteine carboxylmethyltransferase (ICMT), a unique enzyme of RAS post-translational modification, represents a promising strategy to inhibit RAS function.  However, there lacks direct genetic evidence on the role of ICMT in RAS-driven human cancer initiation and maintenance.  Using CRISPR/Cas9 genome editing, we have created Icmt loss-of-function isogenic cell lines for both RAS-transformed human mammary epithelial cells (HME1) and human cancer cell lines MiaPaca-2 and MDA-MB-231 contg. naturally occurring mutant KRAS.  In both in vitro and in vivo tumorigenesis studies, Icmt loss-of-function abolishes the tumor initiation ability of all major isoforms of mutant RAS in HME1 cells, and the tumor maintenance capacity of MiaPaca-2 and MDA-MB-231 cells, establishing the crit. role of ICMT in RAS-driven cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsFJ7p2xGULbVg90H21EOLACvtfcHk0lg3rbK1ReV2_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislGltL8%253D&md5=dbe47533ffa72f013b135df879724521</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.508%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DH.%2BY.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26aulast%3DWang%26aufirst%3DM.%26atitle%3DIsoprenylcysteine%2520carboxylmethyltransferase%2520is%2520critical%2520for%2520malignant%2520transformation%2520and%2520tumor%2520maintenance%2520by%2520all%2520Ras%2520isoforms%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D3934%26epage%3D3942%26doi%3D10.1038%2Fonc.2016.508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winter-Vann, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">dela Cruz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">York, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gooden, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergo, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toone, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span> <span> </span><span class="NLM_article-title">A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">4336</span>– <span class="NLM_lpage">4341</span>, <span class="refDoi"> DOI: 10.1073/pnas.0408107102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1073%2Fpnas.0408107102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=15784746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivFCrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=4336-4341&author=A.+M.+Winter-Vannauthor=R.+A.+Baronauthor=W.+Wongauthor=J.+dela+Cruzauthor=J.+D.+Yorkauthor=D.+M.+Goodenauthor=M.+O.+Bergoauthor=S.+G.+Youngauthor=E.+J.+Tooneauthor=P.+J.+Casey&title=A+small-molecule+inhibitor+of+isoprenylcysteine+carboxyl+methyltransferase+with+antitumor+activity+in+cancer+cells&doi=10.1073%2Fpnas.0408107102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells</span></div><div class="casAuthors">Winter-Vann, Ann M.; Baron, Rudi A.; Wong, Waihay; dela Cruz, June; York, John D.; Gooden, David M.; Bergo, Martin O.; Young, Stephen G.; Toone, Eric J.; Casey, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4336-4341</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Many key regulatory proteins, including members of the Ras family of GTPases, are modified at their C terminus by a process termed prenylation.  This processing is initiated by the addn. of an isoprenoid lipid, and the proteins are further modified by a proteolytic event and methylation of the C-terminal prenylcysteine.  Although the biol. consequences of prenylation have been characterized extensively, the contributions of prenylcysteine methylation to the functions of the modified proteins are not well understood.  This reaction is catalyzed by the enzyme isoprenylcysteine carboxyl methyltransferase (Icmt).  Recent genetic disruption studies have provided strong evidence that blocking Icmt activity has profound consequences on oncogenic transformation.  Here, we report the identification of a selective small-mol. inhibitor of Icmt, 2-[5-(3-methylphenyl)-1-octyl-1H-indol-3-yl]acetamide (cysmethynil).  Cysmethynil treatment results in inhibition of cell growth in an Icmt-dependent fashion, demonstrating mechanism-based activity of the compd.  Treatment of cancer cells with cysmethynil results in mislocalization of Ras and impaired epidermal growth factor signaling.  In a human colon cancer cell line, cysmethynil treatment blocks anchorage-independent growth, and this effect is reversed by overexpression of Icmt.  These findings provide a compelling rationale for development of Icmt inhibitors as another approach to anticancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY-1GtT0roj7Vg90H21EOLACvtfcHk0lg3rbK1ReV2_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivFCrtLk%253D&md5=8cbe478e0911934e2868d5b5eb376a58</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0408107102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0408107102%26sid%3Dliteratum%253Aachs%26aulast%3DWinter-Vann%26aufirst%3DA.%2BM.%26aulast%3DBaron%26aufirst%3DR.%2BA.%26aulast%3DWong%26aufirst%3DW.%26aulast%3Ddela%2BCruz%26aufirst%3DJ.%26aulast%3DYork%26aufirst%3DJ.%2BD.%26aulast%3DGooden%26aufirst%3DD.%2BM.%26aulast%3DBergo%26aufirst%3DM.%2BO.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DToone%26aufirst%3DE.%2BJ.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26atitle%3DA%2520small-molecule%2520inhibitor%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520with%2520antitumor%2520activity%2520in%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D4336%26epage%3D4341%26doi%3D10.1073%2Fpnas.0408107102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coolman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">4959</span>– <span class="NLM_lpage">4970</span>, <span class="refDoi"> DOI: 10.1038/onc.2010.247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1038%2Fonc.2010.247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=20622895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1aitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=4959-4970&author=M.+Wangauthor=M.+S.+Hossainauthor=W.+Tanauthor=B.+Coolmanauthor=J.+Zhouauthor=S.+Liuauthor=P.+J.+Casey&title=Inhibition+of+isoprenylcysteine+carboxylmethyltransferase+induces+autophagic-dependent+apoptosis+and+impairs+tumor+growth&doi=10.1038%2Fonc.2010.247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth</span></div><div class="casAuthors">Wang, M.; Hossain, M. S.; Tan, W.; Coolman, B.; Zhou, J.; Liu, S.; Casey, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">4959-4970</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of isoprenylcysteine carboxylmethyltransferase (Icmt), which catalyzes the final step in the post-translational C-terminal processing of prenylated proteins, suppresses tumor cell growth and induces cell death.  Icmt inhibition by either a small mol. inhibitor termed as cysmethynil or inhibitory RNA induces marked autophagy leading to cell death.  HepG2 cells were used to investigate the function of autophagy in tumor cell death.  Suppression of autophagy, either pharmacol. or through knockdown of the autophagy essential proteins, Atg5 or Atg1, inhibits not only cysmethynil-induced autophagy, but also apoptosis in HepG2 cells.  The dependence of cysmethynil-induced apoptosis on autophagy was further shown using autophagy-deficient mouse embryonic fibroblast (MEF) cells.  Atg5-/- MEF cells were found to be resistant to cysmethynil-induced apoptosis, whereas wild-type MEFs showed high sensitivity to apoptosis induction.  These data indicate that inhibition of Icmt can elicit cell death through two linked mechanisms, autophagy and apoptosis, and that autophagy can be an active player upstream of apoptosis in cell types capable of apoptotic cell death, such as HepG2 and MEFs.  Further, treatment of mice-bearing HepG2-derived tumors with cysmethynil resulted in marked inhibition of tumor growth; anal. of tumor tissue from these mice revealed markers consistent with autophagy induction and cell growth arrest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW_YIMkTsLL7Vg90H21EOLACvtfcHk0ljSF6_dplNGWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1aitr0%253D&md5=2a0466842130fe04a9b9a4cbd4e49e8d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fonc.2010.247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2010.247%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DHossain%26aufirst%3DM.%2BS.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DCoolman%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26atitle%3DInhibition%2520of%2520isoprenylcysteine%2520carboxylmethyltransferase%2520induces%2520autophagic-dependent%2520apoptosis%2520and%2520impairs%2520tumor%2520growth%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D4959%26epage%3D4970%26doi%3D10.1038%2Fonc.2010.247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manu, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teh, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of isoprenylcysteine carboxylmethyltransferase induces cell-cycle arrest and apoptosis through p21 and p21-regulated BNIP3 induction in pancreatic cancer</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">914</span>– <span class="NLM_lpage">923</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1158%2F1535-7163.MCT-16-0703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=28167504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFemsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=914-923&author=K.+A.+Manuauthor=T.+F.+Chaiauthor=J.+T.+Tehauthor=W.+L.+Zhuauthor=P.+J.+Caseyauthor=M.+Wang&title=Inhibition+of+isoprenylcysteine+carboxylmethyltransferase+induces+cell-cycle+arrest+and+apoptosis+through+p21+and+p21-regulated+BNIP3+induction+in+pancreatic+cancer&doi=10.1158%2F1535-7163.MCT-16-0703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer</span></div><div class="casAuthors">Manu, Kanjoormana Aryan; Chai, Tin Fan; Teh, Jing Tsong; Zhu, Wan Long; Casey, Patrick J.; Wang, Mei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">914-923</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Pancreatic cancer remains one of the most difficult to treat human cancers despite recent advances in targeted therapy.  Inhibition of isoprenylcysteine carboxylmethyltransferase (ICMT), an enzyme that posttranslationally modifies a group of proteins including several small GTPases, suppresses proliferation of some human cancer cells.  However, the efficacy of ICMT inhibition on human pancreatic cancer has not been evaluated.  In this study, we have evaluated a panel of human pancreatic cancer cell lines and identified those that are sensitive to ICMT inhibition.  In these cells, ICMT suppression inhibited proliferation and induced apoptosis.  This responsiveness to ICMT inhibition was confirmed in in vivo xenograft tumor mouse models using both a small-mol. inhibitor and shRNA-targeting ICMT.  Mechanistically, we found that, in sensitive pancreatic cancer cells, ICMT inhibition induced mitochondrial respiratory deficiency and cellular energy depletion, leading to significant upregulation of p21.  Furthermore, we characterized the role of p21 as a regulator and coordinator of cell signaling that responds to cell energy depletion.  Apoptosis, but not autophagy, that is induced via p21-activated BNIP3 expression accounts for the efficacy of ICMT inhibition in sensitive pancreatic cancer cells in both in vitro and in vivo models.  In contrast, cells resistant to ICMT inhibition demonstrated no mitochondria dysfunction or p21 signaling changes under ICMT suppression.  These findings not only identify pancreatic cancers as potential therapeutic targets for ICMT suppression but also provide an avenue for identifying those subtypes that would be most responsive to agents targeting this crit. enzyme.  Mol Cancer Ther; 16(5); 914-23. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbBp0WbhKv7LVg90H21EOLACvtfcHk0ljSF6_dplNGWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFemsLs%253D&md5=8c766434a805bfc047d0d7252117e881</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0703%26sid%3Dliteratum%253Aachs%26aulast%3DManu%26aufirst%3DK.%2BA.%26aulast%3DChai%26aufirst%3DT.%2BF.%26aulast%3DTeh%26aufirst%3DJ.%2BT.%26aulast%3DZhu%26aufirst%3DW.%2BL.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26aulast%3DWang%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520isoprenylcysteine%2520carboxylmethyltransferase%2520induces%2520cell-cycle%2520arrest%2520and%2520apoptosis%2520through%2520p21%2520and%2520p21-regulated%2520BNIP3%2520induction%2520in%2520pancreatic%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2017%26volume%3D16%26spage%3D914%26epage%3D923%26doi%3D10.1158%2F1535-7163.MCT-16-0703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Go, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leow, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorla, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schüller, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span> <span> </span><span class="NLM_article-title">Amino derivatives of indole as potent inhibitors of isoprenylcysteine carboxyl methyltransferase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6838</span>– <span class="NLM_lpage">6850</span>, <span class="refDoi"> DOI: 10.1021/jm1002843</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1002843" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSnsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6838-6850&author=M.-L.+Goauthor=J.+L.+Leowauthor=S.+K.+Gorlaauthor=A.+P.+Sch%C3%BCllerauthor=M.+Wangauthor=P.+J.+Casey&title=Amino+derivatives+of+indole+as+potent+inhibitors+of+isoprenylcysteine+carboxyl+methyltransferase&doi=10.1021%2Fjm1002843"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Amino Derivatives of Indole As Potent Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase</span></div><div class="casAuthors">Go, Mei-Lin; Leow, Jo Lene; Gorla, Suresh Kumar; Schuller, Andreas Peter; Wang, Mei; Casey, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6838-6850</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The enzyme isoprenylcysteine carboxyl methyltransferase (Icmt) plays an important role in the post-translational modification of proteins that are involved in the regulation of cell growth.  The indole acetamide cysmethynil(I) is by far the most potent and widely investigated Icmt inhibitor, but it has modest antiproliferative activity and may have pharmacokinetic limitations due to its lipophilic character.  We report here that cysmethynil can be structurally modified to give analogs that are as potent in inhibiting Icmt but with significantly greater antiproliferative activity.  Key modifications were the replacement of the acetamide side chain by tertiary amino groups, the n-octyl side chain by isoprenyl and the 5-m-tolyl ring by fluorine.  Moreover, these analogs have lower lipophilicities that could lead to improved pharmacokinetic profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLOoh-BVsKBLVg90H21EOLACvtfcHk0li_VAMJLfDabA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSnsrbK&md5=7c0749dc74d7651abe3f67a8ddc5979b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm1002843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1002843%26sid%3Dliteratum%253Aachs%26aulast%3DGo%26aufirst%3DM.-L.%26aulast%3DLeow%26aufirst%3DJ.%2BL.%26aulast%3DGorla%26aufirst%3DS.%2BK.%26aulast%3DSch%25C3%25BCller%26aufirst%3DA.%2BP.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26atitle%3DAmino%2520derivatives%2520of%2520indole%2520as%2520potent%2520inhibitors%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6838%26epage%3D6850%26doi%3D10.1021%2Fjm1002843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrycyna, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Non-substrate based, small molecule inhibitors of the human isoprenylcysteine carboxyl methyltransferase</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1016</span>– <span class="NLM_lpage">1021</span>, <span class="refDoi"> DOI: 10.1039/C6MD00130K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1039%2FC6MD00130K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=27547295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsF2ksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1016-1021&author=K.+V.+Butlerauthor=K.+Bohnauthor=C.+A.+Hrycynaauthor=J.+Jin&title=Non-substrate+based%2C+small+molecule+inhibitors+of+the+human+isoprenylcysteine+carboxyl+methyltransferase&doi=10.1039%2FC6MD00130K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Non-substrate based, small molecule inhibitors of the human isoprenylcysteine carboxyl methyltransferase</span></div><div class="casAuthors">Butler, Kyle V.; Bohn, Kelsey; Hrycyna, Christine A.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1016-1021</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Activating mutations of human K-Ras proteins are among the most common oncogenic mutations, present in approx. 30% of all human cancers.  Post-translational modifications to K-Ras guide it to the plasma membrane and disruption of this localization inhibits the growth of Ras-driven cancers.  The human isoprenylcysteine carboxylmethyltransferase (hIcmt) enzyme catalyzes the final α-carboxyl Me esterification of the C-terminal farnesyl cysteine of K-Ras, which is necessary for its proper localization.  Thus, hIcmt inhibition is a regarded as a promising cancer therapy.  A high quality inhibitor of hIcmt with in vivo activity would advance hIcmt research and drug development.  Herein, we report the results of a screen for small mol. hIcmt inhibitors in a library of mols. that were not hIcmt substrate analogs.  The lead compd. identified by this screen (1) was modified to remove chem. liabilities and to increase potency.  The most potent resulting compd. (5) inhibited hIcmt in vitro with low micromolar potency (IC50 = 1.5 ± 0.2 μM) and was kinetically characterized as a competitive inhibitor for prenylated substrates and a non-competitive inhibitor for the cofactor and Me donor S-adenosylmethionine (SAM).  These inhibitors offer important structure activity relationships for the future development of hIcmt inhibitors with in vivo activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSVUxcNKwja7Vg90H21EOLACvtfcHk0li_VAMJLfDabA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsF2ksr4%253D&md5=70f666b6f64ae066f1e6779e5d9081de</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2FC6MD00130K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00130K%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DBohn%26aufirst%3DK.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DNon-substrate%2520based%252C%2520small%2520molecule%2520inhibitors%2520of%2520the%2520human%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%26jtitle%3DMedChemComm%26date%3D2016%26volume%3D7%26spage%3D1016%26epage%3D1021%26doi%3D10.1039%2FC6MD00130K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fechner, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addepalli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forster, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guymer, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, R. J.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of the cancer target, isoprenylcysteine carboxyl methyltransferase, from <i>Hovea parvicalyx</i></span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1886</span>– <span class="NLM_lpage">1889</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2008.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.phytochem.2008.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=18466935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFaqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2008&pages=1886-1889&author=M.+S.+Buchananauthor=A.+R.+Carrollauthor=G.+A.+Fechnerauthor=A.+Boyleauthor=M.+Simpsonauthor=R.+Addepalliauthor=V.+M.+Averyauthor=P.+I.+Forsterauthor=G.+P.+Guymerauthor=T.+Cheungauthor=H.+Chenauthor=R.+J.+Quinn&title=Small-molecule+inhibitors+of+the+cancer+target%2C+isoprenylcysteine+carboxyl+methyltransferase%2C+from+Hovea+parvicalyx&doi=10.1016%2Fj.phytochem.2008.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of the cancer target, isoprenylcysteine carboxyl methyltransferase, from Hovea parvicalyx</span></div><div class="casAuthors">Buchanan, Malcolm S.; Carroll, Anthony R.; Fechner, Gregory A.; Boyle, Anthony; Simpson, Moana; Addepalli, Rama; Avery, Vicky M.; Forster, Paul I.; Guymer, Gordon P.; Cheung, Tony; Chen, Huwei; Quinn, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1886-1889</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Isoprenylcysteine carboxyl methyltransferase (Icmt) is enzyme target in anticancer drug discovery.  An Icmt natural product high-throughput screening campaign was conducted and a hit ext. from the roots of Hovea parvicalyx was identified.  2'-Methoxy-3'-prenyl-licodione and 2'-methoxy-3',3''-diprenyl-licodione, two prenylated β-hydroxychalcone compds., together with the known flavanone (S)-glabrol, were isolated and identified as bioactive constituents.  Their structures were detd. largely by 1D and 2D NMR spectroscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyzV9rMjOywLVg90H21EOLACvtfcHk0lg_azFIbl9fsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFaqurY%253D&md5=f701e2cef744ae2d6af8d154a1b49186</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2008.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2008.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DBuchanan%26aufirst%3DM.%2BS.%26aulast%3DCarroll%26aufirst%3DA.%2BR.%26aulast%3DFechner%26aufirst%3DG.%2BA.%26aulast%3DBoyle%26aufirst%3DA.%26aulast%3DSimpson%26aufirst%3DM.%26aulast%3DAddepalli%26aufirst%3DR.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DForster%26aufirst%3DP.%2BI.%26aulast%3DGuymer%26aufirst%3DG.%2BP.%26aulast%3DCheung%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520cancer%2520target%252C%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%252C%2520from%2520Hovea%2520parvicalyx%26jtitle%3DPhytochemistry%26date%3D2008%26volume%3D69%26spage%3D1886%26epage%3D1889%26doi%3D10.1016%2Fj.phytochem.2008.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fechner, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addepalli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, R. J.</span></span> <span> </span><span class="NLM_article-title">Aplysamine 6, an alkaloidal inhibitor of Isoprenylcysteine carboxyl methyltransferase from the sponge <i>Pseudoceratina sp</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1021/np0706623</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np0706623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktlCitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=1066-1067&author=M.+S.+Buchananauthor=A.+R.+Carrollauthor=G.+A.+Fechnerauthor=A.+Boyleauthor=M.+Simpsonauthor=R.+Addepalliauthor=V.+M.+Averyauthor=J.+N.+Hooperauthor=T.+Cheungauthor=H.+Chenauthor=R.+J.+Quinn&title=Aplysamine+6%2C+an+alkaloidal+inhibitor+of+Isoprenylcysteine+carboxyl+methyltransferase+from+the+sponge+Pseudoceratina+sp&doi=10.1021%2Fnp0706623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Aplysamine 6, an Alkaloidal Inhibitor of Isoprenylcysteine Carboxyl Methyltransferase from the Sponge Pseudoceratina sp.</span></div><div class="casAuthors">Buchanan, Malcolm S.; Carroll, Anthony R.; Fechner, Gregory A.; Boyle, Anthony; Simpson, Moana; Addepalli, Rama; Avery, Vicky M.; Hooper, John N. A.; Cheung, Tony; Chen, Huwei; Quinn, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1066-1067</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">The anticancer target isoprenylcysteine carboxyl methyltransferase (Icmt) was the focus of a natural product high-throughput screening campaign.  The Australian marine sponge Pseudoceratina sp. yielded aplysamine 6 (I), a new bromotyrosine deriv. with an α,β-unsatd. amide linkage, as the bioactive constituent.  Its structure was detd. by 1D and 2D NMR spectroscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB4sAT-kEkcLVg90H21EOLACvtfcHk0lg_azFIbl9fsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktlCitb0%253D&md5=1f89ee78d25e3e33c34244af5e98d4ee</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fnp0706623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp0706623%26sid%3Dliteratum%253Aachs%26aulast%3DBuchanan%26aufirst%3DM.%2BS.%26aulast%3DCarroll%26aufirst%3DA.%2BR.%26aulast%3DFechner%26aufirst%3DG.%2BA.%26aulast%3DBoyle%26aufirst%3DA.%26aulast%3DSimpson%26aufirst%3DM.%26aulast%3DAddepalli%26aufirst%3DR.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DHooper%26aufirst%3DJ.%2BN.%26aulast%3DCheung%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DAplysamine%25206%252C%2520an%2520alkaloidal%2520inhibitor%2520of%2520Isoprenylcysteine%2520carboxyl%2520methyltransferase%2520from%2520the%2520sponge%2520Pseudoceratina%2520sp%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2008%26volume%3D71%26spage%3D1066%26epage%3D1067%26doi%3D10.1021%2Fnp0706623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fechner, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addepalli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, R. J.</span></span> <span> </span><span class="NLM_article-title">Spermatinamine, the first natural product inhibitor of isoprenylcysteine carboxyl methyltransferase, a new cancer target</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6860</span>– <span class="NLM_lpage">6863</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.bmcl.2007.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=17964784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWjtL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6860-6863&author=M.+S.+Buchananauthor=A.+R.+Carrollauthor=G.+A.+Fechnerauthor=A.+Boyleauthor=M.+M.+Simpsonauthor=R.+Addepalliauthor=V.+M.+Averyauthor=J.+N.+Hooperauthor=N.+Suauthor=H.+Chenauthor=R.+J.+Quinn&title=Spermatinamine%2C+the+first+natural+product+inhibitor+of+isoprenylcysteine+carboxyl+methyltransferase%2C+a+new+cancer+target&doi=10.1016%2Fj.bmcl.2007.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Spermatinamine, the first natural product inhibitor of isoprenylcysteine carboxyl methyltransferase, a new cancer target</span></div><div class="casAuthors">Buchanan, Malcolm S.; Carroll, Anthony R.; Fechner, Gregory A.; Boyle, Anthony; Simpson, Moana M.; Addepalli, Rama; Avery, Vicky M.; Hooper, John N. A.; Su, Nancy; Chen, Huawei; Quinn, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6860-6863</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Isoprenylcysteine methyltransferases (Icmt) catalyzes the carboxyl methylation of oncogenic proteins in the final step of a series of post-translational modifications.  The inhibition of Icmt provides an attractive and novel anticancer target.  A natural product high-throughput screening campaign was conducted to discover inhibitors of Icmt.  The Australian marine sponge, Pseudoceratina sp., yielded spermatinamine, a novel alkaloid with a bromotyrosyl-spermine-bromotyrosyl sequence, as the bioactive constituent.  Its structure was detd. by 1D and 2D NMR spectroscopy.  Spermatinamine is the first natural product inhibitor of Icmt.  This paper reports the isolation, structure elucidation, and Icmt inhibitory activity of spermatinamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC2ISo0P6FiLVg90H21EOLACvtfcHk0lg_azFIbl9fsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWjtL%252FO&md5=5451248296c7fc75a40b108889e6f6f6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DBuchanan%26aufirst%3DM.%2BS.%26aulast%3DCarroll%26aufirst%3DA.%2BR.%26aulast%3DFechner%26aufirst%3DG.%2BA.%26aulast%3DBoyle%26aufirst%3DA.%26aulast%3DSimpson%26aufirst%3DM.%2BM.%26aulast%3DAddepalli%26aufirst%3DR.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DHooper%26aufirst%3DJ.%2BN.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DSpermatinamine%252C%2520the%2520first%2520natural%2520product%2520inhibitor%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%252C%2520a%2520new%2520cancer%2520target%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6860%26epage%3D6863%26doi%3D10.1016%2Fj.bmcl.2007.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leow, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, M. L.</span></span> <span> </span><span class="NLM_article-title">Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1025</span>– <span class="NLM_lpage">1032</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.11.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.bmcl.2006.11.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=17157012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12ktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1025-1032&author=J.+L.+Leowauthor=R.+Baronauthor=P.+J.+Caseyauthor=M.+L.+Go&title=Quantitative+structure-activity+relationship+%28QSAR%29+of+indoloacetamides+as+inhibitors+of+human+isoprenylcysteine+carboxyl+methyltransferase&doi=10.1016%2Fj.bmcl.2006.11.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase</span></div><div class="casAuthors">Leow, Jo-Lene; Baron, Rudi; Casey, Patrick J.; Go, Mei-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1025-1032</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A QSAR is developed for the isoprenylcysteine carboxyl methyltransferase (ICMT) inhibitory activities of a series of indoloacetamides (n = 72) that are structurally related to cysmethynil, a selective ICMT inhibitor.  Multivariate anal. tools (principal component anal. (PCA) and projection to latent structures (PLS)), multi-linear regression (MLR) and comparative mol. field anal. (CoMFA) are used to develop a suitably predictive model for the purpose of optimizing and identifying members with more potent inhibitory activity.  The resulting model shows that good activity is detd. largely by the characteristics of the substituent attached to the indole nitrogen, which should be a lipophilic residue with fairly wide dimensions.  In contrast, the substituted Ph ring attached to the indole ring must be of limited dimensions and lipophilicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7HmRpJ6zHhrVg90H21EOLACvtfcHk0lh0QdlSy_850g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12ktb0%253D&md5=840c1c381a1de77937f3f73358b839eb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.11.030%26sid%3Dliteratum%253Aachs%26aulast%3DLeow%26aufirst%3DJ.%2BL.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26aulast%3DGo%26aufirst%3DM.%2BL.%26atitle%3DQuantitative%2520structure-activity%2520relationship%2520%2528QSAR%2529%2520of%2520indoloacetamides%2520as%2520inhibitors%2520of%2520human%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1025%26epage%3D1032%26doi%3D10.1016%2Fj.bmcl.2006.11.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramanujulu, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yap, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, M. L.</span></span> <span> </span><span class="NLM_article-title">Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">378</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.ejmech.2013.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=23514631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFaqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2013&pages=378-386&author=P.+M.+Ramanujuluauthor=T.+Yangauthor=S.+Q.+Yapauthor=F.+C.+Wongauthor=P.+J.+Caseyauthor=M.+Wangauthor=M.+L.+Go&title=Functionalized+indoleamines+as+potent%2C+drug-like+inhibitors+of+isoprenylcysteine+carboxyl+methyltransferase+%28ICMT%29&doi=10.1016%2Fj.ejmech.2013.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt)</span></div><div class="casAuthors">Ramanujulu, Pondy M.; Yang, Tianming; Yap, Siew-Qi; Wong, Fui-Chung; Casey, Patrick J.; Wang, Mei; Go, Mei-Lin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">378-386</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The enzyme isoprenylcysteine carboxyl methyltransferase (Icmt) plays an important role in the post-translational modification of proteins involved in the regulation of cell growth and oncogenesis.  The biol. consequences of Icmt inhibition strongly implicate the enzyme as a potential therapeutic target for cancer and provide a compelling rationale for developing specific Icmt inhibitors as anti-cancer agents.  We report here the systematic modification of the known Icmt inhibitor cysmethynil to give an analog I with greatly improved soly. and PAMPA permeability which was achieved with concurrent gains in Icmt inhibitory and cell-based antiproliferative activities.  The modifications involved replacing the amide side chain of cysmethynil with a tertiary amine, and introducing an aminopyrimidine ring in place of m-tolyl.  The presence of the weakly basic and polar aminopyrimidine ring contributed significantly to the potency and drug-like profile of the final compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraQuKj1ZyZabVg90H21EOLACvtfcHk0lh0QdlSy_850g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFaqurs%253D&md5=7afce963dd545c964b10a67bbae8f712</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DRamanujulu%26aufirst%3DP.%2BM.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DYap%26aufirst%3DS.%2BQ.%26aulast%3DWong%26aufirst%3DF.%2BC.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DGo%26aufirst%3DM.%2BL.%26atitle%3DFunctionalized%2520indoleamines%2520as%2520potent%252C%2520drug-like%2520inhibitors%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520%2528ICMT%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D63%26spage%3D378%26epage%3D386%26doi%3D10.1016%2Fj.ejmech.2013.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanujulu, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirawan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span> <span> </span><span class="NLM_article-title">An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1280</span>– <span class="NLM_lpage">1291</span>, <span class="refDoi"> DOI: 10.4161/cbt.29692</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.4161%2Fcbt.29692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=24971579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2mtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=1280-1291&author=H.+Y.+Lauauthor=P.+M.+Ramanujuluauthor=D.+Guoauthor=T.+Yangauthor=M.+Wirawanauthor=P.+J.+Caseyauthor=M.+L.+Goauthor=M.+Wang&title=An+improved+isoprenylcysteine+carboxylmethyltransferase+inhibitor+induces+cancer+cell+death+and+attenuates+tumor+growth+in+vivo&doi=10.4161%2Fcbt.29692"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo</span></div><div class="casAuthors">Lau, Hiu Yeung; Ramanujulu, Pondy M.; Guo, Dianyan; Yang, Tianming; Wirawan, Melissa; Casey, Patrick J.; Go, Mei-Lin; Wang, Mei</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1280-1291</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Inhibitors of isoprenylcysteine carboxylmethyltransferase (Icmt) are promising anti-cancer agents, as modification by Icmt is an essential component of the protein prenylation pathway for a group of proteins that includes Ras GTPases.  Cysmethynil, a prototypical indole-based inhibitor of Icmt, effectively inhibits tumor cell growth.  However, the phys. properties of cysmethynil, such as its low aq. soly., make it a poor candidate for clin. development.  A novel amino-deriv. of cysmethynil with superior phys. properties and marked improvement in efficacy, termed compd. 8.12, has recently been reported.  We report here that Icmt-/- mouse embryonic fibroblasts (MEFs) are much more resistant to compd. 8.12-induced cell death than their wild-type counterparts, providing evidence that the anti-proliferative effects of this compd. are mediated through an Icmt specific mechanism.  Treatment of PC3 prostate and HepG2 liver cancer cells with compd. 8.12 resulted in pre-lamin A accumulation and Ras delocalization from the plasma membrane, both expected outcomes from inhibition of the Icmt-catalyzed carboxylmethylation.  Treatment with compd. 8.12 induced cell cycle arrest, autophagy and cell death, and abolished anchorage-independent colony formation.  Consistent with its greater in vitro efficacy, compd. 8.12 inhibited tumor growth with greater potency than cysmethynil in a xenograft mouse model.  Further, a drug combination study identified synergistic antitumor efficacy of compd. 8.12 and the epithelial growth factor receptor (EGFR)-inhibitor gefitinib, possibly through enhancement of autophagy.  This study establishes compd. 8.12 as a pharmacol. inhibitor of Icmt that is an attractive candidate for further preclin. and clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLZuGw7pwaW7Vg90H21EOLACvtfcHk0lgubnSLzyrNLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2mtrbN&md5=15ccd2bf30b145cd714933e06c1d08e5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4161%2Fcbt.29692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.29692%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DH.%2BY.%26aulast%3DRamanujulu%26aufirst%3DP.%2BM.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DWirawan%26aufirst%3DM.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26aulast%3DGo%26aufirst%3DM.%2BL.%26aulast%3DWang%26aufirst%3DM.%26atitle%3DAn%2520improved%2520isoprenylcysteine%2520carboxylmethyltransferase%2520inhibitor%2520induces%2520cancer%2520cell%2520death%2520and%2520attenuates%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2014%26volume%3D15%26spage%3D1280%26epage%3D1291%26doi%3D10.4161%2Fcbt.29692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahne, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrycyna, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, R. A.</span></span> <span> </span><span class="NLM_article-title">Lipid and sulfur substituted prenylcysteine analogs as human Icmt inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5616</span>– <span class="NLM_lpage">5619</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.06.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.bmcl.2011.06.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=21782433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKisLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5616-5619&author=J.%0AA.+Bergmanauthor=K.+Hahneauthor=C.+A.+Hrycynaauthor=R.+A.+Gibbs&title=Lipid+and+sulfur+substituted+prenylcysteine+analogs+as+human+Icmt+inhibitors&doi=10.1016%2Fj.bmcl.2011.06.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid and sulfur substituted prenylcysteine analogs as human Icmt inhibitors</span></div><div class="casAuthors">Bergman, Joel A.; Hahne, Kalub; Hrycyna, Christine A.; Gibbs, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5616-5619</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibition of isoprenylcysteine carboxyl methyltransferase (Icmt) offers a promising strategy for K-Ras driven cancers.  The authors describe the synthesis and inhibitory activity of substrate-based analogs derived from several novel scaffolds.  Modifications of both the prenyl group and thioether of N-acetyl-S-farnesyl-L-cysteine (AFC), a substrate for human Icmt (hIcmt), have resulted in low micromolar inhibitors of Icmt and have given insights into the nature of the prenyl binding site of hIcmt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkNJdXofQ_v7Vg90H21EOLACvtfcHk0lgubnSLzyrNLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKisLvO&md5=418a35fcf14a5af16579ba586103a397</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.06.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.06.053%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%2BA.%26aulast%3DHahne%26aufirst%3DK.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DGibbs%26aufirst%3DR.%2BA.%26atitle%3DLipid%2520and%2520sulfur%2520substituted%2520prenylcysteine%2520analogs%2520as%2520human%2520Icmt%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5616%26epage%3D5619%26doi%3D10.1016%2Fj.bmcl.2011.06.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahne, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrycyna, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, R. A.</span></span> <span> </span><span class="NLM_article-title"><i>S</i>-Farnesyl-thiopropionic acid triazoles as potent inhibitors of isoprenylcysteine carboxyl methyltransferase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1021/ml200106d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200106d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaktb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=15-19&author=J.+A.+Bergmanauthor=K.+Hahneauthor=J.+Songauthor=C.+A.+Hrycynaauthor=R.+A.+Gibbs&title=S-Farnesyl-thiopropionic+acid+triazoles+as+potent+inhibitors+of+isoprenylcysteine+carboxyl+methyltransferase&doi=10.1021%2Fml200106d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">S-Farnesyl-Thiopropionic Acid Triazoles as Potent Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase</span></div><div class="casAuthors">Bergman, Joel A.; Hahne, Kalub; Song, Jiao; Hrycyna, Christine A.; Gibbs, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-19</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and synthesis of novel FTPA-triazole compds. is reported as potent inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt), through a focus on thioether and isoprenoid mimetics.  These mimetics were coupled utilizing a copper-assisted cycloaddn. to assemble the potential inhibitors.  Using the resulting triazole from the coupling as an isoprenyl mimetic resulted in the biphenyl-substituted FTPA triazole I.  This lipid-modified analog is a potent inhibitor of Icmt (IC50 = 0.8 ± 0.1 μM; calcd. Ki = 0.4 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3TwFwuCsKV7Vg90H21EOLACvtfcHk0lguZKghFwxPBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaktb7E&md5=32f31247e1db931a204eb7e3ed268996</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fml200106d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200106d%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%2BA.%26aulast%3DHahne%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DGibbs%26aufirst%3DR.%2BA.%26atitle%3DS-Farnesyl-thiopropionic%2520acid%2520triazoles%2520as%2520potent%2520inhibitors%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D15%26epage%3D19%26doi%3D10.1021%2Fml200106d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majmudar, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahne, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrycyna, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, R. A.</span></span> <span> </span><span class="NLM_article-title">Probing the isoprenylcysteine carboxyl methyltransferase (Icmt) binding pocket: Sulfonamide modified farnesyl cysteine (SMFC) analogs as Icmt inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2616</span>– <span class="NLM_lpage">2620</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.01.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.bmcl.2011.01.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=21334890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFKisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2616-2620&author=J.+D.+Majmudarauthor=K.+Hahneauthor=C.+A.+Hrycynaauthor=R.+A.+Gibbs&title=Probing+the+isoprenylcysteine+carboxyl+methyltransferase+%28Icmt%29+binding+pocket%3A+Sulfonamide+modified+farnesyl+cysteine+%28SMFC%29+analogs+as+Icmt+inhibitors&doi=10.1016%2Fj.bmcl.2011.01.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the isoprenylcysteine carboxyl methyltransferase (Icmt) binding pocket: Sulfonamide modified farnesyl cysteine (SMFC) analogs as Icmt inhibitors</span></div><div class="casAuthors">Majmudar, Jaimeen D.; Hahne, Kalub; Hrycyna, Christine A.; Gibbs, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2616-2620</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human isoprenylcysteine carboxyl methyltransferase (hIcmt) is a promising anticancer target as it is important for the post-translational modification of oncogenic Ras proteins.  We herein report the synthesis and biochem. activity of 41 farnesyl-cysteine based analogs vs. hIcmt.  We have demonstrated that the amide linkage of a hIcmt substrate can be replaced by a sulfonamide bond to achieve hIcmt inhibition.  The most potent sulfonamide-modified farnesyl cysteine analog was 6ag with an IC50 of 8.8 ± 0.5 μM for hIcmt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW-55iBH-MXrVg90H21EOLACvtfcHk0lguZKghFwxPBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFKisbs%253D&md5=6d6a7272c83c936d4d99b0b88b134dbb</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.078%26sid%3Dliteratum%253Aachs%26aulast%3DMajmudar%26aufirst%3DJ.%2BD.%26aulast%3DHahne%26aufirst%3DK.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DGibbs%26aufirst%3DR.%2BA.%26atitle%3DProbing%2520the%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520%2528Icmt%2529%2520binding%2520pocket%253A%2520Sulfonamide%2520modified%2520farnesyl%2520cysteine%2520%2528SMFC%2529%2520analogs%2520as%2520Icmt%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2616%26epage%3D2620%26doi%3D10.1016%2Fj.bmcl.2011.01.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Judd, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slattum, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhoite, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valppu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostanin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardsen, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5031</span>– <span class="NLM_lpage">5047</span>, <span class="refDoi"> DOI: 10.1021/jm200249a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200249a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFShsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5031-5047&author=W.+R.+Juddauthor=P.+M.+Slattumauthor=K.+C.+Hoangauthor=L.+Bhoiteauthor=L.+Valppuauthor=G.+Albertsauthor=B.+Brownauthor=B.+Rothauthor=K.+Ostaninauthor=L.+Huangauthor=D.+Wettsteinauthor=B.+Richardsauthor=J.+A.+Willardsen&title=Discovery+and+SAR+of+methylated+tetrahydropyranyl+derivatives+as+inhibitors+of+isoprenylcysteine+carboxyl+methyltransferase+%28ICMT%29&doi=10.1021%2Fjm200249a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and SAR of Methylated Tetrahydropyranyl Derivatives as Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase (ICMT)</span></div><div class="casAuthors">Judd, Weston R.; Slattum, Paul M.; Hoang, Khanh C.; Bhoite, Leena; Valppu, Liisa; Alberts, Glen; Brown, Brita; Roth, Bruce; Ostanin, Kirill; Huang, Liwen; Wettstein, Daniel; Richards, Burt; Willardsen, J. Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5031-5047</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of tetrahydropyranyl (THP) derivs. has been developed as potent inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT) for use as anticancer agents.  Structural modification of the submicromolar hit compd. I led to the potent 3-methoxy substituted analog II [R = H].  Further SAR development around the THP ring resulted in an addnl. 10-fold increase in potency, exemplified by analog II [R = Me] with an IC50 of 1.3 nM.  Active and potent compds. demonstrated a dose-dependent increase in Ras cytosolic protein.  Potent ICMT inhibitors also reduced cell viability in several cancer cell lines with growth inhibition (GI50) values ranging from 0.3 to >100 μM.  However, none of the cellular effects obsd. using ICMT inhibitors were as pronounced as those resulting from a farnesyl-transferase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxtJBz5EBh_LVg90H21EOLACvtfcHk0ljILJ9KpeCqeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFShsrk%253D&md5=70c861a9d4ef4efcde4b94a2e0a88de9</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm200249a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200249a%26sid%3Dliteratum%253Aachs%26aulast%3DJudd%26aufirst%3DW.%2BR.%26aulast%3DSlattum%26aufirst%3DP.%2BM.%26aulast%3DHoang%26aufirst%3DK.%2BC.%26aulast%3DBhoite%26aufirst%3DL.%26aulast%3DValppu%26aufirst%3DL.%26aulast%3DAlberts%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DWettstein%26aufirst%3DD.%26aulast%3DRichards%26aufirst%3DB.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520methylated%2520tetrahydropyranyl%2520derivatives%2520as%2520inhibitors%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520%2528ICMT%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5031%26epage%3D5047%26doi%3D10.1021%2Fjm200249a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manolaridis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mas-Droux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barford, D.</span></span> <span> </span><span class="NLM_article-title">Mechanism of isoprenylcysteine carboxyl methylation from the crystal structure of the integral membrane methyltransferase ICMT</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">997</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2011.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.molcel.2011.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=22195972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1OqsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=997-1004&author=J.+Yangauthor=K.+Kulkarniauthor=I.+Manolaridisauthor=Z.+Zhangauthor=R.+B.+Doddauthor=C.+Mas-Drouxauthor=D.+Barford&title=Mechanism+of+isoprenylcysteine+carboxyl+methylation+from+the+crystal+structure+of+the+integral+membrane+methyltransferase+ICMT&doi=10.1016%2Fj.molcel.2011.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Isoprenylcysteine Carboxyl Methylation from the Crystal Structure of the Integral Membrane Methyltransferase ICMT</span></div><div class="casAuthors">Yang, Jing; Kulkarni, Kiran; Manolaridis, Ioannis; Zhang, Ziguo; Dodd, Roger B.; Mas-Droux, Corine; Barford, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">997-1004</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The posttranslational modification of C-terminal CAAX motifs in proteins such as Ras, most Rho GTPases, and G protein γ subunits, plays an essential role in detg. their subcellular localization and correct biol. function.  An integral membrane methyltransferase, isoprenylcysteine carboxyl methyltransferase (ICMT), catalyzes the final step of CAAX processing after prenylation of the cysteine residue and endoproteolysis of the -AAX motif.  We have detd. the crystal structure of a prokaryotic ICMT ortholog, revealing a markedly different architecture from conventional methyltransferases that utilize S-adenosyl-L-methionine (SAM) as a cofactor.  ICMT comprises a core of five transmembrane α helixes and a cofactor-binding pocket enclosed within a highly conserved C-terminal catalytic subdomain.  A tunnel linking the reactive Me group of SAM to the inner membrane provides access for the prenyl lipid substrate.  This study explains how an integral membrane methyltransferase achieves recognition of both a hydrophilic cofactor and a lipophilic prenyl group attached to a polar protein substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlb0eLuyX5P7Vg90H21EOLACvtfcHk0ljILJ9KpeCqeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1OqsL%252FE&md5=0094e850c208d2ad810e9b177a910fa5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKulkarni%26aufirst%3DK.%26aulast%3DManolaridis%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DDodd%26aufirst%3DR.%2BB.%26aulast%3DMas-Droux%26aufirst%3DC.%26aulast%3DBarford%26aufirst%3DD.%26atitle%3DMechanism%2520of%2520isoprenylcysteine%2520carboxyl%2520methylation%2520from%2520the%2520crystal%2520structure%2520of%2520the%2520integral%2520membrane%2520methyltransferase%2520ICMT%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D44%26spage%3D997%26epage%3D1004%26doi%3D10.1016%2Fj.molcel.2011.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diver, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koide, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koide, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, S. B.</span></span> <span> </span><span class="NLM_article-title">Atomic structure of the eukaryotic intramembrane Ras methyltransferase ICMT</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>553</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.1038/nature25439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1038%2Fnature25439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=29342140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVOisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=553&publication_year=2018&pages=526-529&author=M.+M.+Diverauthor=L.+Pediauthor=A.+Koideauthor=S.+Koideauthor=S.+B.+Long&title=Atomic+structure+of+the+eukaryotic+intramembrane+Ras+methyltransferase+ICMT&doi=10.1038%2Fnature25439"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic structure of the eukaryotic intramembrane RAS methyltransferase ICMT</span></div><div class="casAuthors">Diver, Melinda M.; Pedi, Leanne; Koide, Akiko; Koide, Shohei; Long, Stephen B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">553</span>
        (<span class="NLM_cas:issue">7689</span>),
    <span class="NLM_cas:pages">526-529</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The maturation of RAS GTPases and approx. 200 other cellular CAAX proteins involves three enzymic steps: addn. of a farnesyl or geranylgeranyl prenyl lipid to the cysteine (C) in the C-terminal CAAX motif, proteolytic cleavage of the AAX residues and methylation of the exposed prenylcysteine residue at its terminal carboxylate.  This final step is catalyzed by isoprenylcysteine carboxyl methyltransferase (ICMT), a eukaryote-specific integral membrane enzyme that resides in the endoplasmic reticulum.  ICMT is the only cellular enzyme that is known to methylate prenylcysteine substrates; methylation is important for the biol. functions of these substrates, such as the membrane localization and subsequent activity of RAS, prelamin A and RAB.  Inhibition of ICMT has potential for combating progeria and cancer.  Here we present an X-ray structure of ICMT, in complex with its cofactor, an ordered lipid mol. and a monobody inhibitor, at 2.3 Å resoln.  The active site spans cytosolic and membrane-exposed regions, indicating distinct entry routes for the cytosolic Me donor, S-adenosyl-L-methionine, and for prenylcysteine substrates, which are assocd. with the endoplasmic reticulum membrane.  The structure suggests how ICMT overcomes the topog. challenge and unfavorable energetics of bringing two reactants that have different cellular localizations together in a membrane environment-a relatively uncharacterized but defining feature of many integral membrane enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXFRW8xr3AZbVg90H21EOLACvtfcHk0lgD7CP1UtnIaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVOisb4%253D&md5=612327b61ef2d9448552fbf617e8d891</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnature25439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25439%26sid%3Dliteratum%253Aachs%26aulast%3DDiver%26aufirst%3DM.%2BM.%26aulast%3DPedi%26aufirst%3DL.%26aulast%3DKoide%26aufirst%3DA.%26aulast%3DKoide%26aufirst%3DS.%26aulast%3DLong%26aufirst%3DS.%2BB.%26atitle%3DAtomic%2520structure%2520of%2520the%2520eukaryotic%2520intramembrane%2520Ras%2520methyltransferase%2520ICMT%26jtitle%3DNature%26date%3D2018%26volume%3D553%26spage%3D526%26epage%3D529%26doi%3D10.1038%2Fnature25439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span> <span> </span><span class="NLM_article-title">A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">18678</span>– <span class="NLM_lpage">18684</span>, <span class="refDoi"> DOI: 10.1074/jbc.M801855200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1074%2Fjbc.M801855200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=18434300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsl2qsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=18678-18684&author=M.+Wangauthor=W.+Tanauthor=J.+Zhouauthor=J.+Leowauthor=M.+Goauthor=H.+S.+Leeauthor=P.+J.+Casey&title=A+small+molecule+inhibitor+of+isoprenylcysteine+carboxymethyltransferase+induces+autophagic+cell+death+in+PC3+prostate+cancer+cells&doi=10.1074%2Fjbc.M801855200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A Small Molecule Inhibitor of Isoprenylcysteine Carboxymethyltransferase Induces Autophagic Cell Death in PC3 Prostate Cancer Cells</span></div><div class="casAuthors">Wang, Mei; Tan, Wanloo; Zhou, Jin; Leow, Jolene; Go, Meilin; Lee, How Sung; Casey, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">18678-18684</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A no. of proteins involved in cell growth control, including members of the Ras family of GTPases, are modified at their C terminus by a three-step posttranslational process termed prenylation.  The enzyme isoprenylcysteine carboxylmethyl-transferase (Icmt) catalyzes the last step in this process, and genetic and pharmacol. suppression of Icmt activity significantly impacts on cell growth and oncogenesis.  Screening of a diverse chem. library led to the identification of a specific small mol. inhibitor of Icmt, cysmethynil, that inhibited growth factor signaling and tumorigenesis in an in vitro cancer cell model.  To further evaluate the mechanisms through which this Icmt inhibitor impacts on cancer cells, we developed both in vitro and in vivo models utilizing PC3 prostate cancer cells.  Treatment of these cells with cysmethynil resulted in both an accumulation of cells in the G1 phase and cell death.  Treatment of mice harboring PC3 cell-derived xenograft tumors with cysmethynil resulted in markedly reduced tumor size.  Anal. of cell death pathways unexpectedly showed minimal impact of cysmethynil treatment on apoptosis; rather, drug treatment significantly enhanced autophagy and autophagic cell death.  Cysmethynil-treated cells displayed reduced mammalian target of rapamycin (mTOR) signaling, providing a potential mechanism for the excessive autophagy as well as G1 cell cycle arrest obsd.  These results identify a novel mechanism for the antitumor activity of Icmt inhibition.  Further, the dual effects of cell death and cell cycle arrest by cysmethynil treatment strengthen the rationale for targeting Icmt in cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWTu9-dNQGiLVg90H21EOLACvtfcHk0lgD7CP1UtnIaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsl2qsrc%253D&md5=1d092bd2f6ab14055cbe179d3fbdf456</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M801855200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M801855200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLeow%26aufirst%3DJ.%26aulast%3DGo%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DH.%2BS.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26atitle%3DA%2520small%2520molecule%2520inhibitor%2520of%2520isoprenylcysteine%2520carboxymethyltransferase%2520induces%2520autophagic%2520cell%2520death%2520in%2520PC3%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D18678%26epage%3D18684%26doi%3D10.1074%2Fjbc.M801855200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balmain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Counter, C. M.</span></span> <span> </span><span class="NLM_article-title">A model for Ras mutation patterns in cancers: finding the sweet spot</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">777</span>, <span class="refDoi"> DOI: 10.1038/s41568-018-0076-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1038%2Fs41568-018-0076-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=30420765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Sgur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=767-777&author=S.+Liauthor=A.+Balmainauthor=C.+M.+Counter&title=A+model+for+Ras+mutation+patterns+in+cancers%3A+finding+the+sweet+spot&doi=10.1038%2Fs41568-018-0076-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A model for RAS mutation patterns in cancers: finding the sweet spot</span></div><div class="casAuthors">Li, Siqi; Balmain, Allan; Counter, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">767-777</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The three RAS genes - HRAS, NRAS and KRAS - are collectively mutated in one-third of human cancers, where they act as prototypic oncogenes.  Interestingly, there are rather distinct patterns to RAS mutations; the isoform mutated as well as the position and type of substitution vary between different cancers.  As RAS genes are among the earliest, if not the first, genes mutated in a variety of cancers, understanding how these mutation patterns arise could inform on not only how cancer begins but also the factors influencing this event, which has implications for cancer prevention.  To this end, we suggest that there is a narrow window or 'sweet spot' by which oncogenic RAS signalling can promote tumor initiation in normal cells.  As a consequence, RAS mutation patterns in each normal cell are a product of the specific RAS isoform mutated, as well as the position of the mutation and type of substitution to achieve an ideal level of signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwgiwQPHITKLVg90H21EOLACvtfcHk0lgD7CP1UtnIaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Sgur%252FJ&md5=34d62ae8e9b478af4b7e05d7f5bcab55</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fs41568-018-0076-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41568-018-0076-6%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DCounter%26aufirst%3DC.%2BM.%26atitle%3DA%2520model%2520for%2520Ras%2520mutation%2520patterns%2520in%2520cancers%253A%2520finding%2520the%2520sweet%2520spot%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2018%26volume%3D18%26spage%3D767%26epage%3D777%26doi%3D10.1038%2Fs41568-018-0076-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prior, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattos, C.</span></span> <span> </span><span class="NLM_article-title">A comprehensive survey of Ras mutations in cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2457</span>– <span class="NLM_lpage">2467</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-2612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1158%2F0008-5472.CAN-11-2612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=22589270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvF2ntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2457-2467&author=I.+A.+Priorauthor=P.+D.+Lewisauthor=C.+Mattos&title=A+comprehensive+survey+of+Ras+mutations+in+cancer&doi=10.1158%2F0008-5472.CAN-11-2612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A Comprehensive Survey of Ras Mutations in Cancer</span></div><div class="casAuthors">Prior, Ian A.; Lewis, Paul D.; Mattos, Carla</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2457-2467</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  All mammalian cells express 3 closely related Ras proteins, termed H-Ras, K-Ras, and N-Ras, that promote oncogenesis when they are mutationally activated at codon 12, 13, or 61.  Although there is a high degree of similarity among the isoforms, K-Ras mutations are far more frequently obsd. in cancer, and each isoform displays preferential coupling to particular cancer types.  We examd. the mutational spectra of Ras isoforms curated from large-scale tumor profiling and found that each isoform exhibits surprisingly distinctive codon mutation and amino-acid substitution biases.  These findings were unexpected given that these mutations occur in regions that share 100% amino-acid sequence identity among the 3 isoforms.  Of importance, many of these mutational biases were not due to differences in exposure to mutagens, because the patterns were still evident when compared within specific cancer types.  We discuss potential genetic and epigenetic mechanisms, as well as isoform-specific differences in protein structure and signaling, that may promote these distinct mutation patterns and differential coupling to specific cancers.  Cancer Res; 72(10); 2457-67.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg2lqiicosOLVg90H21EOLACvtfcHk0liP4npaFXumNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvF2ntL4%253D&md5=6d1894847015468f77c8b08b57c6d62a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-2612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-2612%26sid%3Dliteratum%253Aachs%26aulast%3DPrior%26aufirst%3DI.%2BA.%26aulast%3DLewis%26aufirst%3DP.%2BD.%26aulast%3DMattos%26aufirst%3DC.%26atitle%3DA%2520comprehensive%2520survey%2520of%2520Ras%2520mutations%2520in%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2457%26epage%3D2467%26doi%3D10.1158%2F0008-5472.CAN-11-2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stephen, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagni, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, F.</span></span> <span> </span><span class="NLM_article-title">Dragging Ras back in the ring</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2014.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.ccr.2014.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=24651010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksVWhtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=272-281&author=A.+G.+Stephenauthor=D.+Espositoauthor=R.+K.+Bagniauthor=F.+McCormick&title=Dragging+Ras+back+in+the+ring&doi=10.1016%2Fj.ccr.2014.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Dragging Ras Back in the Ring</span></div><div class="casAuthors">Stephen, Andrew G.; Esposito, Dominic; Bagni, Rachel K.; McCormick, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">272-281</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Ras proteins play a major role in human cancers but have not yielded to therapeutic attack.  Ras-driven cancers are among the most difficult to treat and often excluded from therapies.  The Ras proteins have been termed "undruggable," based on failures from an era in which understanding of signaling transduction, feedback loops, redundancy, tumor heterogeneity, and Ras' oncogenic role was poor.  Structures of Ras oncoproteins bound to their effectors or regulators are unsolved, and it is unknown precisely how Ras proteins activate their downstream targets.  These knowledge gaps have impaired development of therapeutic strategies.  A better understanding of Ras biol. and biochem., coupled with new ways of targeting undruggable proteins, is likely to lead to new ways of defeating Ras-driven cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsJEUXbjmDe7Vg90H21EOLACvtfcHk0liP4npaFXumNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksVWhtLY%253D&md5=1ecb33c95db7d5d6f910b9e2af2ec44e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DStephen%26aufirst%3DA.%2BG.%26aulast%3DEsposito%26aufirst%3DD.%26aulast%3DBagni%26aufirst%3DR.%2BK.%26aulast%3DMcCormick%26aufirst%3DF.%26atitle%3DDragging%2520Ras%2520back%2520in%2520the%2520ring%26jtitle%3DCancer%2520Cell%26date%3D2014%26volume%3D25%26spage%3D272%26epage%3D281%26doi%3D10.1016%2Fj.ccr.2014.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michaelson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silletti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philips, M.</span></span> <span> </span><span class="NLM_article-title">Postprenylation CAAX processing is required for proper localization of Ras but not Rho GTPases</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1606</span>– <span class="NLM_lpage">1616</span>, <span class="refDoi"> DOI: 10.1091/mbc.e04-11-0960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1091%2Fmbc.e04-11-0960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=15659645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1Kqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=1606-1616&author=D.+Michaelsonauthor=W.+Aliauthor=V.+K.+Chiuauthor=M.+Bergoauthor=J.+Sillettiauthor=L.+Wrightauthor=S.+G.+Youngauthor=M.+Philips&title=Postprenylation+CAAX+processing+is+required+for+proper+localization+of+Ras+but+not+Rho+GTPases&doi=10.1091%2Fmbc.e04-11-0960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Postprenylation CAAX processing is required for proper localization of Ras but not Rho GTPases</span></div><div class="casAuthors">Michaelson, David; Ali, Wasif; Chiu, Vi K.; Bergo, Martin; Silletti, Joseph; Wright, Latasha; Young, Stephen G.; Philips, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1606-1616</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">The CAAX motif at the C terminus of most monomeric GTPases is required for membrane targeting because it signals for a series of three posttranslational modifications that include isoprenylation, endoproteolytic release of the C-terminal-AAX amino acids, and carboxyl methylation of the newly exposed isoprenylcysteine.  The individual contributions of these modifications to protein trafficking and function are unknown.  To address this issue, we performed a series of expts. with mouse embryonic fibroblasts (MEFs) lacking Rce1 (responsible for removal of the -AAX sequence) or Icmt (responsible for carboxyl methylation of the isoprenylcysteine).  In MEFs lacking Rce1 or Icmt, farnesylated Ras proteins were mislocalized.  In contrast, the intracellular localizations of geranylgeranylated Rho GTPases were not perturbed.  Consistent with the latter finding, RhoGDI binding and actin remodeling were normal in Rce1- and Icmt-deficient cells.  Swapping geranylgeranylation for farnesylation on Ras proteins or vice versa on Rho proteins reversed the differential sensitivities to Rce1 and Icmt deficiency.  These results suggest that postprenylation CAAX processing is required for proper localization of farnesylated Ras but not geranygeranylated Rho proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUrSIABSX_3rVg90H21EOLACvtfcHk0lhDWIX7hdwyiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1Kqtrg%253D&md5=f05b58e64d4df62e6ac6fd9b10ae09d1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e04-11-0960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e04-11-0960%26sid%3Dliteratum%253Aachs%26aulast%3DMichaelson%26aufirst%3DD.%26aulast%3DAli%26aufirst%3DW.%26aulast%3DChiu%26aufirst%3DV.%2BK.%26aulast%3DBergo%26aufirst%3DM.%26aulast%3DSilletti%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DPhilips%26aufirst%3DM.%26atitle%3DPostprenylation%2520CAAX%2520processing%2520is%2520required%2520for%2520proper%2520localization%2520of%2520Ras%2520but%2520not%2520Rho%2520GTPases%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2005%26volume%3D16%26spage%3D1606%26epage%3D1616%26doi%3D10.1091%2Fmbc.e04-11-0960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lobell, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhimnathwala, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brucker, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buser, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davide, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deSolms, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis-Hutchings, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kral, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lumma, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machotka, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rands, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliff, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimbrook, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohl, N. E.</span></span> <span> </span><span class="NLM_article-title">Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8758</span>– <span class="NLM_lpage">8768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=11751396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1OntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=8758-8768&author=R.+B.+Lobellauthor=C.+A.+Omerauthor=M.+T.+Abramsauthor=H.+G.+Bhimnathwalaauthor=M.+J.+Bruckerauthor=C.+A.+Buserauthor=J.+P.+Davideauthor=S.+J.+deSolmsauthor=C.+J.+Dinsmoreauthor=M.+S.+Ellis-Hutchingsauthor=A.+M.+Kralauthor=D.+Liuauthor=W.+C.+Lummaauthor=S.+V.+Machotkaauthor=E.+Randsauthor=T.+M.+Williamsauthor=S.+L.+Grahamauthor=G.+D.+Hartmanauthor=A.+I.+Oliffauthor=D.+C.+Heimbrookauthor=N.+E.+Kohl&title=Evaluation+of+farnesyl%3Aprotein+transferase+and+geranylgeranyl%3Aprotein+transferase+inhibitor+combinations+in+preclinical+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models</span></div><div class="casAuthors">Lobell, Robert B.; Omer, Charles A.; Abrams, Marc T.; Bhimnathwala, Hema G.; Brucker, Mary Jo; Buser, Carolyn A.; Davide, Joseph P.; DeSolms, S. Jane; Dinsmore, Christopher J.; Ellis-Hutchings, Michelle S.; Kral, Astrid M.; Liu, Dongming; Lumma, William C.; Machotka, Samuel V.; Rands, Elaine; Williams, Theresa M.; Graham, Samuel L.; Hartman, George D.; Oliff, Allen I.; Heimbrook, David C.; Kohl, Nancy E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8758-8768</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Farnesyl:protein transferase (FPTase) inhibitors (FTIs) were originally developed as potential anticancer agents targeting the ras oncogene and are currently in clin. trials.  Whereas FTIs inhibit the farnesylation of Ha-Ras, they do not completely inhibit the prenylation of Ki-Ras, the allele most frequently mutated in human cancers.  Whereas farnesylation of Ki-Ras is blocked by FTIs, Ki-Ras remains prenylated in FTI-treated cells because of its modification by the related prenyltransferase, geranylgeranyl:protein transferase type I (GGPTase-I).  Hence, cells transformed with Ki-ras tend to be more resistant to FTIs than Ha-ras-transformed cells.  To det. whether Ki-ras-transformed cells can be targeted by combining an FTI with a GGPTase-I inhibitor (GGTI), we evaluated potent, selective FTIs, GGTIs, and dual prenylation inhibitors (DPIs) that have both FTI and GGTI activity.  We find that in human PSN-1 pancreatic tumor cells, which harbor oncogenic Ki-ras, and in other tumor lines having either wild-type or oncogenic Ki-ras, treatment with an FTI/GGTI combination or with a DPI blocks Ki-Ras prenylation and induces markedly higher levels of apoptosis relative to FTI or GGTI alone.  We demonstrate that these compds. can inhibit their enzyme targets in mice by monitoring pancreatic and tumor tissues from treated animals for inhibition of prenylation of Ki-Ras, HDJ2, a substrate specific for FPTase, and Rap1A, a substrate specific for GGPTase-I.  Continuous infusion (72 h) of varying doses of GGTI in conjunction with a high, fixed dose of FTI causes a dose-dependent inhibition of Ki-Ras prenylation.  However, a 72-h infusion of a GGTI, at a dose sufficient to inhibit Ki-Ras prenylation in the presence of an FTI, causes death within 2 wk of the infusion when administered either as monotherapy or in combination with an FTI.  DPIs are also lethal after a 72-h infusion at doses that inhibit Ki-Ras prenylation.  Because 24 h infusion of a high dose of DPI is tolerated and inhibits Ki-Ras prenylation, we compared the antitumor efficacy from a 24-h FTI infusion to that of a DPI in a nude mouse/PSN-1 tumor cell xenograft model and in Ki-ras transgenic mice with mammary tumors.  The FTI and DPI were dosed at a level that provided comparable inhibition of FPTase.  The FTI and the DPI displayed comparable efficacy, causing a decrease in growth rate of the PSN-1 xenograft tumors and tumor regression in the transgenic model, but neither treatment regimen induced a statistically significant increase in tumor cell apoptosis.  Although FTI/GGTI combinations elicit a greater apoptotic response than either agent alone in vitro, the toxicity assocd. with GGTI treatment in vivo limits the duration of treatment and, thus, may limit the therapeutic benefit that might be gained by inhibiting oncogenic Ki-Ras through dual prenyltransferase inhibitor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN8692wSeB0bVg90H21EOLACvtfcHk0lhDWIX7hdwyiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1OntQ%253D%253D&md5=a6bec938c55d2a308cadbce460d5f098</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DAbrams%26aufirst%3DM.%2BT.%26aulast%3DBhimnathwala%26aufirst%3DH.%2BG.%26aulast%3DBrucker%26aufirst%3DM.%2BJ.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DDavide%26aufirst%3DJ.%2BP.%26aulast%3DdeSolms%26aufirst%3DS.%2BJ.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DEllis-Hutchings%26aufirst%3DM.%2BS.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DLumma%26aufirst%3DW.%2BC.%26aulast%3DMachotka%26aufirst%3DS.%2BV.%26aulast%3DRands%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DOliff%26aufirst%3DA.%2BI.%26aulast%3DHeimbrook%26aufirst%3DD.%2BC.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26atitle%3DEvaluation%2520of%2520farnesyl%253Aprotein%2520transferase%2520and%2520geranylgeranyl%253Aprotein%2520transferase%2520inhibitor%2520combinations%2520in%2520preclinical%2520models%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D8758%26epage%3D8768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hollander, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frommer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallon, R.</span></span> <span> </span><span class="NLM_article-title">Human Ras-converting enzyme (hRCE1) endoproteolytic activity on K-ras-derived peptides</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1006/abio.2000.4795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1006%2Fabio.2000.4795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=11038283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntlKrtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2000&pages=129-137&author=I.+Hollanderauthor=E.+Frommerauthor=R.+Mallon&title=Human+Ras-converting+enzyme+%28hRCE1%29+endoproteolytic+activity+on+K-ras-derived+peptides&doi=10.1006%2Fabio.2000.4795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Human Ras-Converting Enzyme (hRCE1) Endoproteolytic Activity on K-Ras-Derived Peptides</span></div><div class="casAuthors">Hollander, Irwin; Frommer, Eileen; Mallon, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-137</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A human gene responsible for one of the steps in Ras post-translational modification and membrane localization, hRCE1, encodes a 35-kDa membrane-assocd. endoprotease.  We examd. hRCE1 activity using farnesylated 9 aa peptides with the core sequence, KSKTKC(farnesyl)VIM [(farnesyl) = (f)], from the C-terminus of K-Ras.  We first demonstrated hRCE1 specificity in cleavage location and endoproteolysis.  We then describe a direct fluorescent microtiter plate assay.  We demonstrated that hRCE1 protease cleaved KSKTKC(f)VIM peptides between the C(f) and V positions, generating KSKTKC(f) and the corresponding tripeptides as products.  We found that the sequence KSKTKC(f)VI was a better substrate for hRCE1 than KSKTKC(f)VIM.  We also found that hRCE1 cleaved modified versions of KSKTKC(f)VIM that incorporated either MCA or ABZ fluorescent chromophores at the N-terminus, and quenching-group-contg. amino acids at the V or M, but not the I, amino acid positions of VIM.  The quenching-group-contg. amino acids used were either QS (dinitrophenyldiaminopropionic acid) or QL (lysine ε-dinitrophenyl).  Cleavage of KSKTKC(f)VIM and modified versions of this peptide by hRCE1 was initially evaluated by HPLC product resoln. and quantitation.  The hRCE1 cleavage of quenched peptides enabled us to directly monitor proteolytic activity in a 96-well microtiter fluorescent plate assay.  The microtiter format assay was validated by its sensitivity to RPI, an inhibitor of prenyl protein protease.  A direct fluorescent assay provides an effective tool for further characterization of this enzyme and also for detection of novel inhibitors.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0MIthZ2R7Vg90H21EOLACvtfcHk0lg06oLFYmZTSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntlKrtr8%253D&md5=3007a622065e1f91b4e7f97ae090389e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1006%2Fabio.2000.4795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.2000.4795%26sid%3Dliteratum%253Aachs%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DFrommer%26aufirst%3DE.%26aulast%3DMallon%26aufirst%3DR.%26atitle%3DHuman%2520Ras-converting%2520enzyme%2520%2528hRCE1%2529%2520endoproteolytic%2520activity%2520on%2520K-ras-derived%2520peptides%26jtitle%3DAnal.%2520Biochem.%26date%3D2000%26volume%3D286%26spage%3D129%26epage%3D137%26doi%3D10.1006%2Fabio.2000.4795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">López-Rodríguez, M. L.</span>; <span class="NLM_string-name">Ortega-Gutiérrez, S.</span>; <span class="NLM_string-name">Martín-Fontecha, M.</span>; <span class="NLM_string-name">Balabasquer, M.</span>; <span class="NLM_string-name">Ortega-Nogales, F. J.</span>; <span class="NLM_string-name">Marín-Ramos, N. I.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitors of the enzyme isoprenylcysteine carboxyl methyltransferase (ICMT)</span>. <span class="NLM_patent">WO2014118418A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&author=S.+Ortega-Guti%C3%A9rrez&author=M.+Mart%C3%ADn-Fontecha&author=M.+Balabasquer&author=F.+J.+Ortega-Nogales&author=N.+I.+Mar%C3%ADn-Ramos&title=Novel+inhibitors+of+the+enzyme+isoprenylcysteine+carboxyl+methyltransferase+%28ICMT%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DNovel%2520inhibitors%2520of%2520the%2520enzyme%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520%2528ICMT%2529%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Vera, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueda-Zubiaurre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Villa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Couce, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomares, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Fontecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhamu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span> <span> </span><span class="NLM_article-title">Chemoproteomic approach to explore the target profile of GPCR ligands: Application to 5-HT<sub>1A</sub> and 5-HT<sub>6</sub> receptors</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1321</span>, <span class="refDoi"> DOI: 10.1002/chem.201503101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1002%2Fchem.201503101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=26560738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVWmt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=1313-1321&author=A.+M.+Gamoauthor=J.+A.+Gonzalez-Veraauthor=A.+Rueda-Zubiaurreauthor=D.+Alonsoauthor=H.+Vazquez-Villaauthor=L.+Martin-Couceauthor=O.+Palomaresauthor=J.+A.+Lopezauthor=M.+Martin-Fontechaauthor=B.+Benhamuauthor=M.+L.+Lopez-Rodriguezauthor=S.+Ortega-Gutierrez&title=Chemoproteomic+approach+to+explore+the+target+profile+of+GPCR+ligands%3A+Application+to+5-HT1A+and+5-HT6+receptors&doi=10.1002%2Fchem.201503101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoproteomic Approach to Explore the Target Profile of GPCR ligands: Application to 5-HT1A and 5-HT6 Receptors</span></div><div class="casAuthors">Gamo, Ana M.; Gonzalez-Vera, Juan A.; Rueda-Zubiaurre, Ainoa; Alonso, Dulce; Vazquez-Villa, Henar; Martin-Couce, Lidia; Palomares, Oscar; Lopez, Juan A.; Martin-Fontecha, Mar; Benhamu, Bellinda; Lopez-Rodriguez, Maria L.; Ortega-Gutierrez, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1313-1321</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Detn. of the targets of a compd. remains an essential aspect in drug discovery.  A complete understanding of all binding interactions is crit. to recognize in advance both therapeutic effects and undesired consequences.  However, the complete polypharmacol. of many drugs currently in clin. development is still unknown, esp. in the case of G protein-coupled receptor (GPCR) ligands.  The authors have developed a chemoproteomic platform based on the use of chem. probes to explore the target profile of a compd. in biol. systems.  As proof of concept, this methodol. has been applied to selected ligands of the therapeutically relevant serotonin 5-HT1A and 5-HT6 receptors, and the authors have identified and validated some of their off-targets.  This approach could be extended to other drugs of interest to study the targeted proteome in disease-relevant systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxjt-p_Dcdy7Vg90H21EOLACvtfcHk0lg06oLFYmZTSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVWmt7nE&md5=9d54bb52edc83e75826d1938b745a51b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fchem.201503101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201503101%26sid%3Dliteratum%253Aachs%26aulast%3DGamo%26aufirst%3DA.%2BM.%26aulast%3DGonzalez-Vera%26aufirst%3DJ.%2BA.%26aulast%3DRueda-Zubiaurre%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DD.%26aulast%3DVazquez-Villa%26aufirst%3DH.%26aulast%3DMartin-Couce%26aufirst%3DL.%26aulast%3DPalomares%26aufirst%3DO.%26aulast%3DLopez%26aufirst%3DJ.%2BA.%26aulast%3DMartin-Fontecha%26aufirst%3DM.%26aulast%3DBenhamu%26aufirst%3DB.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26atitle%3DChemoproteomic%2520approach%2520to%2520explore%2520the%2520target%2520profile%2520of%2520GPCR%2520ligands%253A%2520Application%2520to%25205-HT1A%2520and%25205-HT6%2520receptors%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2016%26volume%3D22%26spage%3D1313%26epage%3D1321%26doi%3D10.1002%2Fchem.201503101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marin-Ramos, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Nogales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabasquer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Villa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andradas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasco-Benito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Gomez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Barbero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Prado, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Fontecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span> <span> </span><span class="NLM_article-title">New inhibitors of angiogenesis with antitumor activity in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3757</span>– <span class="NLM_lpage">3766</span>, <span class="refDoi"> DOI: 10.1021/jm5019252</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5019252" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVWnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3757-3766&author=N.+I.+Marin-Ramosauthor=D.+Alonsoauthor=S.+Ortega-Gutierrezauthor=F.+J.+Ortega-Nogalesauthor=M.+Balabasquerauthor=H.+Vazquez-Villaauthor=C.+Andradasauthor=S.+Blasco-Benitoauthor=E.+Perez-Gomezauthor=A.+Canalesauthor=J.+Jimenez-Barberoauthor=A.+Marquinaauthor=J.+M.+Del+Pradoauthor=C.+Sanchezauthor=M.+Martin-Fontechaauthor=M.+L.+Lopez-Rodriguez&title=New+inhibitors+of+angiogenesis+with+antitumor+activity+in+vivo&doi=10.1021%2Fjm5019252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">New Inhibitors of Angiogenesis with Antitumor Activity in Vivo</span></div><div class="casAuthors">Marin-Ramos, Nagore I.; Alonso, Dulce; Ortega-Gutierrez, Silvia; Ortega-Nogales, Francisco J.; Balabasquer, Moises; Vazquez-Villa, Henar; Andradas, Clara; Blasco-Benito, Sandra; Perez-Gomez, Eduardo; Canales, Angeles; Jimenez-Barbero, Jesus; Marquina, Ana; del Prado, Jaime Moscoso; Sanchez, Cristina; Martin-Fontecha, Mar; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3757-3766</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Angiogenesis is a requirement for the sustained growth and proliferation of solid tumors, and the development of new compds. that induce a sustained inhibition of the proangiogenic signaling generated by tumor hypoxia still remains as an important unmet need.  In this work, the authors describe a new antiangiogenic compd. I that inhibits proangiogenic signaling under hypoxic conditions in breast cancer cells.  Compd. I blocks the MAPK pathway, impairs cellular migration under hypoxic conditions, and regulates a set of genes related to angiogenesis.  These responses are mediated by HIF-1α, since the effects of compd. I mostly disappear when its expression is knocked-down.  Furthermore, administration of compd. I in a xenograft model of breast cancer produced tumor growth redns. ranging from 46 to 55% in 38% of the treated animals without causing any toxic side effects.  Importantly, in the responding tumors, a significant redn. in the no. of blood vessels was obsd., further supporting the mechanism of action of the compd.  These findings provide a rationale for the development of new antiangiogenic compds. that could eventually lead to new drugs suitable for the treatment of some types of tumors either alone or in combination with other agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeVohlvgZ3HrVg90H21EOLACvtfcHk0ljIOyM2uvDWxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVWnsro%253D&md5=8368805475b518edfc35fece944bdcb6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm5019252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5019252%26sid%3Dliteratum%253Aachs%26aulast%3DMarin-Ramos%26aufirst%3DN.%2BI.%26aulast%3DAlonso%26aufirst%3DD.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26aulast%3DOrtega-Nogales%26aufirst%3DF.%2BJ.%26aulast%3DBalabasquer%26aufirst%3DM.%26aulast%3DVazquez-Villa%26aufirst%3DH.%26aulast%3DAndradas%26aufirst%3DC.%26aulast%3DBlasco-Benito%26aufirst%3DS.%26aulast%3DPerez-Gomez%26aufirst%3DE.%26aulast%3DCanales%26aufirst%3DA.%26aulast%3DJimenez-Barbero%26aufirst%3DJ.%26aulast%3DMarquina%26aufirst%3DA.%26aulast%3DDel%2BPrado%26aufirst%3DJ.%2BM.%26aulast%3DSanchez%26aufirst%3DC.%26aulast%3DMartin-Fontecha%26aufirst%3DM.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26atitle%3DNew%2520inhibitors%2520of%2520angiogenesis%2520with%2520antitumor%2520activity%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3757%26epage%3D3766%26doi%3D10.1021%2Fjm5019252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gajate, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barasoain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollinedo, F.</span></span> <span> </span><span class="NLM_article-title">Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2′,3′,4′-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: protection by Bcl-2 and Bcl-X(L) and cell cycle arrest</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2651</span>– <span class="NLM_lpage">2659</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10825137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsF2gtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=2651-2659&author=C.+Gajateauthor=I.+Barasoainauthor=J.+M.+Andreuauthor=F.+Mollinedo&title=Induction+of+apoptosis+in+leukemic+cells+by+the+reversible+microtubule-disrupting+agent+2-methoxy-5-%282%E2%80%B2%2C3%E2%80%B2%2C4%E2%80%B2-trimethoxyphenyl%29-2%2C4%2C6-cycloheptatrien-1-one%3A+protection+by+Bcl-2+and+Bcl-X%28L%29+and+cell+cycle+arrest"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one:protection by bcl-2 and bcl-xL and cell cycle arrest</span></div><div class="casAuthors">Gajate, Consuelo; Barasoain, Isabel; Andreu, Jose M.; Mollinedo, Faustino</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2651-2659</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have found that the bicyclic colchicine analog 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one (MTC) induced a dose- and time-dependent apoptotic response in human leukemic cells.  MTC and colchicine rapidly disrupted the microtubule integrity and arrested cells at the G2-M phase before the onset of apoptosis.  These responses were mediated by microtubule inhibition because 2-methoxy-5-[[3-(3,4,5-trimethoxyphenyl)propionyl]amino]-2,4,6-cycloheptatrien-1-one and lumicolchicine, inactive analogs of MTC and colchicine, resp., were unable to promote microtubule disassembly, cell cycle arrest, and apoptosis.  Although 1 μM MTC induced a complete microtubule disruption after 1 h of incubation in human leukemic HL-60 cells that led to an accumulation of cells at the G2-M phase, MTC-induced apoptosis occurred after 9 h of treatment.  This indicates the existence of a rather long lag between microtubule disruption and the onset of apoptosis.  Unlike colchicine, the removal of MTC during this lag resulted in rapid microtubule repolymn., followed by restoration of normal cell cycle and cell growth.  MTC, but not 2-methoxy-5-[[3-(3,4,5-trimethoxyphenyl)propionyl]amino]-2,4,6-cycloheptatrien-1-one, induced c-jun expression as well as c-Jun NH2-terminal kinase and caspase activation, indicating that these signaling pathways are triggered by the specific action of MTC on microtubules.  Caspase inhibition prevented MTC-induced apoptosis.  Overexpression of bcl-2 or bcl-xL by gene transfer in human erythroleukemic HEL cells abrogated MTC-induced apoptosis, but cells remained arrested in G2-M, suggesting that bcl-2 and bcl-xL block the signaling pathway between G2-M arrest and triggering of apoptosis.  MTC-treated bcl-2 and bcl-xL-transfected HEL cells recovered their capacity to proliferate after MTC removal.  These results indicate that microtubule inhibition induces G2-M arrest and apoptosis in leukemic cells, showing a lag phase between G2-M arrest and the onset of apoptosis, regulated by bcl-2 and bcl-xL, during which MTC displays a reversible action on microtubule depolymn. and G2-M cell cycle arrest.  Thus, MTC is a potent apoptotic inducer on human leukemic cells and shows a remarkable reversible action on microtubule network and cell cycle before commitment for apoptosis is reached.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZXw9pVySXJLVg90H21EOLACvtfcHk0ljIOyM2uvDWxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsF2gtLw%253D&md5=9c3c2f22521ab0e4cdeef2c8f70e429a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGajate%26aufirst%3DC.%26aulast%3DBarasoain%26aufirst%3DI.%26aulast%3DAndreu%26aufirst%3DJ.%2BM.%26aulast%3DMollinedo%26aufirst%3DF.%26atitle%3DInduction%2520of%2520apoptosis%2520in%2520leukemic%2520cells%2520by%2520the%2520reversible%2520microtubule-disrupting%2520agent%25202-methoxy-5-%25282%25E2%2580%25B2%252C3%25E2%2580%25B2%252C4%25E2%2580%25B2-trimethoxyphenyl%2529-2%252C4%252C6-cycloheptatrien-1-one%253A%2520protection%2520by%2520Bcl-2%2520and%2520Bcl-X%2528L%2529%2520and%2520cell%2520cycle%2520arrest%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D2651%26epage%3D2659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gajate, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonteriz, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabaner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Noves, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Rodriguez, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modolell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollinedo, F.</span></span> <span> </span><span class="NLM_article-title">Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">682</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C674%3A%3AAID-IJC13%3E3.0.CO%3B2-Z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10699948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht1aqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2000&pages=674-682&author=C.+Gajateauthor=R.+I.+Fonterizauthor=C.+Cabanerauthor=G.+Alvarez-Novesauthor=Y.+Alvarez-Rodriguezauthor=M.+Modolellauthor=F.+Mollinedo&title=Intracellular+triggering+of+Fas%2C+independently+of+FasL%2C+as+a+new+mechanism+of+antitumor+ether+lipid-induced+apoptosis&doi=10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C674%3A%3AAID-IJC13%3E3.0.CO%3B2-Z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis</span></div><div class="casAuthors">Gajate, Consuelo; Fonteriz, Rosalba I.; Cabaner, Christelle; Alvarez-Noves, Granada; Alvarez-Rodriguez, Ysmael; Modolell, Manuel; Mollinedo, Faustino</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">674-682</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Antitumor ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3; edelfosine) induces apoptosis in cancer cells, sparing normal cells.  The authors have found that the apoptotic action of ET-18-OCH3 required drug uptake and Fas in the target cell.  Failure to accomplish one of these requirements prevents cell killing by the ether lipid.  In human lymphoid leukemic cells, ET-18-OCH3 does not promote Fas or FasL expression and ET-18-OCH3-induced apoptosis is not inhibited by pre-incubation with an anti-Fas blocking antibody that abrogates cell killing mediated by Fas/FasL interactions.  ET-18-OCH3-resistant normal human Fas-pos. fibroblasts do not incorporate ET-18-OCH3, but undergo apoptosis upon ET-18-OCH3 microinjection.  Murine fibroblasts L929 and L929-Fas, stably transfected with human Fas cDNA, do not incorporate ET-18-OCH3 and are resistant to its action when added exogenously.  Microinjection of ET-18-OCH3 induces apoptosis in L929-Fas cells, but not in wild-type L929 cells.  Confocal laser scanning microscopy shows that ET-18-OCH3 induces Fas clustering and capping during triggering of ET-18-OCH3-induced apoptosis.  Microinjection-induced apoptosis and Fas clustering are specific for the mol. structure of ET-18-OCH3.  The data indicate that ET-18-OCH3 induces apoptosis via Fas after the ether lipid is inside the cell, and this Fas activation is independent of the interaction of Fas with its natural ligand FasL.  This explains the selective action of ET-18-OCH3 on tumors since only cancer cells incorporate sufficient amts. of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBQHGjIxY_17Vg90H21EOLACvtfcHk0lgJWXCBbra9ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht1aqsLw%253D&md5=cd4ad2ca3efe97332d75e694d6580dad</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C674%3A%3AAID-IJC13%3E3.0.CO%3B2-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252820000301%252985%253A5%253C674%253A%253AAID-IJC13%253E3.0.CO%253B2-Z%26sid%3Dliteratum%253Aachs%26aulast%3DGajate%26aufirst%3DC.%26aulast%3DFonteriz%26aufirst%3DR.%2BI.%26aulast%3DCabaner%26aufirst%3DC.%26aulast%3DAlvarez-Noves%26aufirst%3DG.%26aulast%3DAlvarez-Rodriguez%26aufirst%3DY.%26aulast%3DModolell%26aufirst%3DM.%26aulast%3DMollinedo%26aufirst%3DF.%26atitle%3DIntracellular%2520triggering%2520of%2520Fas%252C%2520independently%2520of%2520FasL%252C%2520as%2520a%2520new%2520mechanism%2520of%2520antitumor%2520ether%2520lipid-induced%2520apoptosis%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2000%26volume%3D85%26spage%3D674%26epage%3D682%26doi%3D10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C674%3A%3AAID-IJC13%3E3.0.CO%3B2-Z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Torres, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cipriano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heden, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorklund, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guaza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span> <span> </span><span class="NLM_article-title">A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">13765</span>– <span class="NLM_lpage">13770</span>, <span class="refDoi"> DOI: 10.1002/anie.201407807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1002%2Fanie.201407807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCit7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=13765-13770&author=G.+Hernandez-Torresauthor=M.+Ciprianoauthor=E.+Hedenauthor=E.+Bjorklundauthor=A.+Canalesauthor=D.+Zianauthor=A.+Feliuauthor=M.+Mechaauthor=C.+Guazaauthor=C.+J.+Fowlerauthor=S.+Ortega-Gutierrezauthor=M.+L.+Lopez-Rodriguez&title=A+reversible+and+selective+inhibitor+of+monoacylglycerol+lipase+ameliorates+multiple+sclerosis&doi=10.1002%2Fanie.201407807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis</span></div><div class="casAuthors">Hernandez-Torres, Gloria; Cipriano, Mariateresa; Heden, Erika; Bjoerklund, Emmelie; Canales, Angeles; Zian, Debora; Feliu, Ana; Mecha, Miriam; Guaza, Carmen; Fowler, Christopher J.; Ortega-Gutierrez, Silvia; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">13765-13770</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is the enzyme responsible for the inactivation of the endocannabinoid 2-arachidonoylglycerol (2-AG).  MAGL inhibitors show analgesic and tissue-protecting effects in several disease models.  However, the few efficient and selective MAGL inhibitors described to date block the enzyme irreversibly, and this can lead to pharmacol. tolerance.  Hence, addnl. classes of MAGL inhibitors are needed to validate this enzyme as a therapeutic target.  Here we report a potent, selective, and reversible MAGL inhibitor (IC50=0.18 μM) which is active in vivo and ameliorates the clin. progression of a multiple sclerosis (MS) mouse model without inducing undesirable CB1-mediated side effects.  These results support the interest in MAGL as a target for the treatment of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzujCPuidHArVg90H21EOLACvtfcHk0lgJWXCBbra9ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCit7vF&md5=6cd7f2080f95bbc05daaebba21ee1be2</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fanie.201407807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201407807%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez-Torres%26aufirst%3DG.%26aulast%3DCipriano%26aufirst%3DM.%26aulast%3DHeden%26aufirst%3DE.%26aulast%3DBjorklund%26aufirst%3DE.%26aulast%3DCanales%26aufirst%3DA.%26aulast%3DZian%26aufirst%3DD.%26aulast%3DFeliu%26aufirst%3DA.%26aulast%3DMecha%26aufirst%3DM.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26atitle%3DA%2520reversible%2520and%2520selective%2520inhibitor%2520of%2520monoacylglycerol%2520lipase%2520ameliorates%2520multiple%2520sclerosis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D13765%26epage%3D13770%26doi%3D10.1002%2Fanie.201407807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Torres, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enriquez-Palacios, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueda-Zubiaurre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angelina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Cruz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Fontecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomares, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guaza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena-Cabrera, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span> <span> </span><span class="NLM_article-title">Development of a fluorescent bodipy probe for visualization of the serotonin 5-HT1A receptor in native cells of the immune system</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2021</span>– <span class="NLM_lpage">2027</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.8b00228</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.8b00228" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovFyjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=2021-2027&author=G.+Hernandez-Torresauthor=E.+Enriquez-Palaciosauthor=M.+Mechaauthor=A.+Feliuauthor=A.+Rueda-Zubiaurreauthor=A.+Angelinaauthor=L.+Martin-Cruzauthor=M.+Martin-Fontechaauthor=O.+Palomaresauthor=C.+Guazaauthor=E.+Pena-Cabreraauthor=M.+L.+Lopez-Rodriguezauthor=S.+Ortega-Gutierrez&title=Development+of+a+fluorescent+bodipy+probe+for+visualization+of+the+serotonin+5-HT1A+receptor+in+native+cells+of+the+immune+system&doi=10.1021%2Facs.bioconjchem.8b00228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Fluorescent Bodipy Probe for Visualization of the Serotonin 5-HT1A Receptor in Native Cells of the Immune System</span></div><div class="casAuthors">Hernandez-Torres, Gloria; Enriquez-Palacios, Ernesto; Mecha, Miriam; Feliu, Ana; Rueda-Zubiaurre, Ainoa; Angelina, Alba; Martin-Cruz, Leticia; Martin-Fontecha, Mar; Palomares, Oscar; Guaza, Carmen; Pena-Cabrera, Eduardo; Lopez-Rodriguez, Maria L.; Ortega-Gutierrez, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2021-2027</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Serotonin (5-HT) modulates key aspects of the immune system.  However, its precise function and the receptors involved in the obsd. effects have remained elusive.  Among the different serotonin receptors, 5-HT1A plays an important role in the immune system given its presence in cells involved in both the innate and the adaptive immune responses, but its actual levels of expression under different conditions have not been comprehensively studied due to the lack of suitable tools.  To further clarify the role of 5-HT1A receptor in the immune system, we have developed a fluorescent small mol. probe that enables the direct study of the receptor levels in native cells.  This probe allows direct profiling of the receptor expression in immune cells using flow cytometry.  Our results show that important subsets of immune cells including human monocytes and dendritic cells express functional 5-HT1A and that its activation is assocd. to anti-inflammatory signaling.  Furthermore, application of the probe to the exptl. autoimmune encephalomyelitis model of multiple sclerosis demonstrates its potential to detect the specific overexpression of the 5-HT1A receptor in CD4+ T cells.  Accordingly, the probe reported herein represents a useful tool whose use can be extended to study the levels of 5-HT1A receptor in ex vivo samples of different immune system conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR47IcgWAUrLVg90H21EOLACvtfcHk0liWkqPF0L_kDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovFyjurw%253D&md5=a417ca2ecd7f644ff017318317eb02fe</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.8b00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.8b00228%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez-Torres%26aufirst%3DG.%26aulast%3DEnriquez-Palacios%26aufirst%3DE.%26aulast%3DMecha%26aufirst%3DM.%26aulast%3DFeliu%26aufirst%3DA.%26aulast%3DRueda-Zubiaurre%26aufirst%3DA.%26aulast%3DAngelina%26aufirst%3DA.%26aulast%3DMartin-Cruz%26aufirst%3DL.%26aulast%3DMartin-Fontecha%26aufirst%3DM.%26aulast%3DPalomares%26aufirst%3DO.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DPena-Cabrera%26aufirst%3DE.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26atitle%3DDevelopment%2520of%2520a%2520fluorescent%2520bodipy%2520probe%2520for%2520visualization%2520of%2520the%2520serotonin%25205-HT1A%2520receptor%2520in%2520native%2520cells%2520of%2520the%2520immune%2520system%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26spage%3D2021%26epage%3D2027%26doi%3D10.1021%2Facs.bioconjchem.8b00228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turrado, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Cárceles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhamú, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutiérrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveras, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blancafort, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrero, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colomer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Rodríguez, M. L.</span></span> <span> </span><span class="NLM_article-title">New synthetic inhibitors of fatty acid synthase with anticancer activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5013</span>– <span class="NLM_lpage">5023</span>, <span class="refDoi"> DOI: 10.1021/jm2016045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2016045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFygsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5013-5023&author=C.+Turradoauthor=T.+Puigauthor=J.+Garc%C3%ADa-C%C3%A1rcelesauthor=M.+Artolaauthor=B.+Benham%C3%BAauthor=S.+Ortega-Guti%C3%A9rrezauthor=J.+Relatauthor=G.+Oliverasauthor=A.+Blancafortauthor=D.+Haroauthor=P.+F.+Marreroauthor=R.+Colomerauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=New+synthetic+inhibitors+of+fatty+acid+synthase+with+anticancer+activity&doi=10.1021%2Fjm2016045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity</span></div><div class="casAuthors">Turrado, Carlos; Puig, Teresa; Garcia-Carceles, Javier; Artola, Marta; Benhamu, Bellinda; Ortega-Gutierrez, Silvia; Relat, Joana; Oliveras, Gloria; Blancafort, Adriana; Haro, Diego; Marrero, Pedro F.; Colomer, Ramon; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5013-5023</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid synthase (FASN) is a lipogenic enzyme that is highly expressed in different human cancers.  Here we report the development of a new series of polyphenolic compds. 5-30 that have been evaluated for their cytotoxic capacity in SK-Br3 cells, a human breast cancer cell line with high FASN expression.  The compds. with an IC50 < 50 μM have been tested for their ability to inhibit FASN activity.  Among them, deriv. 30 (I) blocks the 90% of FASN activity at low concn. (4 μM), is highly cytotoxic in a broad panel of tumor cells, induces apoptosis, and blocks the activation of HER2, AKT, and ERK pathways.  Remarkably, 30 does not activate carnitine palmitoyltransferase-1 (CPT-1) nor induces in mice wt. loss, which are the main drawbacks of other previously described FASN inhibitors.  Thus, FASN inhibitor 30 may aid the validation of this enzyme as a therapeutic target for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosV2mbmEyIarVg90H21EOLACvtfcHk0liWkqPF0L_kDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFygsb8%253D&md5=83a7be3e2f53c33e37aa12808f2f283d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm2016045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016045%26sid%3Dliteratum%253Aachs%26aulast%3DTurrado%26aufirst%3DC.%26aulast%3DPuig%26aufirst%3DT.%26aulast%3DGarc%25C3%25ADa-C%25C3%25A1rceles%26aufirst%3DJ.%26aulast%3DArtola%26aufirst%3DM.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DOrtega-Guti%25C3%25A9rrez%26aufirst%3DS.%26aulast%3DRelat%26aufirst%3DJ.%26aulast%3DOliveras%26aufirst%3DG.%26aulast%3DBlancafort%26aufirst%3DA.%26aulast%3DHaro%26aufirst%3DD.%26aulast%3DMarrero%26aufirst%3DP.%2BF.%26aulast%3DColomer%26aufirst%3DR.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DNew%2520synthetic%2520inhibitors%2520of%2520fatty%2520acid%2520synthase%2520with%2520anticancer%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5013%26epage%3D5023%26doi%3D10.1021%2Fjm2016045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Sonia Huecas, Lidia Araújo-Bazán, Federico M. Ruiz, Laura B. Ruiz-Ávila, R. Fernando Martínez, Andrea Escobar-Peña, Marta Artola, Henar Vázquez-Villa, Mar Martín-Fontecha, Carlos Fernández-Tornero, María L. López-Rodríguez, <span class="NLM_string-name hlFld-ContribAuthor">José M. Andreu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the FtsZ Allosteric Binding Site with a Novel Fluorescence Polarization Screen, Cytological and Structural Approaches for Antibacterial Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5730-5745. <a href="https://doi.org/10.1021/acs.jmedchem.0c02207" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02207%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bthe%252BFtsZ%252BAllosteric%252BBinding%252BSite%252Bwith%252Ba%252BNovel%252BFluorescence%252BPolarization%252BScreen%25252C%252BCytological%252Band%252BStructural%252BApproaches%252Bfor%252BAntibacterial%252BDiscovery%26aulast%3DHuecas%26aufirst%3DSonia%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D21122020%26date%3D28042021%26volume%3D64%26issue%3D9%26spage%3D5730%26epage%3D5745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Inés González-Gil, Debora Zian, Henar Vázquez-Villa, Gloria Hernández-Torres, R. Fernando Martínez, Nora Khiar-Fernández, Richard Rivera, Yasuyuki Kihara, Isabel Devesa, Sakthikumar Mathivanan, Cristina Rosell del Valle, Emma Zambrana-Infantes, María Puigdomenech, Giovanni Cincilla, Melchor Sanchez-Martinez, Fernando Rodríguez de Fonseca, Antonio V. Ferrer-Montiel, Jerold Chun, Rubén López-Vales, María L. López-Rodríguez, <span class="NLM_string-name hlFld-ContribAuthor">Silvia Ortega-Gutiérrez</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2372-2390. <a href="https://doi.org/10.1021/acs.jmedchem.9b01287" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01287%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BNovel%252BAgonist%252Bof%252Bthe%252BType%252B1%252BLysophosphatidic%252BAcid%252BReceptor%252B%252528LPA1%252529%25252C%252BUCM-05194%25252C%252BShows%252BEfficacy%252Bin%252BNeuropathic%252BPain%252BAmelioration%26aulast%3DGonz%25C3%25A1lez-Gil%26aufirst%3DIn%25C3%25A9s%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D07082019%26date%3D16122019%26date%3D02122019%26volume%3D63%26issue%3D5%26spage%3D2372%26epage%3D2390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-hua  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Yuan</span>, <span class="hlFld-ContribAuthor ">Mei-jia  Qian</span>, <span class="hlFld-ContribAuthor ">Fang-jie  Yan</span>, <span class="hlFld-ContribAuthor ">Liu  Yang</span>, <span class="hlFld-ContribAuthor ">Qiao-jun  He</span>, <span class="hlFld-ContribAuthor ">Bo  Yang</span>, <span class="hlFld-ContribAuthor ">Jin-jian  Lu</span>, <span class="hlFld-ContribAuthor ">Hong  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Post-translational modification of KRAS: potential targets for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2021,</strong> <em>42 </em>
                                    (8)
                                     , 1201-1211. <a href="https://doi.org/10.1038/s41401-020-00542-y" title="DOI URL">https://doi.org/10.1038/s41401-020-00542-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-020-00542-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-020-00542-y%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DPost-translational%252Bmodification%252Bof%252BKRAS%25253A%252Bpotential%252Btargets%252Bfor%252Bcancer%252Btherapy%26aulast%3DWang%26aufirst%3DWei-hua%26date%3D2021%26date%3D2020%26volume%3D42%26issue%3D8%26spage%3D1201%26epage%3D1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jon  Macicior</span>, <span class="hlFld-ContribAuthor ">Beatriz  Marcos-Ramiro</span>, <span class="hlFld-ContribAuthor ">Silvia  Ortega-Gutiérrez</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Therapeutic Perspectives for the Treatment of Progeria. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (13)
                                     , 7190. <a href="https://doi.org/10.3390/ijms22137190" title="DOI URL">https://doi.org/10.3390/ijms22137190</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22137190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22137190%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSmall-Molecule%252BTherapeutic%252BPerspectives%252Bfor%252Bthe%252BTreatment%252Bof%252BProgeria%26aulast%3DMacicior%26aufirst%3DJon%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D13%26spage%3D7190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miriam  Molina-Arcas</span>, <span class="hlFld-ContribAuthor ">Amit  Samani</span>, <span class="hlFld-ContribAuthor ">Julian  Downward</span>. </span><span class="cited-content_cbyCitation_article-title">Drugging the Undruggable: Advances on RAS Targeting in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Genes</span><span> <strong>2021,</strong> <em>12 </em>
                                    (6)
                                     , 899. <a href="https://doi.org/10.3390/genes12060899" title="DOI URL">https://doi.org/10.3390/genes12060899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/genes12060899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fgenes12060899%26sid%3Dliteratum%253Aachs%26jtitle%3DGenes%26atitle%3DDrugging%252Bthe%252BUndruggable%25253A%252BAdvances%252Bon%252BRAS%252BTargeting%252Bin%252BCancer%26aulast%3DMolina-Arcas%26aufirst%3DMiriam%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D6%26spage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Korzeniecki</span>, <span class="hlFld-ContribAuthor ">Ronny  Priefer</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting KRAS mutant cancers by preventing signaling transduction in the MAPK pathway. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113006. <a href="https://doi.org/10.1016/j.ejmech.2020.113006" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113006%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BKRAS%252Bmutant%252Bcancers%252Bby%252Bpreventing%252Bsignaling%252Btransduction%252Bin%252Bthe%252BMAPK%252Bpathway%26aulast%3DKorzeniecki%26aufirst%3DClaudia%26date%3D2021%26volume%3D211%26spage%3D113006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyaw Z.  Thein</span>, <span class="hlFld-ContribAuthor ">Amadeo B.  Biter</span>, <span class="hlFld-ContribAuthor ">David S.  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutics Targeting Mutant KRAS. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Medicine</span><span> <strong>2021,</strong> <em>72 </em>
                                    (1)
                                     , 349-364. <a href="https://doi.org/10.1146/annurev-med-080819-033145" title="DOI URL">https://doi.org/10.1146/annurev-med-080819-033145</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-med-080819-033145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-med-080819-033145%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Medicine%26atitle%3DTherapeutics%252BTargeting%252BMutant%252BKRAS%26aulast%3DThein%26aufirst%3DKyaw%2BZ.%26date%3D2021%26volume%3D72%26issue%3D1%26spage%3D349%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amanda R.  Moore</span>, <span class="hlFld-ContribAuthor ">Scott C.  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Frank  McCormick</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>. </span><span class="cited-content_cbyCitation_article-title">RAS-targeted therapies: is the undruggable drugged?. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2020,</strong> <em>19 </em>
                                    (8)
                                     , 533-552. <a href="https://doi.org/10.1038/s41573-020-0068-6" title="DOI URL">https://doi.org/10.1038/s41573-020-0068-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-020-0068-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-020-0068-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DRAS-targeted%252Btherapies%25253A%252Bis%252Bthe%252Bundruggable%252Bdrugged%25253F%26aulast%3DMoore%26aufirst%3DAmanda%2BR.%26date%3D2020%26date%3D2020%26volume%3D19%26issue%3D8%26spage%3D533%26epage%3D552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khanh B.  Tran</span>, <span class="hlFld-ContribAuthor ">Christina M.  Buchanan</span>, <span class="hlFld-ContribAuthor ">Peter R.  Shepherd</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of Molecular Targets in Melanoma Treatment. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2020,</strong> <em>26 </em>
                                    (4)
                                     , 396-414. <a href="https://doi.org/10.2174/1381612826666200130091318" title="DOI URL">https://doi.org/10.2174/1381612826666200130091318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612826666200130091318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612826666200130091318%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DEvolution%252Bof%252BMolecular%252BTargets%252Bin%252BMelanoma%252BTreatment%26aulast%3DTran%26aufirst%3DKhanh%2BB.%26date%3D2020%26volume%3D26%26issue%3D4%26spage%3D396%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Misako  Nagasaka</span>, <span class="hlFld-ContribAuthor ">Yiwei  Li</span>, <span class="hlFld-ContribAuthor ">Ammar  Sukari</span>, <span class="hlFld-ContribAuthor ">Sai-Hong Ignatius  Ou</span>, <span class="hlFld-ContribAuthor ">Mohammed Najeeb  Al-Hallak</span>, <span class="hlFld-ContribAuthor ">Asfar S.  Azmi</span>. </span><span class="cited-content_cbyCitation_article-title">KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?. </span><span class="cited-content_cbyCitation_journal-name">Cancer Treatment Reviews</span><span> <strong>2020,</strong> <em>84 </em>, 101974. <a href="https://doi.org/10.1016/j.ctrv.2020.101974" title="DOI URL">https://doi.org/10.1016/j.ctrv.2020.101974</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ctrv.2020.101974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ctrv.2020.101974%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Treatment%2520Reviews%26atitle%3DKRAS%252BG12C%252BGame%252Bof%252BThrones%25252C%252Bwhich%252Bdirect%252BKRAS%252Binhibitor%252Bwill%252Bclaim%252Bthe%252Biron%252Bthrone%25253F%26aulast%3DNagasaka%26aufirst%3DMisako%26date%3D2020%26volume%3D84%26spage%3D101974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Structures of cysmethynil, AFC, and compound <b>1</b>. (B) Tc-ICMT-derived homology model of h-ICMT in complex with cysmethynil (orange) and <i>S</i>-adenosylmethionine (SAM) cofactor (cyan). The indole ring is positioned in front of Trp216, the amide group is located between Arg274 and Asp122, and the octyl tail expands toward Tyr236. (C) Tc-ICMT-derived homology model of h-ICMT in complex with AFC (orange) and SAM cofactor (cyan). AFC positions the carboxyl group between conserved Arg174, His187, Arg247, Trp216 and the methyl group of SAM. The prenyl moiety expands between TM5 and TM8 helices toward Tyr236. Tc-ICMT PDB code is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V7P">5V7P</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Tc-ICMT-derived homology models of h-ICMT in complex with compounds <b>2</b> and <b>3</b>. (A) Compound <b>2</b> (in orange) positions the octyl chain toward the membrane in a similar manner as the hydrophobic tail of cysmethynil and AFC. <i>S</i>-Adenosylmethionine (SAM) cofactor is shown in cyan. (B) Extracellular view of the homology model of the h-ICMT in complex with compound <b>3</b> (orange) and SAM (cyan). Tc ICMT PDB code is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V7P">5V7P</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Synthesized compounds <b>3</b>–<b>34</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>3</b> (5 μM) induces Ras mislocalization from the cellular membrane (left image, white arrows) to intracellular locations in PC-3 cells to higher extent than cysmethynil (Cysm) at the same concentration. Immunofluorescence images show Ras in green stained using an anti-Ras primary antibody followed by the appropriate secondary FITC-labeled antibody. Nuclei (in blue) were stained with Hoechst 33258. Images were obtained in a Leica confocal microscope under the same conditions and are representative of three to five independent experiments. Bars, 30 μm. The bar graphs represent the optical density of the membrane Ras signal quantified with ImageJ. White bar, DMSO; gray bar, compound <b>3</b> (5 μM); black bar, cysmethynil (Cysm, 5 μM). Data correspond to the average ± SEM of three independent experiments and have been analyzed with GraphPad Prism 5. ns, not significant; ∗∗, <i>P</i> < 0.01 vs DMSO (one-way ANOVA followed by the Dunnett’s multiple comparison test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>3</b> significantly reduces the Ras-GTP (active form) levels and its downstream MEK/ERK and PI3K/AKT signaling pathways. (A) Ras-GTP complex from PC-3 cells treated with DMSO, cysmethynil (CYSM, 25 μM), or compound <b>3</b> (10 μM) were immunoprecipitated and visualized by Western blot. The bar graph shows the ratio Ras-GTP/total Ras, expressed as percentage relative to DMSO. (B) Representative Western blots of phosphorylated MEK1/2 (pMEK1/2), ERK1/2 (p-ERK1/2), and AKT (p-AKT) and the corresponding total kinases (T-MEK1/2, T-ERK1/2, and T-AKT). Lysates were obtained from PC-3 cells treated with DMSO, cysmethynil (CYSM, 25 μM), or compound <b>3</b> (10 μM). The bar graphs represent the optical density of the immunoreactive phosphorylated protein normalized to the total corresponding protein and expressed as the percentage relative to DMSO. White bars, DMSO; gray bars, cysmethynil (CYSM, 25 μM); black bars, compound <b>3</b> (10 μM). Data correspond to the average ± SEM of three to five independent experiments. ns, not significant; ∗, <i>P</i> < 0.05; ∗∗, <i>P</i> < 0.01 vs DMSO (Student’s <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>3</b> induces autophagy and apoptosis in PC-3 cells. Cells treated with DMSO, cysmethynil (CYSM, 25 μM), or compound <b>3</b> (10 μM) were lysed and stained for (A) LC-3 expression, (B) PARP levels, and (C) caspase 3 activity. Images are representative of at least three independent experiments, and data in (C) correspond to the average ± SEM of three independent experiments. ∗∗∗, <i>P</i> < 0.001 vs DMSO (Student’s <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>3</b> impairs plasma localization of the four Ras isoforms. Confocal images of live AD-293 cells that had been transiently transfected with H-Ras, K-Ras4A, K-Ras4B, and N-Ras GFP fusion plasmids and treated overnight with vehicle (DMSO), cysmethynil (CYSM, 5 μM), or compound <b>3</b> (5 μM). Live cells were imaged with an inverted Zeiss LSM 510 Meta laser scanning confocal microscope. Similar results were obtained with three independent transfections performed in triplicate. Bars, 10 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>3</b> does not induce cytotoxicity in ICMT-depleted cells nor inhibits FTase or GGTase enzymes. (A) Effect of siRNA-induced silencing of ICMT gene expression on cytotoxicity induced by compound <b>3</b>. Cytotoxicity of compound <b>3</b> at different concentrations is eliminated by siRNA-induced reduction of ICMT expression levels. PC-3 cells were transfected with siRNA-targeting ICMT for 72 h. Equal amounts of total protein from PC-3 cells transfected with siRNA-targeting ICMT or with the control were subjected to immunoblotting analyses with antibodies against ICMT or GADPH as loading control. Results shown in the lower panel are the average ± SEM of three different experiments. Shown gel is representative of those obtained in three independent experiments. ns, not significant; ∗∗∗, <i>p</i> < 0.001 (Student’s <i>t</i> test) vs ICMT expression in siRNA control-transfected cells. (B) Effect of compound <b>3</b> on the prenylation state of HDJ2 and Rap1A proteins. PC-3 cells were treated with vehicle, compound <b>3</b>, GGTase inhibitor GGTI298 (10 μM), or lonafarnib (1 μM), lysed and immunoblotted with antibodies against HDJ2, Rap1A or GADPH (used as loading control). Images are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/medium/jm-2019-001454_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0009.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Antitumor effect of compound <b>3</b> in the Ras-driven model of acute myeloid leukemia. (A) Kaplan–Meier curves indicating survival of HL-60 transplanted NSG mice treated with vehicle (<i>n</i> = 5) or with compound <b>3</b> (<i>n</i> = 9). Statistical significance was determined by the log rank test (<i>p</i> = 0.0274; HR, 6.211; 95% CI or ratio 1.225 to 31.48). Hematoxylin and eosin (H&E) and human HL-60 staining (hCD45) of paraffin-embedded bone marrow (BM) sections from wild-type HL-60 transplanted NSG mice treated with (B) vehicle or (C) compound <b>3</b>. Scale bar represents 125 μm (left images) and 50 μm (right images).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-13/acs.jmedchem.9b00145/20190705/images/large/jm-2019-001454_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00145&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48555" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48555" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westover, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficarro, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacold, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janne, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of oncogenic K-Ras by a covalent catalytic site inhibitor</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1002/anie.201307387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1002%2Fanie.201307387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvValsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=199-204&author=S.+M.+Limauthor=K.+D.+Westoverauthor=S.+B.+Ficarroauthor=R.+A.+Harrisonauthor=H.+G.+Choiauthor=M.+E.+Pacoldauthor=M.+Carrascoauthor=J.+Hunterauthor=N.+D.+Kimauthor=T.+Xieauthor=T.+Simauthor=P.+A.+Janneauthor=M.+Meyersonauthor=J.+A.+Martoauthor=J.+R.+Engenauthor=N.+S.+Gray&title=Therapeutic+targeting+of+oncogenic+K-Ras+by+a+covalent+catalytic+site+inhibitor&doi=10.1002%2Fanie.201307387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Targeting of Oncogenic K-Ras by a Covalent Catalytic Site Inhibitor</span></div><div class="casAuthors">Lim, Sang Min; Westover, Kenneth D.; Ficarro, Scott B.; Harrison, Rane A.; Choi, Hwan Geun; Pacold, Michael E.; Carrasco, Martin; Hunter, John; Kim, Nam Doo; Xie, Ting; Sim, Taebo; Jaenne, Pasi A.; Meyerson, Matthew; Marto, Jarrod A.; Engen, John R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-204</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We report the synthesis of a GDP analog, SML-8-73-1, and a prodrug deriv., SML-10-70-1, which are selective, direct-acting covalent inhibitors of the K-Ras G12C mutant relative to wild-type Ras.  Biochem. and biophys. measurements suggest that modification of K-Ras with SML-8-73-1 renders the protein in an inactive state.  These first-in-class covalent K-Ras inhibitors demonstrate that irreversible targeting of the K-Ras guanine-nucleotide binding site is potentially a viable therapeutic strategy for inhibition of Ras signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfLlkUFFkg-7Vg90H21EOLACvtfcHk0ljFSs1sKYMXcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvValsrbN&md5=f99a8c9603d4139135606c964706a822</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fanie.201307387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201307387%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DS.%2BM.%26aulast%3DWestover%26aufirst%3DK.%2BD.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DHarrison%26aufirst%3DR.%2BA.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DPacold%26aufirst%3DM.%2BE.%26aulast%3DCarrasco%26aufirst%3DM.%26aulast%3DHunter%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DXie%26aufirst%3DT.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTherapeutic%2520targeting%2520of%2520oncogenic%2520K-Ras%2520by%2520a%2520covalent%2520catalytic%2520site%2520inhibitor%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D199%26epage%3D204%26doi%3D10.1002%2Fanie.201307387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marin-Ramos, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span> <span> </span><span class="NLM_article-title">Blocking Ras inhibition as an antitumor strategy</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.semcancer.2018.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.semcancer.2018.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=29409706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFKjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2019&pages=91-100&author=N.+I.+Marin-Ramosauthor=S.+Ortega-Gutierrezauthor=M.+L.+Lopez-Rodriguez&title=Blocking+Ras+inhibition+as+an+antitumor+strategy&doi=10.1016%2Fj.semcancer.2018.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Blocking Ras inhibition as an antitumor strategy</span></div><div class="casAuthors">Marin-Ramos, Nagore I.; Ortega-Gutierrez, Silvia; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">91-100</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ras proteins are among the most frequently mutated drivers in human cancer and remain an elusive pharmaceutical targeting.  Previous studies have improved the understanding of Ras structure, processing, and signaling pathways in cancer cells and have opened new possibilities for inhibiting Ras function.  In this review we discuss the most recent advances towards inhibiting Ras activity with small mols., highlighting the two approaches: (i) compds. that bind directly to Ras protein and (ii) inhibitors of the enzymes involved in the post-translational modifications of Ras.  In the former, we analyze the most recent contributions in each of the main classes of Ras direct binders, including the different types of nucleotide exchange inhibitors, allosteric compds., and mols. that interfere with the interaction between Ras and its effectors.  In the latter, we examine the compds. that inhibit Ras activation by blocking any of its post-translational modifications.  Also, a special focus is made on those mols. that have progressed the farthest from medicinal chem. and drug development points of view.  Finally, the current scene regarding the clin. trials of Ras inhibitors, together with the future promising avenues for further development of the challenging Ras field are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWw2RqFhpnErVg90H21EOLACvtfcHk0ljFSs1sKYMXcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFKjs74%253D&md5=721a62e21dddff7fc9d25732ec30040f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2018.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2018.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DMarin-Ramos%26aufirst%3DN.%2BI.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26atitle%3DBlocking%2520Ras%2520inhibition%2520as%2520an%2520antitumor%2520strategy%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2019%26volume%3D54%26spage%3D91%26epage%3D100%26doi%3D10.1016%2Fj.semcancer.2018.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marín-Ramos, N.
I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piñar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Villa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín-Fontecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canales, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Algar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Barbero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajate, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollinedo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutiérrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Rodríguez, M. L.</span></span> <span> </span><span class="NLM_article-title">Development of a nucleotide exchange inhibitor that impairs Ras oncogenic signaling</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1685</span>, <span class="refDoi"> DOI: 10.1002/chem.201604905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1002%2Fchem.201604905" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=27885731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGhsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=1676-1685&author=N.%0AI.+Mar%C3%ADn-Ramosauthor=C.+Pi%C3%B1arauthor=H.+V%C3%A1zquez-Villaauthor=M.+Mart%C3%ADn-Fontechaauthor=%C3%81.+Gonz%C3%A1lezauthor=%C3%81.+Canalesauthor=S.+Algarauthor=P.+P.+Mayoauthor=J.+Jim%C3%A9nez-Barberoauthor=C.+Gajateauthor=F.+Mollinedoauthor=L.+Pardoauthor=S.+Ortega-Guti%C3%A9rrezauthor=A.+Visoauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=Development+of+a+nucleotide+exchange+inhibitor+that+impairs+Ras+oncogenic+signaling&doi=10.1002%2Fchem.201604905"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Nucleotide Exchange Inhibitor That Impairs Ras Oncogenic Signaling</span></div><div class="casAuthors">Marin-Ramos, Nagore I.; Pinar, Carmen; Vazquez-Villa, Henar; Martin-Fontecha, Mar; Gonzalez, Angel; Canales, Angeles; Algar, Sergio; Mayo, Paloma P.; Jimenez-Barbero, Jesus; Gajate, Consuelo; Mollinedo, Faustino; Pardo, Leonardo; Ortega-Gutierrez, Silvia; Viso, Alma; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1676-1685</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Despite more than three decades of intense effort, no anti-Ras therapies have reached clin. application.  Contributing to this failure has been an underestimation of Ras complexity and a dearth of structural information.  In this regard, recent studies have revealed the highly dynamic character of the Ras surface and the existence of transient pockets suitable for small-mol. binding, opening up new possibilities for the development of Ras modulators.  Herein, a novel Ras inhibitor (compd. 12) is described that selectively impairs mutated Ras activity in a reversible manner without significantly affecting wild-type Ras, reduces the Ras-guanosine triphosphate (GTP) levels, inhibits the activation of the mitogen-activated protein kinase (MAPK) pathway, and exhibits remarkable cytotoxic activity in Ras-driven cellular models.  The use of mol. dynamics simulations and NMR spectroscopy expts. has enabled the mol. bases responsible for the interactions between compd. 12 and Ras protein to be explored.  The new Ras inhibitor binds partially to the GTP-binding region and extends into the adjacent hydrophobic pocket delimited by switch II.  Hence, Ras inhibitor 12 could represent a new compd. for the development of more efficacious drugs to target Ras-driven cancers; a currently unmet clin. need.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp58dPubMr9DbVg90H21EOLACvtfcHk0ljFSs1sKYMXcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGhsrjJ&md5=306d9a9b923f9b1fac12d3fd3ae93210</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fchem.201604905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201604905%26sid%3Dliteratum%253Aachs%26aulast%3DMar%25C3%25ADn-Ramos%26aufirst%3DN.%2BI.%26aulast%3DPi%25C3%25B1ar%26aufirst%3DC.%26aulast%3DV%25C3%25A1zquez-Villa%26aufirst%3DH.%26aulast%3DMart%25C3%25ADn-Fontecha%26aufirst%3DM.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3D%25C3%2581.%26aulast%3DCanales%26aufirst%3D%25C3%2581.%26aulast%3DAlgar%26aufirst%3DS.%26aulast%3DMayo%26aufirst%3DP.%2BP.%26aulast%3DJim%25C3%25A9nez-Barbero%26aufirst%3DJ.%26aulast%3DGajate%26aufirst%3DC.%26aulast%3DMollinedo%26aufirst%3DF.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DOrtega-Guti%25C3%25A9rrez%26aufirst%3DS.%26aulast%3DViso%26aufirst%3DA.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DDevelopment%2520of%2520a%2520nucleotide%2520exchange%2520inhibitor%2520that%2520impairs%2520Ras%2520oncogenic%2520signaling%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D1676%26epage%3D1685%26doi%3D10.1002%2Fchem.201604905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostrem, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Direct small-molecule inhibitors of KRas: from structural insights to mechanism-based design</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1038%2Fnrd.2016.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=27469033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=771-785&author=J.+M.+Ostremauthor=K.+M.+Shokat&title=Direct+small-molecule+inhibitors+of+KRas%3A+from+structural+insights+to+mechanism-based+design&doi=10.1038%2Fnrd.2016.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design</span></div><div class="casAuthors">Ostrem, Jonathan M. L.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">771-785</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">KRAS is the most frequently mutated oncogene in human cancer.  In addn. to holding this distinction, unsuccessful attempts to target this protein have led to the characterization of RAS as 'undruggable'.  However, recent advances in technol. and novel approaches to drug discovery have renewed hope that a direct KRAS inhibitor may be on the horizon.  In this Review, we provide an in-depth anal. of the structure, dynamics, mutational activation and inactivation, and signalling mechanisms of RAS.  From this perspective, we then consider potential mechanisms of action for effective RAS inhibitors.  Finally, we examine each of the many recent reports of direct RAS inhibitors and discuss promising avenues for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBobrhZLF3V7Vg90H21EOLACvtfcHk0lgDkAcZ8NHsTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FK&md5=b0832c7ef45cc0555e11c59baccc5abd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.139%26sid%3Dliteratum%253Aachs%26aulast%3DOstrem%26aufirst%3DJ.%2BM.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DDirect%2520small-molecule%2520inhibitors%2520of%2520KRas%253A%2520from%2520structural%2520insights%2520to%2520mechanism-based%2520design%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D771%26epage%3D785%26doi%3D10.1038%2Fnrd.2016.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, R. B.</span></span> <span> </span><span class="NLM_article-title">Therapeutic strategies to target Ras-mutant cancers</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">709</span>– <span class="NLM_lpage">720</span>, <span class="refDoi"> DOI: 10.1038/s41571-018-0105-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1038%2Fs41571-018-0105-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=30275515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVeqs7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=709-720&author=M.+B.+Ryanauthor=R.+B.+Corcoran&title=Therapeutic+strategies+to+target+Ras-mutant+cancers&doi=10.1038%2Fs41571-018-0105-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic strategies to target RAS-mutant cancers</span></div><div class="casAuthors">Ryan, Meagan B.; Corcoran, Ryan B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">709-720</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  RAS genes are the most commonly mutated oncogenes in cancer, but effective therapeutic strategies to target RAS-mutant cancers have proved elusive.  A key aspect of this challenge is the fact that direct inhibition of RAS proteins has proved difficult, leading researchers to test numerous alternative strategies aimed at exploiting RAS-related vulnerabilities or targeting RAS effectors.  In the past few years, we have witnessed renewed efforts to target RAS directly, with several promising strategies being tested in clin. trials at different stages of completion.  Important advances have also been made in approaches designed to indirectly target RAS by improving inhibition of RAS effectors, exploiting synthetic lethal interactions or metabolic dependencies, using therapeutic combination strategies or harnessing the immune system.  In this Review, we describe historical and ongoing efforts to target RAS-mutant cancers and outline the current therapeutic landscape in the collective quest to overcome the effects of this crucial oncogene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojQcBt2xwv47Vg90H21EOLACvtfcHk0lgDkAcZ8NHsTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVeqs7bM&md5=44839eb1482998d710b74e9362f4e0ea</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fs41571-018-0105-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41571-018-0105-0%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DM.%2BB.%26aulast%3DCorcoran%26aufirst%3DR.%2BB.%26atitle%3DTherapeutic%2520strategies%2520to%2520target%2520Ras-mutant%2520cancers%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2018%26volume%3D15%26spage%3D709%26epage%3D720%26doi%3D10.1038%2Fs41571-018-0105-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sautier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nising, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, L.</span></span> <span> </span><span class="NLM_article-title">Latest advances towards Ras inhibition: a medicinal chemistry perspective</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">15982</span>– <span class="NLM_lpage">15988</span>, <span class="refDoi"> DOI: 10.1002/anie.201608270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1002%2Fanie.201608270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFahtL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=15982-15988&author=B.+Sautierauthor=C.+F.+Nisingauthor=L.+Wortmann&title=Latest+advances+towards+Ras+inhibition%3A+a+medicinal+chemistry+perspective&doi=10.1002%2Fanie.201608270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Latest Advances Towards Ras Inhibition: A Medicinal Chemistry Perspective</span></div><div class="casAuthors">Sautier, Brice; Nising, Carl F.; Wortmann, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">15982-15988</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Owing to their high occurrence rate across many human cancers and their lack of druggability so far, mutant forms of the signaling protein Ras are currently among the most attractive (and elusive) oncol. targets.  This strong appeal explains the sustained effort in the field, and the ensuing progress has rekindled optimism regarding the discovery of Ras inhibitors.  In this Minireview, the authors discuss the most recent advances towards irreversible inhibitors, and highlight approaches to inhibitors of Ras-effector interactions that have been overshadowed by the current focus on direct Ras inhibition.  At the same time, the authors provide a crit. assessment from a medicinal chem. perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFjaiRaV3EarVg90H21EOLACvtfcHk0lgDkAcZ8NHsTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFahtL7F&md5=9aead7b14a7534e188f4c2b721e11903</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fanie.201608270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201608270%26sid%3Dliteratum%253Aachs%26aulast%3DSautier%26aufirst%3DB.%26aulast%3DNising%26aufirst%3DC.%2BF.%26aulast%3DWortmann%26aufirst%3DL.%26atitle%3DLatest%2520advances%2520towards%2520Ras%2520inhibition%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D15982%26epage%3D15988%26doi%3D10.1002%2Fanie.201608270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frett, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. Y.</span></span> <span> </span><span class="NLM_article-title">Targeting mutant KRas for anticancer therapeutics: a review of novel small molecule modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5219</span>– <span class="NLM_lpage">5230</span>, <span class="refDoi"> DOI: 10.1021/jm3017706</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3017706" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsV2gsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5219-5230&author=Y.+Wangauthor=C.+E.+Kaiserauthor=B.+Frettauthor=H.+Y.+Li&title=Targeting+mutant+KRas+for+anticancer+therapeutics%3A+a+review+of+novel+small+molecule+modulators&doi=10.1021%2Fjm3017706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Mutant KRAS for Anticancer Therapeutics: A Review of Novel Small Molecule Modulators</span></div><div class="casAuthors">Wang, Yuanxiang; Kaiser, Christine E.; Frett, Brendan; Li, Hong-yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5219-5230</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The RAS proteins play a role in cell differentiation, proliferation, and survival.  Aberrant RAS signaling has been found to play a role in 30% of all cancers.  KRAS, a key member of the RAS protein family, is an attractive cancer target, as frequent point mutations in the KRAS gene render the protein constitutively active.  A no. of attempts have been made to target aberrant KRAS signaling by identifying small mol. compds. that (1) are synthetic lethal to mutant KRAS, (2) block KRAS/GEF interactions, (3) inhibit downstream KRAS effectors, or (4) inhibit the post-translational processing of RAS proteins.  In addn., inhibition of novel targets outside the main KRAS signaling pathway, specifically the cell cycle related kinase PLK1, has been shown have an effect in cells that harbor mutant KRAS.  Herein we review the use of various high-throughput screening assays utilized to identify new small-mol. compds. capable of targeting mutant KRAS-driven cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogrA1KFIgQuLVg90H21EOLACvtfcHk0ljBNld9QGC3fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsV2gsbc%253D&md5=83623863b372993bdb0171d93e1db205</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm3017706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3017706%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKaiser%26aufirst%3DC.%2BE.%26aulast%3DFrett%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DH.%2BY.%26atitle%3DTargeting%2520mutant%2520KRas%2520for%2520anticancer%2520therapeutics%253A%2520a%2520review%2520of%2520novel%2520small%2520molecule%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5219%26epage%3D5230%26doi%3D10.1021%2Fjm3017706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span> <span> </span><span class="NLM_article-title">Protein prenylation: unique fats make their mark on biology</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1038/nrm.2015.11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1038%2Fnrm.2015.11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=26790532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=110-122&author=M.+Wangauthor=P.+J.+Casey&title=Protein+prenylation%3A+unique+fats+make+their+mark+on+biology&doi=10.1038%2Fnrm.2015.11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Protein prenylation: unique fats make their mark on biology</span></div><div class="casAuthors">Wang, Mei; Casey, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">110-122</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The modification of eukaryotic proteins by isoprenoid lipids, which is known as prenylation, controls the localization and activity of a range of proteins that have crucial functions in biol. regulation.  The roles of prenylated proteins in cells are well conserved across species, underscoring the biol. and evolutionary importance of this lipid modification pathway.  Genetic suppression and pharmacol. inhibition of the protein prenylation machinery have provided insights into several cellular processes and into the etiol. of diseases in which prenylation is involved.  The functional dependence of prenylation substrates, such as RAS proteins, on this modification and the therapeutic potential of targeting the prenylation process in pathol. conditions accentuate the need to fully understand this form of post-translational modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr08TXPqy6XorVg90H21EOLACvtfcHk0ljBNld9QGC3fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOrsrk%253D&md5=b6694153ce758f85c4e01c499d8de74a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrm.2015.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm.2015.11%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26atitle%3DProtein%2520prenylation%253A%2520unique%2520fats%2520make%2520their%2520mark%2520on%2520biology%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2016%26volume%3D17%26spage%3D110%26epage%3D122%26doi%3D10.1038%2Fnrm.2015.11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Der, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philips, M. R.</span></span> <span> </span><span class="NLM_article-title">Targeting Ras membrane association: back to the future for anti-Ras drug discovery?</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1819</span>– <span class="NLM_lpage">1827</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-3214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1158%2F1078-0432.CCR-14-3214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=25878363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsl2gt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=1819-1827&author=A.+D.+Coxauthor=C.+J.+Derauthor=M.+R.+Philips&title=Targeting+Ras+membrane+association%3A+back+to+the+future+for+anti-Ras+drug+discovery%3F&doi=10.1158%2F1078-0432.CCR-14-3214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?</span></div><div class="casAuthors">Cox, Adrienne D.; Der, Channing J.; Philips, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1819-1827</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">RAS proteins require membrane assocn. for their biol. activity, making this assocn. a logical target for anti-RAS therapeutics.  Lipid modification of RAS proteins by a farnesyl isoprenoid is an obligate step in that assocn., and is an enzymic process.  Accordingly, farnesyltransferase inhibitors (FTI) were developed as potential anti-RAS drugs.  The lack of efficacy of FTIs as anticancer drugs was widely seen as indicating that blocking RAS membrane assocn. was a flawed approach to cancer treatment.  However, a deeper understanding of RAS modification and trafficking has revealed that this was an erroneous conclusion.  In the presence of FTIs, KRAS and NRAS, which are the RAS isoforms most frequently mutated in cancer, become substrates for alternative modification, can still assoc. with membranes, and can still function.  Thus, FTIs failed not because blocking RAS membrane assocn. is an ineffective approach, but because FTIs failed to accomplish that task.  Recent findings regarding RAS isoform trafficking and the regulation of RAS subcellular localization have rekindled interest in efforts to target these processes.  In particular, improved understanding of the palmitoylation/depalmitoylation cycle that regulates RAS interaction with the plasma membrane, endomembranes, and cytosol, and of the potential importance of RAS chaperones, have led to new approaches.  Efforts to validate and target other enzymically regulated posttranslational modifications are also ongoing.  In this review, we revisit lessons learned, describe the current state of the art, and highlight challenging but promising directions to achieve the goal of disrupting RAS membrane assocn. and subcellular localization for anti-RAS drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCImUyZbuCKrVg90H21EOLACvtfcHk0lgZJQroinbFOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsl2gt74%253D&md5=6f41ac23a7d14b90633755e374b6ffea</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-3214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-3214%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DA.%2BD.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26aulast%3DPhilips%26aufirst%3DM.%2BR.%26atitle%3DTargeting%2520Ras%2520membrane%2520association%253A%2520back%2520to%2520the%2520future%2520for%2520anti-Ras%2520drug%2520discovery%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D1819%26epage%3D1827%26doi%3D10.1158%2F1078-0432.CCR-14-3214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergo, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavino, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beigneux, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. G.</span></span> <span> </span><span class="NLM_article-title">Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1172/JCI200418829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1172%2FJCI200418829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=14966563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFKhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2004&pages=539-550&author=M.+O.+Bergoauthor=B.+J.+Gavinoauthor=C.+Hongauthor=A.+P.+Beigneuxauthor=M.+McMahonauthor=P.+J.+Caseyauthor=S.+G.+Young&title=Inactivation+of+Icmt+inhibits+transformation+by+oncogenic+K-Ras+and+B-Raf&doi=10.1172%2FJCI200418829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf</span></div><div class="casAuthors">Bergo, Martin O.; Gavino, Bryant J.; Hong, Christine; Beigneux, Anne P.; McMahon, Martin; Casey, Patrick J.; Young, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">539-550</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Isoprenylcysteine carboxyl methyltransferase (Icmt) methylates the carboxyl-terminal isoprenylcysteine of CAAX proteins (e.g., Ras and Rho proteins).  In the case of the Ras proteins, carboxyl methylation is important for targeting of the proteins to the plasma membrane.  We hypothesized that a knockout of Icmt would reduce the ability of cells to be transformed by K-Ras.  Fibroblasts harboring a floxed Icmt allele and expressing activated K-Ras (K-Ras-Icmtflx/flx) were treated with Cre-adenovirus, producing K-Ras-IcmtΔ/Δ fibroblasts.  Inactivation of Icmt inhibited cell growth and K-Ras-induced oncogenic transformation, both in soft agar assays and in a nude mice model.  The inactivation of Icmt did not affect growth factor-stimulated phosphorylation of Erk1/2 or Akt1.  However, levels of RhoA were greatly reduced as a consequence of accelerated protein turnover.  In addn., there was a large Ras/Erk1/2-dependent increase in p21Cip1, which was probably a consequence of the reduced levels of RhoA.  Deletion of p21Cip1 restored the ability of K-Ras-IcmtΔ/Δ fibroblasts to grow in soft agar.  The effect of inactivating Icmt was not limited to the inhibition of K-Ras-induced transformation: inactivation of Icmt blocked transformation by an oncogenic form of B-Raf (V599E).  These studies identify Icmt as a potential target for reducing the growth of K-Ras- and B-Raf-induced malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgtsUKYvB3B7Vg90H21EOLACvtfcHk0lgZJQroinbFOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFKhsb0%253D&md5=521e9d001c068e7aef840765d1f3d748</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1172%2FJCI200418829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI200418829%26sid%3Dliteratum%253Aachs%26aulast%3DBergo%26aufirst%3DM.%2BO.%26aulast%3DGavino%26aufirst%3DB.%2BJ.%26aulast%3DHong%26aufirst%3DC.%26aulast%3DBeigneux%26aufirst%3DA.%2BP.%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26atitle%3DInactivation%2520of%2520Icmt%2520inhibits%2520transformation%2520by%2520oncogenic%2520K-Ras%2520and%2520B-Raf%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2004%26volume%3D113%26spage%3D539%26epage%3D550%26doi%3D10.1172%2FJCI200418829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wahlstrom, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutts, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindskog, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjogren, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergo, M. O.</span></span> <span> </span><span class="NLM_article-title">Inactivating Icmt ameliorates K-Ras-induced myeloproliferative disease</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">1357</span>– <span class="NLM_lpage">1365</span>, <span class="refDoi"> DOI: 10.1182/blood-2007-06-094060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1182%2Fblood-2007-06-094060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=18502828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvVOktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=1357-1365&author=A.+M.+Wahlstromauthor=B.+A.+Cuttsauthor=M.+Liuauthor=A.+Lindskogauthor=C.+Karlssonauthor=A.+K.+Sjogrenauthor=K.+M.+Anderssonauthor=S.+G.+Youngauthor=M.+O.+Bergo&title=Inactivating+Icmt+ameliorates+K-Ras-induced+myeloproliferative+disease&doi=10.1182%2Fblood-2007-06-094060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivating Icmt ameliorates K-RAS-induced myeloproliferative disease</span></div><div class="casAuthors">Wahlstrom, Annika M.; Cutts, Briony A.; Liu, Meng; Lindskog, Annika; Karlsson, Christin; Sjogren, Anna-Karin M.; Andersson, Karin M. E.; Young, Stephen G.; Bergo, Martin O.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1357-1365</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Hyperactive signaling through the RAS proteins is involved in the pathogenesis of many forms of cancer.  The RAS proteins and many other intracellular signaling proteins are either farneslated or geranylgeranylated at a carboxylterminal cysteine.  That isoprenylcysteine is then carboxyl methylated by isoprenylcysteine carboxyl methyltransferase (ICMT).  We previously showed that inactivation of Icmt mislocalizes the RAS proteins away from the plasma membrane and blocks RAS transformation of mouse fibroblasts, suggesting that ICMT could be a therapeutic target.  However, nothing is known about the impact of inhibiting ICMT on the development of malignancies in vivo.  In the current study, we tested the hypothesis that inactivation of Icmt would inhibit the development or progression of a K-RAS-induced myeloproliferative disease in mice.  We found that inactivating Icmt reduced splenomegaly, the no. of immature myeloid cells in peripheral blood, and tissue infiltration by myeloid cells.  Moreover, in the absence of Icmt, the ability of K-RAS-expressing hematopoietic cells to form colonies in methylcellulose without exogenous growth factors was reduced dramatically.  Finally, inactivating Icmt reduced lung tumor development and myeloproliferation phenotypes in a mouse model of K-RAS-induced cancer.  We conclude that inactivation of Icmt ameliorates phenotypes of K-RAS-induced malignancies in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriOROOZKs_wbVg90H21EOLACvtfcHk0lgZJQroinbFOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvVOktLg%253D&md5=eaa0e2fa401c0823cba19480efc1b8a1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-06-094060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-06-094060%26sid%3Dliteratum%253Aachs%26aulast%3DWahlstrom%26aufirst%3DA.%2BM.%26aulast%3DCutts%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLindskog%26aufirst%3DA.%26aulast%3DKarlsson%26aufirst%3DC.%26aulast%3DSjogren%26aufirst%3DA.%2BK.%26aulast%3DAndersson%26aufirst%3DK.%2BM.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DBergo%26aufirst%3DM.%2BO.%26atitle%3DInactivating%2520Icmt%2520ameliorates%2520K-Ras-induced%2520myeloproliferative%2520disease%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D1357%26epage%3D1365%26doi%3D10.1182%2Fblood-2007-06-094060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span> <span> </span><span class="NLM_article-title">Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all Ras isoforms</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">3934</span>– <span class="NLM_lpage">3942</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1038%2Fonc.2016.508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=28192404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislGltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=3934-3942&author=H.+Y.+Lauauthor=J.+Tangauthor=P.+J.+Caseyauthor=M.+Wang&title=Isoprenylcysteine+carboxylmethyltransferase+is+critical+for+malignant+transformation+and+tumor+maintenance+by+all+Ras+isoforms&doi=10.1038%2Fonc.2016.508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms</span></div><div class="casAuthors">Lau, H. Y.; Tang, J.; Casey, P. J.; Wang, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3934-3942</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite extensive effort, there has been limited progress in the development of direct RAS inhibitors.  Targeting isoprenylcysteine carboxylmethyltransferase (ICMT), a unique enzyme of RAS post-translational modification, represents a promising strategy to inhibit RAS function.  However, there lacks direct genetic evidence on the role of ICMT in RAS-driven human cancer initiation and maintenance.  Using CRISPR/Cas9 genome editing, we have created Icmt loss-of-function isogenic cell lines for both RAS-transformed human mammary epithelial cells (HME1) and human cancer cell lines MiaPaca-2 and MDA-MB-231 contg. naturally occurring mutant KRAS.  In both in vitro and in vivo tumorigenesis studies, Icmt loss-of-function abolishes the tumor initiation ability of all major isoforms of mutant RAS in HME1 cells, and the tumor maintenance capacity of MiaPaca-2 and MDA-MB-231 cells, establishing the crit. role of ICMT in RAS-driven cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsFJ7p2xGULbVg90H21EOLACvtfcHk0lis1DcK3Pq-XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislGltL8%253D&md5=dbe47533ffa72f013b135df879724521</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.508%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DH.%2BY.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26aulast%3DWang%26aufirst%3DM.%26atitle%3DIsoprenylcysteine%2520carboxylmethyltransferase%2520is%2520critical%2520for%2520malignant%2520transformation%2520and%2520tumor%2520maintenance%2520by%2520all%2520Ras%2520isoforms%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D3934%26epage%3D3942%26doi%3D10.1038%2Fonc.2016.508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winter-Vann, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">dela Cruz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">York, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gooden, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergo, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toone, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span> <span> </span><span class="NLM_article-title">A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">4336</span>– <span class="NLM_lpage">4341</span>, <span class="refDoi"> DOI: 10.1073/pnas.0408107102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1073%2Fpnas.0408107102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=15784746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivFCrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=4336-4341&author=A.+M.+Winter-Vannauthor=R.+A.+Baronauthor=W.+Wongauthor=J.+dela+Cruzauthor=J.+D.+Yorkauthor=D.+M.+Goodenauthor=M.+O.+Bergoauthor=S.+G.+Youngauthor=E.+J.+Tooneauthor=P.+J.+Casey&title=A+small-molecule+inhibitor+of+isoprenylcysteine+carboxyl+methyltransferase+with+antitumor+activity+in+cancer+cells&doi=10.1073%2Fpnas.0408107102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells</span></div><div class="casAuthors">Winter-Vann, Ann M.; Baron, Rudi A.; Wong, Waihay; dela Cruz, June; York, John D.; Gooden, David M.; Bergo, Martin O.; Young, Stephen G.; Toone, Eric J.; Casey, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4336-4341</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Many key regulatory proteins, including members of the Ras family of GTPases, are modified at their C terminus by a process termed prenylation.  This processing is initiated by the addn. of an isoprenoid lipid, and the proteins are further modified by a proteolytic event and methylation of the C-terminal prenylcysteine.  Although the biol. consequences of prenylation have been characterized extensively, the contributions of prenylcysteine methylation to the functions of the modified proteins are not well understood.  This reaction is catalyzed by the enzyme isoprenylcysteine carboxyl methyltransferase (Icmt).  Recent genetic disruption studies have provided strong evidence that blocking Icmt activity has profound consequences on oncogenic transformation.  Here, we report the identification of a selective small-mol. inhibitor of Icmt, 2-[5-(3-methylphenyl)-1-octyl-1H-indol-3-yl]acetamide (cysmethynil).  Cysmethynil treatment results in inhibition of cell growth in an Icmt-dependent fashion, demonstrating mechanism-based activity of the compd.  Treatment of cancer cells with cysmethynil results in mislocalization of Ras and impaired epidermal growth factor signaling.  In a human colon cancer cell line, cysmethynil treatment blocks anchorage-independent growth, and this effect is reversed by overexpression of Icmt.  These findings provide a compelling rationale for development of Icmt inhibitors as another approach to anticancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY-1GtT0roj7Vg90H21EOLACvtfcHk0lis1DcK3Pq-XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivFCrtLk%253D&md5=8cbe478e0911934e2868d5b5eb376a58</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0408107102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0408107102%26sid%3Dliteratum%253Aachs%26aulast%3DWinter-Vann%26aufirst%3DA.%2BM.%26aulast%3DBaron%26aufirst%3DR.%2BA.%26aulast%3DWong%26aufirst%3DW.%26aulast%3Ddela%2BCruz%26aufirst%3DJ.%26aulast%3DYork%26aufirst%3DJ.%2BD.%26aulast%3DGooden%26aufirst%3DD.%2BM.%26aulast%3DBergo%26aufirst%3DM.%2BO.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DToone%26aufirst%3DE.%2BJ.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26atitle%3DA%2520small-molecule%2520inhibitor%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520with%2520antitumor%2520activity%2520in%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D4336%26epage%3D4341%26doi%3D10.1073%2Fpnas.0408107102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coolman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">4959</span>– <span class="NLM_lpage">4970</span>, <span class="refDoi"> DOI: 10.1038/onc.2010.247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1038%2Fonc.2010.247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=20622895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1aitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=4959-4970&author=M.+Wangauthor=M.+S.+Hossainauthor=W.+Tanauthor=B.+Coolmanauthor=J.+Zhouauthor=S.+Liuauthor=P.+J.+Casey&title=Inhibition+of+isoprenylcysteine+carboxylmethyltransferase+induces+autophagic-dependent+apoptosis+and+impairs+tumor+growth&doi=10.1038%2Fonc.2010.247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth</span></div><div class="casAuthors">Wang, M.; Hossain, M. S.; Tan, W.; Coolman, B.; Zhou, J.; Liu, S.; Casey, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">4959-4970</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of isoprenylcysteine carboxylmethyltransferase (Icmt), which catalyzes the final step in the post-translational C-terminal processing of prenylated proteins, suppresses tumor cell growth and induces cell death.  Icmt inhibition by either a small mol. inhibitor termed as cysmethynil or inhibitory RNA induces marked autophagy leading to cell death.  HepG2 cells were used to investigate the function of autophagy in tumor cell death.  Suppression of autophagy, either pharmacol. or through knockdown of the autophagy essential proteins, Atg5 or Atg1, inhibits not only cysmethynil-induced autophagy, but also apoptosis in HepG2 cells.  The dependence of cysmethynil-induced apoptosis on autophagy was further shown using autophagy-deficient mouse embryonic fibroblast (MEF) cells.  Atg5-/- MEF cells were found to be resistant to cysmethynil-induced apoptosis, whereas wild-type MEFs showed high sensitivity to apoptosis induction.  These data indicate that inhibition of Icmt can elicit cell death through two linked mechanisms, autophagy and apoptosis, and that autophagy can be an active player upstream of apoptosis in cell types capable of apoptotic cell death, such as HepG2 and MEFs.  Further, treatment of mice-bearing HepG2-derived tumors with cysmethynil resulted in marked inhibition of tumor growth; anal. of tumor tissue from these mice revealed markers consistent with autophagy induction and cell growth arrest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW_YIMkTsLL7Vg90H21EOLACvtfcHk0lgtlkMqCQm_Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1aitr0%253D&md5=2a0466842130fe04a9b9a4cbd4e49e8d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fonc.2010.247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2010.247%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DHossain%26aufirst%3DM.%2BS.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DCoolman%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26atitle%3DInhibition%2520of%2520isoprenylcysteine%2520carboxylmethyltransferase%2520induces%2520autophagic-dependent%2520apoptosis%2520and%2520impairs%2520tumor%2520growth%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D4959%26epage%3D4970%26doi%3D10.1038%2Fonc.2010.247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manu, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teh, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of isoprenylcysteine carboxylmethyltransferase induces cell-cycle arrest and apoptosis through p21 and p21-regulated BNIP3 induction in pancreatic cancer</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">914</span>– <span class="NLM_lpage">923</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1158%2F1535-7163.MCT-16-0703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=28167504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFemsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=914-923&author=K.+A.+Manuauthor=T.+F.+Chaiauthor=J.+T.+Tehauthor=W.+L.+Zhuauthor=P.+J.+Caseyauthor=M.+Wang&title=Inhibition+of+isoprenylcysteine+carboxylmethyltransferase+induces+cell-cycle+arrest+and+apoptosis+through+p21+and+p21-regulated+BNIP3+induction+in+pancreatic+cancer&doi=10.1158%2F1535-7163.MCT-16-0703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer</span></div><div class="casAuthors">Manu, Kanjoormana Aryan; Chai, Tin Fan; Teh, Jing Tsong; Zhu, Wan Long; Casey, Patrick J.; Wang, Mei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">914-923</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Pancreatic cancer remains one of the most difficult to treat human cancers despite recent advances in targeted therapy.  Inhibition of isoprenylcysteine carboxylmethyltransferase (ICMT), an enzyme that posttranslationally modifies a group of proteins including several small GTPases, suppresses proliferation of some human cancer cells.  However, the efficacy of ICMT inhibition on human pancreatic cancer has not been evaluated.  In this study, we have evaluated a panel of human pancreatic cancer cell lines and identified those that are sensitive to ICMT inhibition.  In these cells, ICMT suppression inhibited proliferation and induced apoptosis.  This responsiveness to ICMT inhibition was confirmed in in vivo xenograft tumor mouse models using both a small-mol. inhibitor and shRNA-targeting ICMT.  Mechanistically, we found that, in sensitive pancreatic cancer cells, ICMT inhibition induced mitochondrial respiratory deficiency and cellular energy depletion, leading to significant upregulation of p21.  Furthermore, we characterized the role of p21 as a regulator and coordinator of cell signaling that responds to cell energy depletion.  Apoptosis, but not autophagy, that is induced via p21-activated BNIP3 expression accounts for the efficacy of ICMT inhibition in sensitive pancreatic cancer cells in both in vitro and in vivo models.  In contrast, cells resistant to ICMT inhibition demonstrated no mitochondria dysfunction or p21 signaling changes under ICMT suppression.  These findings not only identify pancreatic cancers as potential therapeutic targets for ICMT suppression but also provide an avenue for identifying those subtypes that would be most responsive to agents targeting this crit. enzyme.  Mol Cancer Ther; 16(5); 914-23. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbBp0WbhKv7LVg90H21EOLACvtfcHk0lgtlkMqCQm_Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFemsLs%253D&md5=8c766434a805bfc047d0d7252117e881</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0703%26sid%3Dliteratum%253Aachs%26aulast%3DManu%26aufirst%3DK.%2BA.%26aulast%3DChai%26aufirst%3DT.%2BF.%26aulast%3DTeh%26aufirst%3DJ.%2BT.%26aulast%3DZhu%26aufirst%3DW.%2BL.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26aulast%3DWang%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520isoprenylcysteine%2520carboxylmethyltransferase%2520induces%2520cell-cycle%2520arrest%2520and%2520apoptosis%2520through%2520p21%2520and%2520p21-regulated%2520BNIP3%2520induction%2520in%2520pancreatic%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2017%26volume%3D16%26spage%3D914%26epage%3D923%26doi%3D10.1158%2F1535-7163.MCT-16-0703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Go, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leow, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorla, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schüller, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span> <span> </span><span class="NLM_article-title">Amino derivatives of indole as potent inhibitors of isoprenylcysteine carboxyl methyltransferase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6838</span>– <span class="NLM_lpage">6850</span>, <span class="refDoi"> DOI: 10.1021/jm1002843</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1002843" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSnsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6838-6850&author=M.-L.+Goauthor=J.+L.+Leowauthor=S.+K.+Gorlaauthor=A.+P.+Sch%C3%BCllerauthor=M.+Wangauthor=P.+J.+Casey&title=Amino+derivatives+of+indole+as+potent+inhibitors+of+isoprenylcysteine+carboxyl+methyltransferase&doi=10.1021%2Fjm1002843"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Amino Derivatives of Indole As Potent Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase</span></div><div class="casAuthors">Go, Mei-Lin; Leow, Jo Lene; Gorla, Suresh Kumar; Schuller, Andreas Peter; Wang, Mei; Casey, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6838-6850</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The enzyme isoprenylcysteine carboxyl methyltransferase (Icmt) plays an important role in the post-translational modification of proteins that are involved in the regulation of cell growth.  The indole acetamide cysmethynil(I) is by far the most potent and widely investigated Icmt inhibitor, but it has modest antiproliferative activity and may have pharmacokinetic limitations due to its lipophilic character.  We report here that cysmethynil can be structurally modified to give analogs that are as potent in inhibiting Icmt but with significantly greater antiproliferative activity.  Key modifications were the replacement of the acetamide side chain by tertiary amino groups, the n-octyl side chain by isoprenyl and the 5-m-tolyl ring by fluorine.  Moreover, these analogs have lower lipophilicities that could lead to improved pharmacokinetic profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLOoh-BVsKBLVg90H21EOLACvtfcHk0ljTLOVOhAHXnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSnsrbK&md5=7c0749dc74d7651abe3f67a8ddc5979b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm1002843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1002843%26sid%3Dliteratum%253Aachs%26aulast%3DGo%26aufirst%3DM.-L.%26aulast%3DLeow%26aufirst%3DJ.%2BL.%26aulast%3DGorla%26aufirst%3DS.%2BK.%26aulast%3DSch%25C3%25BCller%26aufirst%3DA.%2BP.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26atitle%3DAmino%2520derivatives%2520of%2520indole%2520as%2520potent%2520inhibitors%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6838%26epage%3D6850%26doi%3D10.1021%2Fjm1002843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrycyna, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Non-substrate based, small molecule inhibitors of the human isoprenylcysteine carboxyl methyltransferase</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1016</span>– <span class="NLM_lpage">1021</span>, <span class="refDoi"> DOI: 10.1039/C6MD00130K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1039%2FC6MD00130K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=27547295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsF2ksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1016-1021&author=K.+V.+Butlerauthor=K.+Bohnauthor=C.+A.+Hrycynaauthor=J.+Jin&title=Non-substrate+based%2C+small+molecule+inhibitors+of+the+human+isoprenylcysteine+carboxyl+methyltransferase&doi=10.1039%2FC6MD00130K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Non-substrate based, small molecule inhibitors of the human isoprenylcysteine carboxyl methyltransferase</span></div><div class="casAuthors">Butler, Kyle V.; Bohn, Kelsey; Hrycyna, Christine A.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1016-1021</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Activating mutations of human K-Ras proteins are among the most common oncogenic mutations, present in approx. 30% of all human cancers.  Post-translational modifications to K-Ras guide it to the plasma membrane and disruption of this localization inhibits the growth of Ras-driven cancers.  The human isoprenylcysteine carboxylmethyltransferase (hIcmt) enzyme catalyzes the final α-carboxyl Me esterification of the C-terminal farnesyl cysteine of K-Ras, which is necessary for its proper localization.  Thus, hIcmt inhibition is a regarded as a promising cancer therapy.  A high quality inhibitor of hIcmt with in vivo activity would advance hIcmt research and drug development.  Herein, we report the results of a screen for small mol. hIcmt inhibitors in a library of mols. that were not hIcmt substrate analogs.  The lead compd. identified by this screen (1) was modified to remove chem. liabilities and to increase potency.  The most potent resulting compd. (5) inhibited hIcmt in vitro with low micromolar potency (IC50 = 1.5 ± 0.2 μM) and was kinetically characterized as a competitive inhibitor for prenylated substrates and a non-competitive inhibitor for the cofactor and Me donor S-adenosylmethionine (SAM).  These inhibitors offer important structure activity relationships for the future development of hIcmt inhibitors with in vivo activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSVUxcNKwja7Vg90H21EOLACvtfcHk0ljTLOVOhAHXnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsF2ksr4%253D&md5=70f666b6f64ae066f1e6779e5d9081de</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2FC6MD00130K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00130K%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DBohn%26aufirst%3DK.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DNon-substrate%2520based%252C%2520small%2520molecule%2520inhibitors%2520of%2520the%2520human%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%26jtitle%3DMedChemComm%26date%3D2016%26volume%3D7%26spage%3D1016%26epage%3D1021%26doi%3D10.1039%2FC6MD00130K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fechner, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addepalli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forster, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guymer, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, R. J.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of the cancer target, isoprenylcysteine carboxyl methyltransferase, from <i>Hovea parvicalyx</i></span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1886</span>– <span class="NLM_lpage">1889</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2008.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.phytochem.2008.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=18466935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFaqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2008&pages=1886-1889&author=M.+S.+Buchananauthor=A.+R.+Carrollauthor=G.+A.+Fechnerauthor=A.+Boyleauthor=M.+Simpsonauthor=R.+Addepalliauthor=V.+M.+Averyauthor=P.+I.+Forsterauthor=G.+P.+Guymerauthor=T.+Cheungauthor=H.+Chenauthor=R.+J.+Quinn&title=Small-molecule+inhibitors+of+the+cancer+target%2C+isoprenylcysteine+carboxyl+methyltransferase%2C+from+Hovea+parvicalyx&doi=10.1016%2Fj.phytochem.2008.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of the cancer target, isoprenylcysteine carboxyl methyltransferase, from Hovea parvicalyx</span></div><div class="casAuthors">Buchanan, Malcolm S.; Carroll, Anthony R.; Fechner, Gregory A.; Boyle, Anthony; Simpson, Moana; Addepalli, Rama; Avery, Vicky M.; Forster, Paul I.; Guymer, Gordon P.; Cheung, Tony; Chen, Huwei; Quinn, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1886-1889</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Isoprenylcysteine carboxyl methyltransferase (Icmt) is enzyme target in anticancer drug discovery.  An Icmt natural product high-throughput screening campaign was conducted and a hit ext. from the roots of Hovea parvicalyx was identified.  2'-Methoxy-3'-prenyl-licodione and 2'-methoxy-3',3''-diprenyl-licodione, two prenylated β-hydroxychalcone compds., together with the known flavanone (S)-glabrol, were isolated and identified as bioactive constituents.  Their structures were detd. largely by 1D and 2D NMR spectroscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyzV9rMjOywLVg90H21EOLACvtfcHk0lgMmzEXxs96-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFaqurY%253D&md5=f701e2cef744ae2d6af8d154a1b49186</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2008.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2008.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DBuchanan%26aufirst%3DM.%2BS.%26aulast%3DCarroll%26aufirst%3DA.%2BR.%26aulast%3DFechner%26aufirst%3DG.%2BA.%26aulast%3DBoyle%26aufirst%3DA.%26aulast%3DSimpson%26aufirst%3DM.%26aulast%3DAddepalli%26aufirst%3DR.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DForster%26aufirst%3DP.%2BI.%26aulast%3DGuymer%26aufirst%3DG.%2BP.%26aulast%3DCheung%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520cancer%2520target%252C%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%252C%2520from%2520Hovea%2520parvicalyx%26jtitle%3DPhytochemistry%26date%3D2008%26volume%3D69%26spage%3D1886%26epage%3D1889%26doi%3D10.1016%2Fj.phytochem.2008.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fechner, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addepalli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, R. J.</span></span> <span> </span><span class="NLM_article-title">Aplysamine 6, an alkaloidal inhibitor of Isoprenylcysteine carboxyl methyltransferase from the sponge <i>Pseudoceratina sp</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1021/np0706623</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np0706623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktlCitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=1066-1067&author=M.+S.+Buchananauthor=A.+R.+Carrollauthor=G.+A.+Fechnerauthor=A.+Boyleauthor=M.+Simpsonauthor=R.+Addepalliauthor=V.+M.+Averyauthor=J.+N.+Hooperauthor=T.+Cheungauthor=H.+Chenauthor=R.+J.+Quinn&title=Aplysamine+6%2C+an+alkaloidal+inhibitor+of+Isoprenylcysteine+carboxyl+methyltransferase+from+the+sponge+Pseudoceratina+sp&doi=10.1021%2Fnp0706623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Aplysamine 6, an Alkaloidal Inhibitor of Isoprenylcysteine Carboxyl Methyltransferase from the Sponge Pseudoceratina sp.</span></div><div class="casAuthors">Buchanan, Malcolm S.; Carroll, Anthony R.; Fechner, Gregory A.; Boyle, Anthony; Simpson, Moana; Addepalli, Rama; Avery, Vicky M.; Hooper, John N. A.; Cheung, Tony; Chen, Huwei; Quinn, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1066-1067</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">The anticancer target isoprenylcysteine carboxyl methyltransferase (Icmt) was the focus of a natural product high-throughput screening campaign.  The Australian marine sponge Pseudoceratina sp. yielded aplysamine 6 (I), a new bromotyrosine deriv. with an α,β-unsatd. amide linkage, as the bioactive constituent.  Its structure was detd. by 1D and 2D NMR spectroscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB4sAT-kEkcLVg90H21EOLACvtfcHk0lgMmzEXxs96-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktlCitb0%253D&md5=1f89ee78d25e3e33c34244af5e98d4ee</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fnp0706623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp0706623%26sid%3Dliteratum%253Aachs%26aulast%3DBuchanan%26aufirst%3DM.%2BS.%26aulast%3DCarroll%26aufirst%3DA.%2BR.%26aulast%3DFechner%26aufirst%3DG.%2BA.%26aulast%3DBoyle%26aufirst%3DA.%26aulast%3DSimpson%26aufirst%3DM.%26aulast%3DAddepalli%26aufirst%3DR.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DHooper%26aufirst%3DJ.%2BN.%26aulast%3DCheung%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DAplysamine%25206%252C%2520an%2520alkaloidal%2520inhibitor%2520of%2520Isoprenylcysteine%2520carboxyl%2520methyltransferase%2520from%2520the%2520sponge%2520Pseudoceratina%2520sp%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2008%26volume%3D71%26spage%3D1066%26epage%3D1067%26doi%3D10.1021%2Fnp0706623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fechner, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addepalli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, R. J.</span></span> <span> </span><span class="NLM_article-title">Spermatinamine, the first natural product inhibitor of isoprenylcysteine carboxyl methyltransferase, a new cancer target</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6860</span>– <span class="NLM_lpage">6863</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.bmcl.2007.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=17964784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWjtL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6860-6863&author=M.+S.+Buchananauthor=A.+R.+Carrollauthor=G.+A.+Fechnerauthor=A.+Boyleauthor=M.+M.+Simpsonauthor=R.+Addepalliauthor=V.+M.+Averyauthor=J.+N.+Hooperauthor=N.+Suauthor=H.+Chenauthor=R.+J.+Quinn&title=Spermatinamine%2C+the+first+natural+product+inhibitor+of+isoprenylcysteine+carboxyl+methyltransferase%2C+a+new+cancer+target&doi=10.1016%2Fj.bmcl.2007.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Spermatinamine, the first natural product inhibitor of isoprenylcysteine carboxyl methyltransferase, a new cancer target</span></div><div class="casAuthors">Buchanan, Malcolm S.; Carroll, Anthony R.; Fechner, Gregory A.; Boyle, Anthony; Simpson, Moana M.; Addepalli, Rama; Avery, Vicky M.; Hooper, John N. A.; Su, Nancy; Chen, Huawei; Quinn, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6860-6863</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Isoprenylcysteine methyltransferases (Icmt) catalyzes the carboxyl methylation of oncogenic proteins in the final step of a series of post-translational modifications.  The inhibition of Icmt provides an attractive and novel anticancer target.  A natural product high-throughput screening campaign was conducted to discover inhibitors of Icmt.  The Australian marine sponge, Pseudoceratina sp., yielded spermatinamine, a novel alkaloid with a bromotyrosyl-spermine-bromotyrosyl sequence, as the bioactive constituent.  Its structure was detd. by 1D and 2D NMR spectroscopy.  Spermatinamine is the first natural product inhibitor of Icmt.  This paper reports the isolation, structure elucidation, and Icmt inhibitory activity of spermatinamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC2ISo0P6FiLVg90H21EOLACvtfcHk0ljRT1_XTS3YHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWjtL%252FO&md5=5451248296c7fc75a40b108889e6f6f6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DBuchanan%26aufirst%3DM.%2BS.%26aulast%3DCarroll%26aufirst%3DA.%2BR.%26aulast%3DFechner%26aufirst%3DG.%2BA.%26aulast%3DBoyle%26aufirst%3DA.%26aulast%3DSimpson%26aufirst%3DM.%2BM.%26aulast%3DAddepalli%26aufirst%3DR.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DHooper%26aufirst%3DJ.%2BN.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DSpermatinamine%252C%2520the%2520first%2520natural%2520product%2520inhibitor%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%252C%2520a%2520new%2520cancer%2520target%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6860%26epage%3D6863%26doi%3D10.1016%2Fj.bmcl.2007.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leow, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, M. L.</span></span> <span> </span><span class="NLM_article-title">Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1025</span>– <span class="NLM_lpage">1032</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.11.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.bmcl.2006.11.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=17157012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12ktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1025-1032&author=J.+L.+Leowauthor=R.+Baronauthor=P.+J.+Caseyauthor=M.+L.+Go&title=Quantitative+structure-activity+relationship+%28QSAR%29+of+indoloacetamides+as+inhibitors+of+human+isoprenylcysteine+carboxyl+methyltransferase&doi=10.1016%2Fj.bmcl.2006.11.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase</span></div><div class="casAuthors">Leow, Jo-Lene; Baron, Rudi; Casey, Patrick J.; Go, Mei-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1025-1032</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A QSAR is developed for the isoprenylcysteine carboxyl methyltransferase (ICMT) inhibitory activities of a series of indoloacetamides (n = 72) that are structurally related to cysmethynil, a selective ICMT inhibitor.  Multivariate anal. tools (principal component anal. (PCA) and projection to latent structures (PLS)), multi-linear regression (MLR) and comparative mol. field anal. (CoMFA) are used to develop a suitably predictive model for the purpose of optimizing and identifying members with more potent inhibitory activity.  The resulting model shows that good activity is detd. largely by the characteristics of the substituent attached to the indole nitrogen, which should be a lipophilic residue with fairly wide dimensions.  In contrast, the substituted Ph ring attached to the indole ring must be of limited dimensions and lipophilicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7HmRpJ6zHhrVg90H21EOLACvtfcHk0ljRT1_XTS3YHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12ktb0%253D&md5=840c1c381a1de77937f3f73358b839eb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.11.030%26sid%3Dliteratum%253Aachs%26aulast%3DLeow%26aufirst%3DJ.%2BL.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26aulast%3DGo%26aufirst%3DM.%2BL.%26atitle%3DQuantitative%2520structure-activity%2520relationship%2520%2528QSAR%2529%2520of%2520indoloacetamides%2520as%2520inhibitors%2520of%2520human%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1025%26epage%3D1032%26doi%3D10.1016%2Fj.bmcl.2006.11.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramanujulu, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yap, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, M. L.</span></span> <span> </span><span class="NLM_article-title">Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">378</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.ejmech.2013.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=23514631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFaqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2013&pages=378-386&author=P.+M.+Ramanujuluauthor=T.+Yangauthor=S.+Q.+Yapauthor=F.+C.+Wongauthor=P.+J.+Caseyauthor=M.+Wangauthor=M.+L.+Go&title=Functionalized+indoleamines+as+potent%2C+drug-like+inhibitors+of+isoprenylcysteine+carboxyl+methyltransferase+%28ICMT%29&doi=10.1016%2Fj.ejmech.2013.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt)</span></div><div class="casAuthors">Ramanujulu, Pondy M.; Yang, Tianming; Yap, Siew-Qi; Wong, Fui-Chung; Casey, Patrick J.; Wang, Mei; Go, Mei-Lin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">378-386</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The enzyme isoprenylcysteine carboxyl methyltransferase (Icmt) plays an important role in the post-translational modification of proteins involved in the regulation of cell growth and oncogenesis.  The biol. consequences of Icmt inhibition strongly implicate the enzyme as a potential therapeutic target for cancer and provide a compelling rationale for developing specific Icmt inhibitors as anti-cancer agents.  We report here the systematic modification of the known Icmt inhibitor cysmethynil to give an analog I with greatly improved soly. and PAMPA permeability which was achieved with concurrent gains in Icmt inhibitory and cell-based antiproliferative activities.  The modifications involved replacing the amide side chain of cysmethynil with a tertiary amine, and introducing an aminopyrimidine ring in place of m-tolyl.  The presence of the weakly basic and polar aminopyrimidine ring contributed significantly to the potency and drug-like profile of the final compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraQuKj1ZyZabVg90H21EOLACvtfcHk0lhIQ7A6XaHkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFaqurs%253D&md5=7afce963dd545c964b10a67bbae8f712</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DRamanujulu%26aufirst%3DP.%2BM.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DYap%26aufirst%3DS.%2BQ.%26aulast%3DWong%26aufirst%3DF.%2BC.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DGo%26aufirst%3DM.%2BL.%26atitle%3DFunctionalized%2520indoleamines%2520as%2520potent%252C%2520drug-like%2520inhibitors%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520%2528ICMT%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D63%26spage%3D378%26epage%3D386%26doi%3D10.1016%2Fj.ejmech.2013.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanujulu, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirawan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span> <span> </span><span class="NLM_article-title">An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1280</span>– <span class="NLM_lpage">1291</span>, <span class="refDoi"> DOI: 10.4161/cbt.29692</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.4161%2Fcbt.29692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=24971579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2mtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=1280-1291&author=H.+Y.+Lauauthor=P.+M.+Ramanujuluauthor=D.+Guoauthor=T.+Yangauthor=M.+Wirawanauthor=P.+J.+Caseyauthor=M.+L.+Goauthor=M.+Wang&title=An+improved+isoprenylcysteine+carboxylmethyltransferase+inhibitor+induces+cancer+cell+death+and+attenuates+tumor+growth+in+vivo&doi=10.4161%2Fcbt.29692"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo</span></div><div class="casAuthors">Lau, Hiu Yeung; Ramanujulu, Pondy M.; Guo, Dianyan; Yang, Tianming; Wirawan, Melissa; Casey, Patrick J.; Go, Mei-Lin; Wang, Mei</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1280-1291</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Inhibitors of isoprenylcysteine carboxylmethyltransferase (Icmt) are promising anti-cancer agents, as modification by Icmt is an essential component of the protein prenylation pathway for a group of proteins that includes Ras GTPases.  Cysmethynil, a prototypical indole-based inhibitor of Icmt, effectively inhibits tumor cell growth.  However, the phys. properties of cysmethynil, such as its low aq. soly., make it a poor candidate for clin. development.  A novel amino-deriv. of cysmethynil with superior phys. properties and marked improvement in efficacy, termed compd. 8.12, has recently been reported.  We report here that Icmt-/- mouse embryonic fibroblasts (MEFs) are much more resistant to compd. 8.12-induced cell death than their wild-type counterparts, providing evidence that the anti-proliferative effects of this compd. are mediated through an Icmt specific mechanism.  Treatment of PC3 prostate and HepG2 liver cancer cells with compd. 8.12 resulted in pre-lamin A accumulation and Ras delocalization from the plasma membrane, both expected outcomes from inhibition of the Icmt-catalyzed carboxylmethylation.  Treatment with compd. 8.12 induced cell cycle arrest, autophagy and cell death, and abolished anchorage-independent colony formation.  Consistent with its greater in vitro efficacy, compd. 8.12 inhibited tumor growth with greater potency than cysmethynil in a xenograft mouse model.  Further, a drug combination study identified synergistic antitumor efficacy of compd. 8.12 and the epithelial growth factor receptor (EGFR)-inhibitor gefitinib, possibly through enhancement of autophagy.  This study establishes compd. 8.12 as a pharmacol. inhibitor of Icmt that is an attractive candidate for further preclin. and clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLZuGw7pwaW7Vg90H21EOLACvtfcHk0lhIQ7A6XaHkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2mtrbN&md5=15ccd2bf30b145cd714933e06c1d08e5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4161%2Fcbt.29692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.29692%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DH.%2BY.%26aulast%3DRamanujulu%26aufirst%3DP.%2BM.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DWirawan%26aufirst%3DM.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26aulast%3DGo%26aufirst%3DM.%2BL.%26aulast%3DWang%26aufirst%3DM.%26atitle%3DAn%2520improved%2520isoprenylcysteine%2520carboxylmethyltransferase%2520inhibitor%2520induces%2520cancer%2520cell%2520death%2520and%2520attenuates%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2014%26volume%3D15%26spage%3D1280%26epage%3D1291%26doi%3D10.4161%2Fcbt.29692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahne, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrycyna, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, R. A.</span></span> <span> </span><span class="NLM_article-title">Lipid and sulfur substituted prenylcysteine analogs as human Icmt inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5616</span>– <span class="NLM_lpage">5619</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.06.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.bmcl.2011.06.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=21782433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKisLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5616-5619&author=J.%0AA.+Bergmanauthor=K.+Hahneauthor=C.+A.+Hrycynaauthor=R.+A.+Gibbs&title=Lipid+and+sulfur+substituted+prenylcysteine+analogs+as+human+Icmt+inhibitors&doi=10.1016%2Fj.bmcl.2011.06.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid and sulfur substituted prenylcysteine analogs as human Icmt inhibitors</span></div><div class="casAuthors">Bergman, Joel A.; Hahne, Kalub; Hrycyna, Christine A.; Gibbs, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5616-5619</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibition of isoprenylcysteine carboxyl methyltransferase (Icmt) offers a promising strategy for K-Ras driven cancers.  The authors describe the synthesis and inhibitory activity of substrate-based analogs derived from several novel scaffolds.  Modifications of both the prenyl group and thioether of N-acetyl-S-farnesyl-L-cysteine (AFC), a substrate for human Icmt (hIcmt), have resulted in low micromolar inhibitors of Icmt and have given insights into the nature of the prenyl binding site of hIcmt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkNJdXofQ_v7Vg90H21EOLACvtfcHk0lhIQ7A6XaHkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKisLvO&md5=418a35fcf14a5af16579ba586103a397</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.06.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.06.053%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%2BA.%26aulast%3DHahne%26aufirst%3DK.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DGibbs%26aufirst%3DR.%2BA.%26atitle%3DLipid%2520and%2520sulfur%2520substituted%2520prenylcysteine%2520analogs%2520as%2520human%2520Icmt%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5616%26epage%3D5619%26doi%3D10.1016%2Fj.bmcl.2011.06.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahne, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrycyna, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, R. A.</span></span> <span> </span><span class="NLM_article-title"><i>S</i>-Farnesyl-thiopropionic acid triazoles as potent inhibitors of isoprenylcysteine carboxyl methyltransferase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1021/ml200106d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200106d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaktb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=15-19&author=J.+A.+Bergmanauthor=K.+Hahneauthor=J.+Songauthor=C.+A.+Hrycynaauthor=R.+A.+Gibbs&title=S-Farnesyl-thiopropionic+acid+triazoles+as+potent+inhibitors+of+isoprenylcysteine+carboxyl+methyltransferase&doi=10.1021%2Fml200106d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">S-Farnesyl-Thiopropionic Acid Triazoles as Potent Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase</span></div><div class="casAuthors">Bergman, Joel A.; Hahne, Kalub; Song, Jiao; Hrycyna, Christine A.; Gibbs, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-19</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and synthesis of novel FTPA-triazole compds. is reported as potent inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt), through a focus on thioether and isoprenoid mimetics.  These mimetics were coupled utilizing a copper-assisted cycloaddn. to assemble the potential inhibitors.  Using the resulting triazole from the coupling as an isoprenyl mimetic resulted in the biphenyl-substituted FTPA triazole I.  This lipid-modified analog is a potent inhibitor of Icmt (IC50 = 0.8 ± 0.1 μM; calcd. Ki = 0.4 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3TwFwuCsKV7Vg90H21EOLACvtfcHk0lh4rKT8sMGJJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaktb7E&md5=32f31247e1db931a204eb7e3ed268996</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fml200106d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200106d%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%2BA.%26aulast%3DHahne%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DGibbs%26aufirst%3DR.%2BA.%26atitle%3DS-Farnesyl-thiopropionic%2520acid%2520triazoles%2520as%2520potent%2520inhibitors%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D15%26epage%3D19%26doi%3D10.1021%2Fml200106d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majmudar, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahne, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrycyna, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, R. A.</span></span> <span> </span><span class="NLM_article-title">Probing the isoprenylcysteine carboxyl methyltransferase (Icmt) binding pocket: Sulfonamide modified farnesyl cysteine (SMFC) analogs as Icmt inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2616</span>– <span class="NLM_lpage">2620</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.01.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.bmcl.2011.01.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=21334890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFKisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2616-2620&author=J.+D.+Majmudarauthor=K.+Hahneauthor=C.+A.+Hrycynaauthor=R.+A.+Gibbs&title=Probing+the+isoprenylcysteine+carboxyl+methyltransferase+%28Icmt%29+binding+pocket%3A+Sulfonamide+modified+farnesyl+cysteine+%28SMFC%29+analogs+as+Icmt+inhibitors&doi=10.1016%2Fj.bmcl.2011.01.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the isoprenylcysteine carboxyl methyltransferase (Icmt) binding pocket: Sulfonamide modified farnesyl cysteine (SMFC) analogs as Icmt inhibitors</span></div><div class="casAuthors">Majmudar, Jaimeen D.; Hahne, Kalub; Hrycyna, Christine A.; Gibbs, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2616-2620</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human isoprenylcysteine carboxyl methyltransferase (hIcmt) is a promising anticancer target as it is important for the post-translational modification of oncogenic Ras proteins.  We herein report the synthesis and biochem. activity of 41 farnesyl-cysteine based analogs vs. hIcmt.  We have demonstrated that the amide linkage of a hIcmt substrate can be replaced by a sulfonamide bond to achieve hIcmt inhibition.  The most potent sulfonamide-modified farnesyl cysteine analog was 6ag with an IC50 of 8.8 ± 0.5 μM for hIcmt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW-55iBH-MXrVg90H21EOLACvtfcHk0ljSzyaQZsTVaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFKisbs%253D&md5=6d6a7272c83c936d4d99b0b88b134dbb</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.078%26sid%3Dliteratum%253Aachs%26aulast%3DMajmudar%26aufirst%3DJ.%2BD.%26aulast%3DHahne%26aufirst%3DK.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DGibbs%26aufirst%3DR.%2BA.%26atitle%3DProbing%2520the%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520%2528Icmt%2529%2520binding%2520pocket%253A%2520Sulfonamide%2520modified%2520farnesyl%2520cysteine%2520%2528SMFC%2529%2520analogs%2520as%2520Icmt%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2616%26epage%3D2620%26doi%3D10.1016%2Fj.bmcl.2011.01.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Judd, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slattum, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhoite, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valppu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostanin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardsen, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5031</span>– <span class="NLM_lpage">5047</span>, <span class="refDoi"> DOI: 10.1021/jm200249a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200249a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFShsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5031-5047&author=W.+R.+Juddauthor=P.+M.+Slattumauthor=K.+C.+Hoangauthor=L.+Bhoiteauthor=L.+Valppuauthor=G.+Albertsauthor=B.+Brownauthor=B.+Rothauthor=K.+Ostaninauthor=L.+Huangauthor=D.+Wettsteinauthor=B.+Richardsauthor=J.+A.+Willardsen&title=Discovery+and+SAR+of+methylated+tetrahydropyranyl+derivatives+as+inhibitors+of+isoprenylcysteine+carboxyl+methyltransferase+%28ICMT%29&doi=10.1021%2Fjm200249a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and SAR of Methylated Tetrahydropyranyl Derivatives as Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase (ICMT)</span></div><div class="casAuthors">Judd, Weston R.; Slattum, Paul M.; Hoang, Khanh C.; Bhoite, Leena; Valppu, Liisa; Alberts, Glen; Brown, Brita; Roth, Bruce; Ostanin, Kirill; Huang, Liwen; Wettstein, Daniel; Richards, Burt; Willardsen, J. Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5031-5047</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of tetrahydropyranyl (THP) derivs. has been developed as potent inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT) for use as anticancer agents.  Structural modification of the submicromolar hit compd. I led to the potent 3-methoxy substituted analog II [R = H].  Further SAR development around the THP ring resulted in an addnl. 10-fold increase in potency, exemplified by analog II [R = Me] with an IC50 of 1.3 nM.  Active and potent compds. demonstrated a dose-dependent increase in Ras cytosolic protein.  Potent ICMT inhibitors also reduced cell viability in several cancer cell lines with growth inhibition (GI50) values ranging from 0.3 to >100 μM.  However, none of the cellular effects obsd. using ICMT inhibitors were as pronounced as those resulting from a farnesyl-transferase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxtJBz5EBh_LVg90H21EOLACvtfcHk0ljSzyaQZsTVaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFShsrk%253D&md5=70c861a9d4ef4efcde4b94a2e0a88de9</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm200249a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200249a%26sid%3Dliteratum%253Aachs%26aulast%3DJudd%26aufirst%3DW.%2BR.%26aulast%3DSlattum%26aufirst%3DP.%2BM.%26aulast%3DHoang%26aufirst%3DK.%2BC.%26aulast%3DBhoite%26aufirst%3DL.%26aulast%3DValppu%26aufirst%3DL.%26aulast%3DAlberts%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DWettstein%26aufirst%3DD.%26aulast%3DRichards%26aufirst%3DB.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520methylated%2520tetrahydropyranyl%2520derivatives%2520as%2520inhibitors%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520%2528ICMT%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5031%26epage%3D5047%26doi%3D10.1021%2Fjm200249a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manolaridis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mas-Droux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barford, D.</span></span> <span> </span><span class="NLM_article-title">Mechanism of isoprenylcysteine carboxyl methylation from the crystal structure of the integral membrane methyltransferase ICMT</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">997</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2011.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.molcel.2011.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=22195972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1OqsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=997-1004&author=J.+Yangauthor=K.+Kulkarniauthor=I.+Manolaridisauthor=Z.+Zhangauthor=R.+B.+Doddauthor=C.+Mas-Drouxauthor=D.+Barford&title=Mechanism+of+isoprenylcysteine+carboxyl+methylation+from+the+crystal+structure+of+the+integral+membrane+methyltransferase+ICMT&doi=10.1016%2Fj.molcel.2011.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Isoprenylcysteine Carboxyl Methylation from the Crystal Structure of the Integral Membrane Methyltransferase ICMT</span></div><div class="casAuthors">Yang, Jing; Kulkarni, Kiran; Manolaridis, Ioannis; Zhang, Ziguo; Dodd, Roger B.; Mas-Droux, Corine; Barford, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">997-1004</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The posttranslational modification of C-terminal CAAX motifs in proteins such as Ras, most Rho GTPases, and G protein γ subunits, plays an essential role in detg. their subcellular localization and correct biol. function.  An integral membrane methyltransferase, isoprenylcysteine carboxyl methyltransferase (ICMT), catalyzes the final step of CAAX processing after prenylation of the cysteine residue and endoproteolysis of the -AAX motif.  We have detd. the crystal structure of a prokaryotic ICMT ortholog, revealing a markedly different architecture from conventional methyltransferases that utilize S-adenosyl-L-methionine (SAM) as a cofactor.  ICMT comprises a core of five transmembrane α helixes and a cofactor-binding pocket enclosed within a highly conserved C-terminal catalytic subdomain.  A tunnel linking the reactive Me group of SAM to the inner membrane provides access for the prenyl lipid substrate.  This study explains how an integral membrane methyltransferase achieves recognition of both a hydrophilic cofactor and a lipophilic prenyl group attached to a polar protein substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlb0eLuyX5P7Vg90H21EOLACvtfcHk0ljSzyaQZsTVaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1OqsL%252FE&md5=0094e850c208d2ad810e9b177a910fa5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKulkarni%26aufirst%3DK.%26aulast%3DManolaridis%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DDodd%26aufirst%3DR.%2BB.%26aulast%3DMas-Droux%26aufirst%3DC.%26aulast%3DBarford%26aufirst%3DD.%26atitle%3DMechanism%2520of%2520isoprenylcysteine%2520carboxyl%2520methylation%2520from%2520the%2520crystal%2520structure%2520of%2520the%2520integral%2520membrane%2520methyltransferase%2520ICMT%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D44%26spage%3D997%26epage%3D1004%26doi%3D10.1016%2Fj.molcel.2011.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diver, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koide, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koide, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, S. B.</span></span> <span> </span><span class="NLM_article-title">Atomic structure of the eukaryotic intramembrane Ras methyltransferase ICMT</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>553</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.1038/nature25439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1038%2Fnature25439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=29342140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVOisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=553&publication_year=2018&pages=526-529&author=M.+M.+Diverauthor=L.+Pediauthor=A.+Koideauthor=S.+Koideauthor=S.+B.+Long&title=Atomic+structure+of+the+eukaryotic+intramembrane+Ras+methyltransferase+ICMT&doi=10.1038%2Fnature25439"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic structure of the eukaryotic intramembrane RAS methyltransferase ICMT</span></div><div class="casAuthors">Diver, Melinda M.; Pedi, Leanne; Koide, Akiko; Koide, Shohei; Long, Stephen B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">553</span>
        (<span class="NLM_cas:issue">7689</span>),
    <span class="NLM_cas:pages">526-529</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The maturation of RAS GTPases and approx. 200 other cellular CAAX proteins involves three enzymic steps: addn. of a farnesyl or geranylgeranyl prenyl lipid to the cysteine (C) in the C-terminal CAAX motif, proteolytic cleavage of the AAX residues and methylation of the exposed prenylcysteine residue at its terminal carboxylate.  This final step is catalyzed by isoprenylcysteine carboxyl methyltransferase (ICMT), a eukaryote-specific integral membrane enzyme that resides in the endoplasmic reticulum.  ICMT is the only cellular enzyme that is known to methylate prenylcysteine substrates; methylation is important for the biol. functions of these substrates, such as the membrane localization and subsequent activity of RAS, prelamin A and RAB.  Inhibition of ICMT has potential for combating progeria and cancer.  Here we present an X-ray structure of ICMT, in complex with its cofactor, an ordered lipid mol. and a monobody inhibitor, at 2.3 Å resoln.  The active site spans cytosolic and membrane-exposed regions, indicating distinct entry routes for the cytosolic Me donor, S-adenosyl-L-methionine, and for prenylcysteine substrates, which are assocd. with the endoplasmic reticulum membrane.  The structure suggests how ICMT overcomes the topog. challenge and unfavorable energetics of bringing two reactants that have different cellular localizations together in a membrane environment-a relatively uncharacterized but defining feature of many integral membrane enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXFRW8xr3AZbVg90H21EOLACvtfcHk0lj0Yd5D3R5uuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVOisb4%253D&md5=612327b61ef2d9448552fbf617e8d891</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnature25439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25439%26sid%3Dliteratum%253Aachs%26aulast%3DDiver%26aufirst%3DM.%2BM.%26aulast%3DPedi%26aufirst%3DL.%26aulast%3DKoide%26aufirst%3DA.%26aulast%3DKoide%26aufirst%3DS.%26aulast%3DLong%26aufirst%3DS.%2BB.%26atitle%3DAtomic%2520structure%2520of%2520the%2520eukaryotic%2520intramembrane%2520Ras%2520methyltransferase%2520ICMT%26jtitle%3DNature%26date%3D2018%26volume%3D553%26spage%3D526%26epage%3D529%26doi%3D10.1038%2Fnature25439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span> <span> </span><span class="NLM_article-title">A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">18678</span>– <span class="NLM_lpage">18684</span>, <span class="refDoi"> DOI: 10.1074/jbc.M801855200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1074%2Fjbc.M801855200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=18434300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsl2qsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=18678-18684&author=M.+Wangauthor=W.+Tanauthor=J.+Zhouauthor=J.+Leowauthor=M.+Goauthor=H.+S.+Leeauthor=P.+J.+Casey&title=A+small+molecule+inhibitor+of+isoprenylcysteine+carboxymethyltransferase+induces+autophagic+cell+death+in+PC3+prostate+cancer+cells&doi=10.1074%2Fjbc.M801855200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A Small Molecule Inhibitor of Isoprenylcysteine Carboxymethyltransferase Induces Autophagic Cell Death in PC3 Prostate Cancer Cells</span></div><div class="casAuthors">Wang, Mei; Tan, Wanloo; Zhou, Jin; Leow, Jolene; Go, Meilin; Lee, How Sung; Casey, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">18678-18684</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A no. of proteins involved in cell growth control, including members of the Ras family of GTPases, are modified at their C terminus by a three-step posttranslational process termed prenylation.  The enzyme isoprenylcysteine carboxylmethyl-transferase (Icmt) catalyzes the last step in this process, and genetic and pharmacol. suppression of Icmt activity significantly impacts on cell growth and oncogenesis.  Screening of a diverse chem. library led to the identification of a specific small mol. inhibitor of Icmt, cysmethynil, that inhibited growth factor signaling and tumorigenesis in an in vitro cancer cell model.  To further evaluate the mechanisms through which this Icmt inhibitor impacts on cancer cells, we developed both in vitro and in vivo models utilizing PC3 prostate cancer cells.  Treatment of these cells with cysmethynil resulted in both an accumulation of cells in the G1 phase and cell death.  Treatment of mice harboring PC3 cell-derived xenograft tumors with cysmethynil resulted in markedly reduced tumor size.  Anal. of cell death pathways unexpectedly showed minimal impact of cysmethynil treatment on apoptosis; rather, drug treatment significantly enhanced autophagy and autophagic cell death.  Cysmethynil-treated cells displayed reduced mammalian target of rapamycin (mTOR) signaling, providing a potential mechanism for the excessive autophagy as well as G1 cell cycle arrest obsd.  These results identify a novel mechanism for the antitumor activity of Icmt inhibition.  Further, the dual effects of cell death and cell cycle arrest by cysmethynil treatment strengthen the rationale for targeting Icmt in cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWTu9-dNQGiLVg90H21EOLACvtfcHk0lj0Yd5D3R5uuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsl2qsrc%253D&md5=1d092bd2f6ab14055cbe179d3fbdf456</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M801855200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M801855200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLeow%26aufirst%3DJ.%26aulast%3DGo%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DH.%2BS.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26atitle%3DA%2520small%2520molecule%2520inhibitor%2520of%2520isoprenylcysteine%2520carboxymethyltransferase%2520induces%2520autophagic%2520cell%2520death%2520in%2520PC3%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D18678%26epage%3D18684%26doi%3D10.1074%2Fjbc.M801855200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balmain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Counter, C. M.</span></span> <span> </span><span class="NLM_article-title">A model for Ras mutation patterns in cancers: finding the sweet spot</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">777</span>, <span class="refDoi"> DOI: 10.1038/s41568-018-0076-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1038%2Fs41568-018-0076-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=30420765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Sgur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=767-777&author=S.+Liauthor=A.+Balmainauthor=C.+M.+Counter&title=A+model+for+Ras+mutation+patterns+in+cancers%3A+finding+the+sweet+spot&doi=10.1038%2Fs41568-018-0076-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A model for RAS mutation patterns in cancers: finding the sweet spot</span></div><div class="casAuthors">Li, Siqi; Balmain, Allan; Counter, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">767-777</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The three RAS genes - HRAS, NRAS and KRAS - are collectively mutated in one-third of human cancers, where they act as prototypic oncogenes.  Interestingly, there are rather distinct patterns to RAS mutations; the isoform mutated as well as the position and type of substitution vary between different cancers.  As RAS genes are among the earliest, if not the first, genes mutated in a variety of cancers, understanding how these mutation patterns arise could inform on not only how cancer begins but also the factors influencing this event, which has implications for cancer prevention.  To this end, we suggest that there is a narrow window or 'sweet spot' by which oncogenic RAS signalling can promote tumor initiation in normal cells.  As a consequence, RAS mutation patterns in each normal cell are a product of the specific RAS isoform mutated, as well as the position of the mutation and type of substitution to achieve an ideal level of signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwgiwQPHITKLVg90H21EOLACvtfcHk0lj0Yd5D3R5uuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Sgur%252FJ&md5=34d62ae8e9b478af4b7e05d7f5bcab55</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fs41568-018-0076-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41568-018-0076-6%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DCounter%26aufirst%3DC.%2BM.%26atitle%3DA%2520model%2520for%2520Ras%2520mutation%2520patterns%2520in%2520cancers%253A%2520finding%2520the%2520sweet%2520spot%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2018%26volume%3D18%26spage%3D767%26epage%3D777%26doi%3D10.1038%2Fs41568-018-0076-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prior, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattos, C.</span></span> <span> </span><span class="NLM_article-title">A comprehensive survey of Ras mutations in cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2457</span>– <span class="NLM_lpage">2467</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-2612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1158%2F0008-5472.CAN-11-2612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=22589270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvF2ntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2457-2467&author=I.+A.+Priorauthor=P.+D.+Lewisauthor=C.+Mattos&title=A+comprehensive+survey+of+Ras+mutations+in+cancer&doi=10.1158%2F0008-5472.CAN-11-2612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A Comprehensive Survey of Ras Mutations in Cancer</span></div><div class="casAuthors">Prior, Ian A.; Lewis, Paul D.; Mattos, Carla</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2457-2467</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  All mammalian cells express 3 closely related Ras proteins, termed H-Ras, K-Ras, and N-Ras, that promote oncogenesis when they are mutationally activated at codon 12, 13, or 61.  Although there is a high degree of similarity among the isoforms, K-Ras mutations are far more frequently obsd. in cancer, and each isoform displays preferential coupling to particular cancer types.  We examd. the mutational spectra of Ras isoforms curated from large-scale tumor profiling and found that each isoform exhibits surprisingly distinctive codon mutation and amino-acid substitution biases.  These findings were unexpected given that these mutations occur in regions that share 100% amino-acid sequence identity among the 3 isoforms.  Of importance, many of these mutational biases were not due to differences in exposure to mutagens, because the patterns were still evident when compared within specific cancer types.  We discuss potential genetic and epigenetic mechanisms, as well as isoform-specific differences in protein structure and signaling, that may promote these distinct mutation patterns and differential coupling to specific cancers.  Cancer Res; 72(10); 2457-67.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg2lqiicosOLVg90H21EOLACvtfcHk0lhEzNxLWFk6mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvF2ntL4%253D&md5=6d1894847015468f77c8b08b57c6d62a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-2612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-2612%26sid%3Dliteratum%253Aachs%26aulast%3DPrior%26aufirst%3DI.%2BA.%26aulast%3DLewis%26aufirst%3DP.%2BD.%26aulast%3DMattos%26aufirst%3DC.%26atitle%3DA%2520comprehensive%2520survey%2520of%2520Ras%2520mutations%2520in%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2457%26epage%3D2467%26doi%3D10.1158%2F0008-5472.CAN-11-2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stephen, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagni, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, F.</span></span> <span> </span><span class="NLM_article-title">Dragging Ras back in the ring</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2014.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1016%2Fj.ccr.2014.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=24651010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksVWhtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=272-281&author=A.+G.+Stephenauthor=D.+Espositoauthor=R.+K.+Bagniauthor=F.+McCormick&title=Dragging+Ras+back+in+the+ring&doi=10.1016%2Fj.ccr.2014.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Dragging Ras Back in the Ring</span></div><div class="casAuthors">Stephen, Andrew G.; Esposito, Dominic; Bagni, Rachel K.; McCormick, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">272-281</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Ras proteins play a major role in human cancers but have not yielded to therapeutic attack.  Ras-driven cancers are among the most difficult to treat and often excluded from therapies.  The Ras proteins have been termed "undruggable," based on failures from an era in which understanding of signaling transduction, feedback loops, redundancy, tumor heterogeneity, and Ras' oncogenic role was poor.  Structures of Ras oncoproteins bound to their effectors or regulators are unsolved, and it is unknown precisely how Ras proteins activate their downstream targets.  These knowledge gaps have impaired development of therapeutic strategies.  A better understanding of Ras biol. and biochem., coupled with new ways of targeting undruggable proteins, is likely to lead to new ways of defeating Ras-driven cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsJEUXbjmDe7Vg90H21EOLACvtfcHk0lhEzNxLWFk6mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksVWhtLY%253D&md5=1ecb33c95db7d5d6f910b9e2af2ec44e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DStephen%26aufirst%3DA.%2BG.%26aulast%3DEsposito%26aufirst%3DD.%26aulast%3DBagni%26aufirst%3DR.%2BK.%26aulast%3DMcCormick%26aufirst%3DF.%26atitle%3DDragging%2520Ras%2520back%2520in%2520the%2520ring%26jtitle%3DCancer%2520Cell%26date%3D2014%26volume%3D25%26spage%3D272%26epage%3D281%26doi%3D10.1016%2Fj.ccr.2014.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michaelson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silletti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philips, M.</span></span> <span> </span><span class="NLM_article-title">Postprenylation CAAX processing is required for proper localization of Ras but not Rho GTPases</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1606</span>– <span class="NLM_lpage">1616</span>, <span class="refDoi"> DOI: 10.1091/mbc.e04-11-0960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1091%2Fmbc.e04-11-0960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=15659645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1Kqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=1606-1616&author=D.+Michaelsonauthor=W.+Aliauthor=V.+K.+Chiuauthor=M.+Bergoauthor=J.+Sillettiauthor=L.+Wrightauthor=S.+G.+Youngauthor=M.+Philips&title=Postprenylation+CAAX+processing+is+required+for+proper+localization+of+Ras+but+not+Rho+GTPases&doi=10.1091%2Fmbc.e04-11-0960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Postprenylation CAAX processing is required for proper localization of Ras but not Rho GTPases</span></div><div class="casAuthors">Michaelson, David; Ali, Wasif; Chiu, Vi K.; Bergo, Martin; Silletti, Joseph; Wright, Latasha; Young, Stephen G.; Philips, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1606-1616</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">The CAAX motif at the C terminus of most monomeric GTPases is required for membrane targeting because it signals for a series of three posttranslational modifications that include isoprenylation, endoproteolytic release of the C-terminal-AAX amino acids, and carboxyl methylation of the newly exposed isoprenylcysteine.  The individual contributions of these modifications to protein trafficking and function are unknown.  To address this issue, we performed a series of expts. with mouse embryonic fibroblasts (MEFs) lacking Rce1 (responsible for removal of the -AAX sequence) or Icmt (responsible for carboxyl methylation of the isoprenylcysteine).  In MEFs lacking Rce1 or Icmt, farnesylated Ras proteins were mislocalized.  In contrast, the intracellular localizations of geranylgeranylated Rho GTPases were not perturbed.  Consistent with the latter finding, RhoGDI binding and actin remodeling were normal in Rce1- and Icmt-deficient cells.  Swapping geranylgeranylation for farnesylation on Ras proteins or vice versa on Rho proteins reversed the differential sensitivities to Rce1 and Icmt deficiency.  These results suggest that postprenylation CAAX processing is required for proper localization of farnesylated Ras but not geranygeranylated Rho proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUrSIABSX_3rVg90H21EOLACvtfcHk0lhEzNxLWFk6mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1Kqtrg%253D&md5=f05b58e64d4df62e6ac6fd9b10ae09d1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e04-11-0960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e04-11-0960%26sid%3Dliteratum%253Aachs%26aulast%3DMichaelson%26aufirst%3DD.%26aulast%3DAli%26aufirst%3DW.%26aulast%3DChiu%26aufirst%3DV.%2BK.%26aulast%3DBergo%26aufirst%3DM.%26aulast%3DSilletti%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DPhilips%26aufirst%3DM.%26atitle%3DPostprenylation%2520CAAX%2520processing%2520is%2520required%2520for%2520proper%2520localization%2520of%2520Ras%2520but%2520not%2520Rho%2520GTPases%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2005%26volume%3D16%26spage%3D1606%26epage%3D1616%26doi%3D10.1091%2Fmbc.e04-11-0960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lobell, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhimnathwala, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brucker, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buser, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davide, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deSolms, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis-Hutchings, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kral, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lumma, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machotka, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rands, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliff, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimbrook, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohl, N. E.</span></span> <span> </span><span class="NLM_article-title">Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8758</span>– <span class="NLM_lpage">8768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=11751396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1OntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=8758-8768&author=R.+B.+Lobellauthor=C.+A.+Omerauthor=M.+T.+Abramsauthor=H.+G.+Bhimnathwalaauthor=M.+J.+Bruckerauthor=C.+A.+Buserauthor=J.+P.+Davideauthor=S.+J.+deSolmsauthor=C.+J.+Dinsmoreauthor=M.+S.+Ellis-Hutchingsauthor=A.+M.+Kralauthor=D.+Liuauthor=W.+C.+Lummaauthor=S.+V.+Machotkaauthor=E.+Randsauthor=T.+M.+Williamsauthor=S.+L.+Grahamauthor=G.+D.+Hartmanauthor=A.+I.+Oliffauthor=D.+C.+Heimbrookauthor=N.+E.+Kohl&title=Evaluation+of+farnesyl%3Aprotein+transferase+and+geranylgeranyl%3Aprotein+transferase+inhibitor+combinations+in+preclinical+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models</span></div><div class="casAuthors">Lobell, Robert B.; Omer, Charles A.; Abrams, Marc T.; Bhimnathwala, Hema G.; Brucker, Mary Jo; Buser, Carolyn A.; Davide, Joseph P.; DeSolms, S. Jane; Dinsmore, Christopher J.; Ellis-Hutchings, Michelle S.; Kral, Astrid M.; Liu, Dongming; Lumma, William C.; Machotka, Samuel V.; Rands, Elaine; Williams, Theresa M.; Graham, Samuel L.; Hartman, George D.; Oliff, Allen I.; Heimbrook, David C.; Kohl, Nancy E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8758-8768</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Farnesyl:protein transferase (FPTase) inhibitors (FTIs) were originally developed as potential anticancer agents targeting the ras oncogene and are currently in clin. trials.  Whereas FTIs inhibit the farnesylation of Ha-Ras, they do not completely inhibit the prenylation of Ki-Ras, the allele most frequently mutated in human cancers.  Whereas farnesylation of Ki-Ras is blocked by FTIs, Ki-Ras remains prenylated in FTI-treated cells because of its modification by the related prenyltransferase, geranylgeranyl:protein transferase type I (GGPTase-I).  Hence, cells transformed with Ki-ras tend to be more resistant to FTIs than Ha-ras-transformed cells.  To det. whether Ki-ras-transformed cells can be targeted by combining an FTI with a GGPTase-I inhibitor (GGTI), we evaluated potent, selective FTIs, GGTIs, and dual prenylation inhibitors (DPIs) that have both FTI and GGTI activity.  We find that in human PSN-1 pancreatic tumor cells, which harbor oncogenic Ki-ras, and in other tumor lines having either wild-type or oncogenic Ki-ras, treatment with an FTI/GGTI combination or with a DPI blocks Ki-Ras prenylation and induces markedly higher levels of apoptosis relative to FTI or GGTI alone.  We demonstrate that these compds. can inhibit their enzyme targets in mice by monitoring pancreatic and tumor tissues from treated animals for inhibition of prenylation of Ki-Ras, HDJ2, a substrate specific for FPTase, and Rap1A, a substrate specific for GGPTase-I.  Continuous infusion (72 h) of varying doses of GGTI in conjunction with a high, fixed dose of FTI causes a dose-dependent inhibition of Ki-Ras prenylation.  However, a 72-h infusion of a GGTI, at a dose sufficient to inhibit Ki-Ras prenylation in the presence of an FTI, causes death within 2 wk of the infusion when administered either as monotherapy or in combination with an FTI.  DPIs are also lethal after a 72-h infusion at doses that inhibit Ki-Ras prenylation.  Because 24 h infusion of a high dose of DPI is tolerated and inhibits Ki-Ras prenylation, we compared the antitumor efficacy from a 24-h FTI infusion to that of a DPI in a nude mouse/PSN-1 tumor cell xenograft model and in Ki-ras transgenic mice with mammary tumors.  The FTI and DPI were dosed at a level that provided comparable inhibition of FPTase.  The FTI and the DPI displayed comparable efficacy, causing a decrease in growth rate of the PSN-1 xenograft tumors and tumor regression in the transgenic model, but neither treatment regimen induced a statistically significant increase in tumor cell apoptosis.  Although FTI/GGTI combinations elicit a greater apoptotic response than either agent alone in vitro, the toxicity assocd. with GGTI treatment in vivo limits the duration of treatment and, thus, may limit the therapeutic benefit that might be gained by inhibiting oncogenic Ki-Ras through dual prenyltransferase inhibitor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN8692wSeB0bVg90H21EOLACvtfcHk0ljkZoIBkRU1Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1OntQ%253D%253D&md5=a6bec938c55d2a308cadbce460d5f098</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DAbrams%26aufirst%3DM.%2BT.%26aulast%3DBhimnathwala%26aufirst%3DH.%2BG.%26aulast%3DBrucker%26aufirst%3DM.%2BJ.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DDavide%26aufirst%3DJ.%2BP.%26aulast%3DdeSolms%26aufirst%3DS.%2BJ.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DEllis-Hutchings%26aufirst%3DM.%2BS.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DLumma%26aufirst%3DW.%2BC.%26aulast%3DMachotka%26aufirst%3DS.%2BV.%26aulast%3DRands%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DOliff%26aufirst%3DA.%2BI.%26aulast%3DHeimbrook%26aufirst%3DD.%2BC.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26atitle%3DEvaluation%2520of%2520farnesyl%253Aprotein%2520transferase%2520and%2520geranylgeranyl%253Aprotein%2520transferase%2520inhibitor%2520combinations%2520in%2520preclinical%2520models%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D8758%26epage%3D8768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hollander, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frommer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallon, R.</span></span> <span> </span><span class="NLM_article-title">Human Ras-converting enzyme (hRCE1) endoproteolytic activity on K-ras-derived peptides</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1006/abio.2000.4795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1006%2Fabio.2000.4795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=11038283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntlKrtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2000&pages=129-137&author=I.+Hollanderauthor=E.+Frommerauthor=R.+Mallon&title=Human+Ras-converting+enzyme+%28hRCE1%29+endoproteolytic+activity+on+K-ras-derived+peptides&doi=10.1006%2Fabio.2000.4795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Human Ras-Converting Enzyme (hRCE1) Endoproteolytic Activity on K-Ras-Derived Peptides</span></div><div class="casAuthors">Hollander, Irwin; Frommer, Eileen; Mallon, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-137</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A human gene responsible for one of the steps in Ras post-translational modification and membrane localization, hRCE1, encodes a 35-kDa membrane-assocd. endoprotease.  We examd. hRCE1 activity using farnesylated 9 aa peptides with the core sequence, KSKTKC(farnesyl)VIM [(farnesyl) = (f)], from the C-terminus of K-Ras.  We first demonstrated hRCE1 specificity in cleavage location and endoproteolysis.  We then describe a direct fluorescent microtiter plate assay.  We demonstrated that hRCE1 protease cleaved KSKTKC(f)VIM peptides between the C(f) and V positions, generating KSKTKC(f) and the corresponding tripeptides as products.  We found that the sequence KSKTKC(f)VI was a better substrate for hRCE1 than KSKTKC(f)VIM.  We also found that hRCE1 cleaved modified versions of KSKTKC(f)VIM that incorporated either MCA or ABZ fluorescent chromophores at the N-terminus, and quenching-group-contg. amino acids at the V or M, but not the I, amino acid positions of VIM.  The quenching-group-contg. amino acids used were either QS (dinitrophenyldiaminopropionic acid) or QL (lysine ε-dinitrophenyl).  Cleavage of KSKTKC(f)VIM and modified versions of this peptide by hRCE1 was initially evaluated by HPLC product resoln. and quantitation.  The hRCE1 cleavage of quenched peptides enabled us to directly monitor proteolytic activity in a 96-well microtiter fluorescent plate assay.  The microtiter format assay was validated by its sensitivity to RPI, an inhibitor of prenyl protein protease.  A direct fluorescent assay provides an effective tool for further characterization of this enzyme and also for detection of novel inhibitors.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0MIthZ2R7Vg90H21EOLACvtfcHk0ljkZoIBkRU1Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntlKrtr8%253D&md5=3007a622065e1f91b4e7f97ae090389e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1006%2Fabio.2000.4795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.2000.4795%26sid%3Dliteratum%253Aachs%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DFrommer%26aufirst%3DE.%26aulast%3DMallon%26aufirst%3DR.%26atitle%3DHuman%2520Ras-converting%2520enzyme%2520%2528hRCE1%2529%2520endoproteolytic%2520activity%2520on%2520K-ras-derived%2520peptides%26jtitle%3DAnal.%2520Biochem.%26date%3D2000%26volume%3D286%26spage%3D129%26epage%3D137%26doi%3D10.1006%2Fabio.2000.4795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">López-Rodríguez, M. L.</span>; <span class="NLM_string-name">Ortega-Gutiérrez, S.</span>; <span class="NLM_string-name">Martín-Fontecha, M.</span>; <span class="NLM_string-name">Balabasquer, M.</span>; <span class="NLM_string-name">Ortega-Nogales, F. J.</span>; <span class="NLM_string-name">Marín-Ramos, N. I.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitors of the enzyme isoprenylcysteine carboxyl methyltransferase (ICMT)</span>. <span class="NLM_patent">WO2014118418A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&author=S.+Ortega-Guti%C3%A9rrez&author=M.+Mart%C3%ADn-Fontecha&author=M.+Balabasquer&author=F.+J.+Ortega-Nogales&author=N.+I.+Mar%C3%ADn-Ramos&title=Novel+inhibitors+of+the+enzyme+isoprenylcysteine+carboxyl+methyltransferase+%28ICMT%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DNovel%2520inhibitors%2520of%2520the%2520enzyme%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520%2528ICMT%2529%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Vera, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueda-Zubiaurre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Villa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Couce, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomares, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Fontecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhamu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span> <span> </span><span class="NLM_article-title">Chemoproteomic approach to explore the target profile of GPCR ligands: Application to 5-HT<sub>1A</sub> and 5-HT<sub>6</sub> receptors</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1321</span>, <span class="refDoi"> DOI: 10.1002/chem.201503101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1002%2Fchem.201503101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=26560738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVWmt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=1313-1321&author=A.+M.+Gamoauthor=J.+A.+Gonzalez-Veraauthor=A.+Rueda-Zubiaurreauthor=D.+Alonsoauthor=H.+Vazquez-Villaauthor=L.+Martin-Couceauthor=O.+Palomaresauthor=J.+A.+Lopezauthor=M.+Martin-Fontechaauthor=B.+Benhamuauthor=M.+L.+Lopez-Rodriguezauthor=S.+Ortega-Gutierrez&title=Chemoproteomic+approach+to+explore+the+target+profile+of+GPCR+ligands%3A+Application+to+5-HT1A+and+5-HT6+receptors&doi=10.1002%2Fchem.201503101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoproteomic Approach to Explore the Target Profile of GPCR ligands: Application to 5-HT1A and 5-HT6 Receptors</span></div><div class="casAuthors">Gamo, Ana M.; Gonzalez-Vera, Juan A.; Rueda-Zubiaurre, Ainoa; Alonso, Dulce; Vazquez-Villa, Henar; Martin-Couce, Lidia; Palomares, Oscar; Lopez, Juan A.; Martin-Fontecha, Mar; Benhamu, Bellinda; Lopez-Rodriguez, Maria L.; Ortega-Gutierrez, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1313-1321</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Detn. of the targets of a compd. remains an essential aspect in drug discovery.  A complete understanding of all binding interactions is crit. to recognize in advance both therapeutic effects and undesired consequences.  However, the complete polypharmacol. of many drugs currently in clin. development is still unknown, esp. in the case of G protein-coupled receptor (GPCR) ligands.  The authors have developed a chemoproteomic platform based on the use of chem. probes to explore the target profile of a compd. in biol. systems.  As proof of concept, this methodol. has been applied to selected ligands of the therapeutically relevant serotonin 5-HT1A and 5-HT6 receptors, and the authors have identified and validated some of their off-targets.  This approach could be extended to other drugs of interest to study the targeted proteome in disease-relevant systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxjt-p_Dcdy7Vg90H21EOLACvtfcHk0liXGdPc6yka0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVWmt7nE&md5=9d54bb52edc83e75826d1938b745a51b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fchem.201503101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201503101%26sid%3Dliteratum%253Aachs%26aulast%3DGamo%26aufirst%3DA.%2BM.%26aulast%3DGonzalez-Vera%26aufirst%3DJ.%2BA.%26aulast%3DRueda-Zubiaurre%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DD.%26aulast%3DVazquez-Villa%26aufirst%3DH.%26aulast%3DMartin-Couce%26aufirst%3DL.%26aulast%3DPalomares%26aufirst%3DO.%26aulast%3DLopez%26aufirst%3DJ.%2BA.%26aulast%3DMartin-Fontecha%26aufirst%3DM.%26aulast%3DBenhamu%26aufirst%3DB.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26atitle%3DChemoproteomic%2520approach%2520to%2520explore%2520the%2520target%2520profile%2520of%2520GPCR%2520ligands%253A%2520Application%2520to%25205-HT1A%2520and%25205-HT6%2520receptors%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2016%26volume%3D22%26spage%3D1313%26epage%3D1321%26doi%3D10.1002%2Fchem.201503101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marin-Ramos, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Nogales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabasquer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Villa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andradas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasco-Benito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Gomez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Barbero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Prado, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Fontecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span> <span> </span><span class="NLM_article-title">New inhibitors of angiogenesis with antitumor activity in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3757</span>– <span class="NLM_lpage">3766</span>, <span class="refDoi"> DOI: 10.1021/jm5019252</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5019252" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVWnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3757-3766&author=N.+I.+Marin-Ramosauthor=D.+Alonsoauthor=S.+Ortega-Gutierrezauthor=F.+J.+Ortega-Nogalesauthor=M.+Balabasquerauthor=H.+Vazquez-Villaauthor=C.+Andradasauthor=S.+Blasco-Benitoauthor=E.+Perez-Gomezauthor=A.+Canalesauthor=J.+Jimenez-Barberoauthor=A.+Marquinaauthor=J.+M.+Del+Pradoauthor=C.+Sanchezauthor=M.+Martin-Fontechaauthor=M.+L.+Lopez-Rodriguez&title=New+inhibitors+of+angiogenesis+with+antitumor+activity+in+vivo&doi=10.1021%2Fjm5019252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">New Inhibitors of Angiogenesis with Antitumor Activity in Vivo</span></div><div class="casAuthors">Marin-Ramos, Nagore I.; Alonso, Dulce; Ortega-Gutierrez, Silvia; Ortega-Nogales, Francisco J.; Balabasquer, Moises; Vazquez-Villa, Henar; Andradas, Clara; Blasco-Benito, Sandra; Perez-Gomez, Eduardo; Canales, Angeles; Jimenez-Barbero, Jesus; Marquina, Ana; del Prado, Jaime Moscoso; Sanchez, Cristina; Martin-Fontecha, Mar; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3757-3766</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Angiogenesis is a requirement for the sustained growth and proliferation of solid tumors, and the development of new compds. that induce a sustained inhibition of the proangiogenic signaling generated by tumor hypoxia still remains as an important unmet need.  In this work, the authors describe a new antiangiogenic compd. I that inhibits proangiogenic signaling under hypoxic conditions in breast cancer cells.  Compd. I blocks the MAPK pathway, impairs cellular migration under hypoxic conditions, and regulates a set of genes related to angiogenesis.  These responses are mediated by HIF-1α, since the effects of compd. I mostly disappear when its expression is knocked-down.  Furthermore, administration of compd. I in a xenograft model of breast cancer produced tumor growth redns. ranging from 46 to 55% in 38% of the treated animals without causing any toxic side effects.  Importantly, in the responding tumors, a significant redn. in the no. of blood vessels was obsd., further supporting the mechanism of action of the compd.  These findings provide a rationale for the development of new antiangiogenic compds. that could eventually lead to new drugs suitable for the treatment of some types of tumors either alone or in combination with other agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeVohlvgZ3HrVg90H21EOLACvtfcHk0liXGdPc6yka0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVWnsro%253D&md5=8368805475b518edfc35fece944bdcb6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm5019252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5019252%26sid%3Dliteratum%253Aachs%26aulast%3DMarin-Ramos%26aufirst%3DN.%2BI.%26aulast%3DAlonso%26aufirst%3DD.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26aulast%3DOrtega-Nogales%26aufirst%3DF.%2BJ.%26aulast%3DBalabasquer%26aufirst%3DM.%26aulast%3DVazquez-Villa%26aufirst%3DH.%26aulast%3DAndradas%26aufirst%3DC.%26aulast%3DBlasco-Benito%26aufirst%3DS.%26aulast%3DPerez-Gomez%26aufirst%3DE.%26aulast%3DCanales%26aufirst%3DA.%26aulast%3DJimenez-Barbero%26aufirst%3DJ.%26aulast%3DMarquina%26aufirst%3DA.%26aulast%3DDel%2BPrado%26aufirst%3DJ.%2BM.%26aulast%3DSanchez%26aufirst%3DC.%26aulast%3DMartin-Fontecha%26aufirst%3DM.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26atitle%3DNew%2520inhibitors%2520of%2520angiogenesis%2520with%2520antitumor%2520activity%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3757%26epage%3D3766%26doi%3D10.1021%2Fjm5019252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gajate, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barasoain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollinedo, F.</span></span> <span> </span><span class="NLM_article-title">Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2′,3′,4′-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: protection by Bcl-2 and Bcl-X(L) and cell cycle arrest</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2651</span>– <span class="NLM_lpage">2659</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10825137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsF2gtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=2651-2659&author=C.+Gajateauthor=I.+Barasoainauthor=J.+M.+Andreuauthor=F.+Mollinedo&title=Induction+of+apoptosis+in+leukemic+cells+by+the+reversible+microtubule-disrupting+agent+2-methoxy-5-%282%E2%80%B2%2C3%E2%80%B2%2C4%E2%80%B2-trimethoxyphenyl%29-2%2C4%2C6-cycloheptatrien-1-one%3A+protection+by+Bcl-2+and+Bcl-X%28L%29+and+cell+cycle+arrest"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one:protection by bcl-2 and bcl-xL and cell cycle arrest</span></div><div class="casAuthors">Gajate, Consuelo; Barasoain, Isabel; Andreu, Jose M.; Mollinedo, Faustino</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2651-2659</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have found that the bicyclic colchicine analog 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one (MTC) induced a dose- and time-dependent apoptotic response in human leukemic cells.  MTC and colchicine rapidly disrupted the microtubule integrity and arrested cells at the G2-M phase before the onset of apoptosis.  These responses were mediated by microtubule inhibition because 2-methoxy-5-[[3-(3,4,5-trimethoxyphenyl)propionyl]amino]-2,4,6-cycloheptatrien-1-one and lumicolchicine, inactive analogs of MTC and colchicine, resp., were unable to promote microtubule disassembly, cell cycle arrest, and apoptosis.  Although 1 μM MTC induced a complete microtubule disruption after 1 h of incubation in human leukemic HL-60 cells that led to an accumulation of cells at the G2-M phase, MTC-induced apoptosis occurred after 9 h of treatment.  This indicates the existence of a rather long lag between microtubule disruption and the onset of apoptosis.  Unlike colchicine, the removal of MTC during this lag resulted in rapid microtubule repolymn., followed by restoration of normal cell cycle and cell growth.  MTC, but not 2-methoxy-5-[[3-(3,4,5-trimethoxyphenyl)propionyl]amino]-2,4,6-cycloheptatrien-1-one, induced c-jun expression as well as c-Jun NH2-terminal kinase and caspase activation, indicating that these signaling pathways are triggered by the specific action of MTC on microtubules.  Caspase inhibition prevented MTC-induced apoptosis.  Overexpression of bcl-2 or bcl-xL by gene transfer in human erythroleukemic HEL cells abrogated MTC-induced apoptosis, but cells remained arrested in G2-M, suggesting that bcl-2 and bcl-xL block the signaling pathway between G2-M arrest and triggering of apoptosis.  MTC-treated bcl-2 and bcl-xL-transfected HEL cells recovered their capacity to proliferate after MTC removal.  These results indicate that microtubule inhibition induces G2-M arrest and apoptosis in leukemic cells, showing a lag phase between G2-M arrest and the onset of apoptosis, regulated by bcl-2 and bcl-xL, during which MTC displays a reversible action on microtubule depolymn. and G2-M cell cycle arrest.  Thus, MTC is a potent apoptotic inducer on human leukemic cells and shows a remarkable reversible action on microtubule network and cell cycle before commitment for apoptosis is reached.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZXw9pVySXJLVg90H21EOLACvtfcHk0ljjOK-KQG576g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsF2gtLw%253D&md5=9c3c2f22521ab0e4cdeef2c8f70e429a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGajate%26aufirst%3DC.%26aulast%3DBarasoain%26aufirst%3DI.%26aulast%3DAndreu%26aufirst%3DJ.%2BM.%26aulast%3DMollinedo%26aufirst%3DF.%26atitle%3DInduction%2520of%2520apoptosis%2520in%2520leukemic%2520cells%2520by%2520the%2520reversible%2520microtubule-disrupting%2520agent%25202-methoxy-5-%25282%25E2%2580%25B2%252C3%25E2%2580%25B2%252C4%25E2%2580%25B2-trimethoxyphenyl%2529-2%252C4%252C6-cycloheptatrien-1-one%253A%2520protection%2520by%2520Bcl-2%2520and%2520Bcl-X%2528L%2529%2520and%2520cell%2520cycle%2520arrest%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D2651%26epage%3D2659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gajate, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonteriz, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabaner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Noves, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Rodriguez, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modolell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollinedo, F.</span></span> <span> </span><span class="NLM_article-title">Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">682</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C674%3A%3AAID-IJC13%3E3.0.CO%3B2-Z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10699948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht1aqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2000&pages=674-682&author=C.+Gajateauthor=R.+I.+Fonterizauthor=C.+Cabanerauthor=G.+Alvarez-Novesauthor=Y.+Alvarez-Rodriguezauthor=M.+Modolellauthor=F.+Mollinedo&title=Intracellular+triggering+of+Fas%2C+independently+of+FasL%2C+as+a+new+mechanism+of+antitumor+ether+lipid-induced+apoptosis&doi=10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C674%3A%3AAID-IJC13%3E3.0.CO%3B2-Z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis</span></div><div class="casAuthors">Gajate, Consuelo; Fonteriz, Rosalba I.; Cabaner, Christelle; Alvarez-Noves, Granada; Alvarez-Rodriguez, Ysmael; Modolell, Manuel; Mollinedo, Faustino</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">674-682</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Antitumor ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3; edelfosine) induces apoptosis in cancer cells, sparing normal cells.  The authors have found that the apoptotic action of ET-18-OCH3 required drug uptake and Fas in the target cell.  Failure to accomplish one of these requirements prevents cell killing by the ether lipid.  In human lymphoid leukemic cells, ET-18-OCH3 does not promote Fas or FasL expression and ET-18-OCH3-induced apoptosis is not inhibited by pre-incubation with an anti-Fas blocking antibody that abrogates cell killing mediated by Fas/FasL interactions.  ET-18-OCH3-resistant normal human Fas-pos. fibroblasts do not incorporate ET-18-OCH3, but undergo apoptosis upon ET-18-OCH3 microinjection.  Murine fibroblasts L929 and L929-Fas, stably transfected with human Fas cDNA, do not incorporate ET-18-OCH3 and are resistant to its action when added exogenously.  Microinjection of ET-18-OCH3 induces apoptosis in L929-Fas cells, but not in wild-type L929 cells.  Confocal laser scanning microscopy shows that ET-18-OCH3 induces Fas clustering and capping during triggering of ET-18-OCH3-induced apoptosis.  Microinjection-induced apoptosis and Fas clustering are specific for the mol. structure of ET-18-OCH3.  The data indicate that ET-18-OCH3 induces apoptosis via Fas after the ether lipid is inside the cell, and this Fas activation is independent of the interaction of Fas with its natural ligand FasL.  This explains the selective action of ET-18-OCH3 on tumors since only cancer cells incorporate sufficient amts. of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBQHGjIxY_17Vg90H21EOLACvtfcHk0ljjOK-KQG576g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht1aqsLw%253D&md5=cd4ad2ca3efe97332d75e694d6580dad</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C674%3A%3AAID-IJC13%3E3.0.CO%3B2-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252820000301%252985%253A5%253C674%253A%253AAID-IJC13%253E3.0.CO%253B2-Z%26sid%3Dliteratum%253Aachs%26aulast%3DGajate%26aufirst%3DC.%26aulast%3DFonteriz%26aufirst%3DR.%2BI.%26aulast%3DCabaner%26aufirst%3DC.%26aulast%3DAlvarez-Noves%26aufirst%3DG.%26aulast%3DAlvarez-Rodriguez%26aufirst%3DY.%26aulast%3DModolell%26aufirst%3DM.%26aulast%3DMollinedo%26aufirst%3DF.%26atitle%3DIntracellular%2520triggering%2520of%2520Fas%252C%2520independently%2520of%2520FasL%252C%2520as%2520a%2520new%2520mechanism%2520of%2520antitumor%2520ether%2520lipid-induced%2520apoptosis%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2000%26volume%3D85%26spage%3D674%26epage%3D682%26doi%3D10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C674%3A%3AAID-IJC13%3E3.0.CO%3B2-Z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Torres, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cipriano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heden, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorklund, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guaza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span> <span> </span><span class="NLM_article-title">A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">13765</span>– <span class="NLM_lpage">13770</span>, <span class="refDoi"> DOI: 10.1002/anie.201407807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=10.1002%2Fanie.201407807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCit7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=13765-13770&author=G.+Hernandez-Torresauthor=M.+Ciprianoauthor=E.+Hedenauthor=E.+Bjorklundauthor=A.+Canalesauthor=D.+Zianauthor=A.+Feliuauthor=M.+Mechaauthor=C.+Guazaauthor=C.+J.+Fowlerauthor=S.+Ortega-Gutierrezauthor=M.+L.+Lopez-Rodriguez&title=A+reversible+and+selective+inhibitor+of+monoacylglycerol+lipase+ameliorates+multiple+sclerosis&doi=10.1002%2Fanie.201407807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis</span></div><div class="casAuthors">Hernandez-Torres, Gloria; Cipriano, Mariateresa; Heden, Erika; Bjoerklund, Emmelie; Canales, Angeles; Zian, Debora; Feliu, Ana; Mecha, Miriam; Guaza, Carmen; Fowler, Christopher J.; Ortega-Gutierrez, Silvia; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">13765-13770</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is the enzyme responsible for the inactivation of the endocannabinoid 2-arachidonoylglycerol (2-AG).  MAGL inhibitors show analgesic and tissue-protecting effects in several disease models.  However, the few efficient and selective MAGL inhibitors described to date block the enzyme irreversibly, and this can lead to pharmacol. tolerance.  Hence, addnl. classes of MAGL inhibitors are needed to validate this enzyme as a therapeutic target.  Here we report a potent, selective, and reversible MAGL inhibitor (IC50=0.18 μM) which is active in vivo and ameliorates the clin. progression of a multiple sclerosis (MS) mouse model without inducing undesirable CB1-mediated side effects.  These results support the interest in MAGL as a target for the treatment of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzujCPuidHArVg90H21EOLACvtfcHk0ljjOK-KQG576g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCit7vF&md5=6cd7f2080f95bbc05daaebba21ee1be2</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fanie.201407807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201407807%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez-Torres%26aufirst%3DG.%26aulast%3DCipriano%26aufirst%3DM.%26aulast%3DHeden%26aufirst%3DE.%26aulast%3DBjorklund%26aufirst%3DE.%26aulast%3DCanales%26aufirst%3DA.%26aulast%3DZian%26aufirst%3DD.%26aulast%3DFeliu%26aufirst%3DA.%26aulast%3DMecha%26aufirst%3DM.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26atitle%3DA%2520reversible%2520and%2520selective%2520inhibitor%2520of%2520monoacylglycerol%2520lipase%2520ameliorates%2520multiple%2520sclerosis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D13765%26epage%3D13770%26doi%3D10.1002%2Fanie.201407807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Torres, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enriquez-Palacios, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueda-Zubiaurre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angelina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Cruz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Fontecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomares, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guaza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena-Cabrera, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span> <span> </span><span class="NLM_article-title">Development of a fluorescent bodipy probe for visualization of the serotonin 5-HT1A receptor in native cells of the immune system</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2021</span>– <span class="NLM_lpage">2027</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.8b00228</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.8b00228" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovFyjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=2021-2027&author=G.+Hernandez-Torresauthor=E.+Enriquez-Palaciosauthor=M.+Mechaauthor=A.+Feliuauthor=A.+Rueda-Zubiaurreauthor=A.+Angelinaauthor=L.+Martin-Cruzauthor=M.+Martin-Fontechaauthor=O.+Palomaresauthor=C.+Guazaauthor=E.+Pena-Cabreraauthor=M.+L.+Lopez-Rodriguezauthor=S.+Ortega-Gutierrez&title=Development+of+a+fluorescent+bodipy+probe+for+visualization+of+the+serotonin+5-HT1A+receptor+in+native+cells+of+the+immune+system&doi=10.1021%2Facs.bioconjchem.8b00228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Fluorescent Bodipy Probe for Visualization of the Serotonin 5-HT1A Receptor in Native Cells of the Immune System</span></div><div class="casAuthors">Hernandez-Torres, Gloria; Enriquez-Palacios, Ernesto; Mecha, Miriam; Feliu, Ana; Rueda-Zubiaurre, Ainoa; Angelina, Alba; Martin-Cruz, Leticia; Martin-Fontecha, Mar; Palomares, Oscar; Guaza, Carmen; Pena-Cabrera, Eduardo; Lopez-Rodriguez, Maria L.; Ortega-Gutierrez, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2021-2027</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Serotonin (5-HT) modulates key aspects of the immune system.  However, its precise function and the receptors involved in the obsd. effects have remained elusive.  Among the different serotonin receptors, 5-HT1A plays an important role in the immune system given its presence in cells involved in both the innate and the adaptive immune responses, but its actual levels of expression under different conditions have not been comprehensively studied due to the lack of suitable tools.  To further clarify the role of 5-HT1A receptor in the immune system, we have developed a fluorescent small mol. probe that enables the direct study of the receptor levels in native cells.  This probe allows direct profiling of the receptor expression in immune cells using flow cytometry.  Our results show that important subsets of immune cells including human monocytes and dendritic cells express functional 5-HT1A and that its activation is assocd. to anti-inflammatory signaling.  Furthermore, application of the probe to the exptl. autoimmune encephalomyelitis model of multiple sclerosis demonstrates its potential to detect the specific overexpression of the 5-HT1A receptor in CD4+ T cells.  Accordingly, the probe reported herein represents a useful tool whose use can be extended to study the levels of 5-HT1A receptor in ex vivo samples of different immune system conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR47IcgWAUrLVg90H21EOLACvtfcHk0ljQNVvbPXYy0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovFyjurw%253D&md5=a417ca2ecd7f644ff017318317eb02fe</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.8b00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.8b00228%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez-Torres%26aufirst%3DG.%26aulast%3DEnriquez-Palacios%26aufirst%3DE.%26aulast%3DMecha%26aufirst%3DM.%26aulast%3DFeliu%26aufirst%3DA.%26aulast%3DRueda-Zubiaurre%26aufirst%3DA.%26aulast%3DAngelina%26aufirst%3DA.%26aulast%3DMartin-Cruz%26aufirst%3DL.%26aulast%3DMartin-Fontecha%26aufirst%3DM.%26aulast%3DPalomares%26aufirst%3DO.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DPena-Cabrera%26aufirst%3DE.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26atitle%3DDevelopment%2520of%2520a%2520fluorescent%2520bodipy%2520probe%2520for%2520visualization%2520of%2520the%2520serotonin%25205-HT1A%2520receptor%2520in%2520native%2520cells%2520of%2520the%2520immune%2520system%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26spage%3D2021%26epage%3D2027%26doi%3D10.1021%2Facs.bioconjchem.8b00228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turrado, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Cárceles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhamú, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutiérrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveras, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blancafort, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrero, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colomer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Rodríguez, M. L.</span></span> <span> </span><span class="NLM_article-title">New synthetic inhibitors of fatty acid synthase with anticancer activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5013</span>– <span class="NLM_lpage">5023</span>, <span class="refDoi"> DOI: 10.1021/jm2016045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2016045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFygsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5013-5023&author=C.+Turradoauthor=T.+Puigauthor=J.+Garc%C3%ADa-C%C3%A1rcelesauthor=M.+Artolaauthor=B.+Benham%C3%BAauthor=S.+Ortega-Guti%C3%A9rrezauthor=J.+Relatauthor=G.+Oliverasauthor=A.+Blancafortauthor=D.+Haroauthor=P.+F.+Marreroauthor=R.+Colomerauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=New+synthetic+inhibitors+of+fatty+acid+synthase+with+anticancer+activity&doi=10.1021%2Fjm2016045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity</span></div><div class="casAuthors">Turrado, Carlos; Puig, Teresa; Garcia-Carceles, Javier; Artola, Marta; Benhamu, Bellinda; Ortega-Gutierrez, Silvia; Relat, Joana; Oliveras, Gloria; Blancafort, Adriana; Haro, Diego; Marrero, Pedro F.; Colomer, Ramon; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5013-5023</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid synthase (FASN) is a lipogenic enzyme that is highly expressed in different human cancers.  Here we report the development of a new series of polyphenolic compds. 5-30 that have been evaluated for their cytotoxic capacity in SK-Br3 cells, a human breast cancer cell line with high FASN expression.  The compds. with an IC50 < 50 μM have been tested for their ability to inhibit FASN activity.  Among them, deriv. 30 (I) blocks the 90% of FASN activity at low concn. (4 μM), is highly cytotoxic in a broad panel of tumor cells, induces apoptosis, and blocks the activation of HER2, AKT, and ERK pathways.  Remarkably, 30 does not activate carnitine palmitoyltransferase-1 (CPT-1) nor induces in mice wt. loss, which are the main drawbacks of other previously described FASN inhibitors.  Thus, FASN inhibitor 30 may aid the validation of this enzyme as a therapeutic target for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosV2mbmEyIarVg90H21EOLACvtfcHk0ljQNVvbPXYy0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFygsb8%253D&md5=83a7be3e2f53c33e37aa12808f2f283d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm2016045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016045%26sid%3Dliteratum%253Aachs%26aulast%3DTurrado%26aufirst%3DC.%26aulast%3DPuig%26aufirst%3DT.%26aulast%3DGarc%25C3%25ADa-C%25C3%25A1rceles%26aufirst%3DJ.%26aulast%3DArtola%26aufirst%3DM.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DOrtega-Guti%25C3%25A9rrez%26aufirst%3DS.%26aulast%3DRelat%26aufirst%3DJ.%26aulast%3DOliveras%26aufirst%3DG.%26aulast%3DBlancafort%26aufirst%3DA.%26aulast%3DHaro%26aufirst%3DD.%26aulast%3DMarrero%26aufirst%3DP.%2BF.%26aulast%3DColomer%26aufirst%3DR.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DNew%2520synthetic%2520inhibitors%2520of%2520fatty%2520acid%2520synthase%2520with%2520anticancer%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5013%26epage%3D5023%26doi%3D10.1021%2Fjm2016045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V7P" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V7P','PDB','5V7P'); return false;">PDB: 5V7P</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A2N" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A2N','PDB','4A2N'); return false;">PDB: 4A2N</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i31"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00145">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_66813"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00145">10.1021/acs.jmedchem.9b00145</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Ma- and Tc-ICMT derived homology models of h-ICMT (Figures S1 and S2), concentration–response curves for cysmethynil and compound <b>3</b> (Figure S3), effect of compound <b>3</b> on the membrane association of Ras (Figure S4) and Fyn (Figure S5) and of farnesylated and geranylgeranylated K-Ras (Figure S6) and on Rce1 enzyme (Figure S7), effect of compound <b>3</b> on the induction of apoptosis en human pancreatic cancer cells (Figures S8 and S9) and plasma concentration of compound <b>3</b> after ip injection (Figure S10), computational models, detailed synthetic procedures, characterization data of final compounds <b>1</b>, <b>2</b>, <b>4</b>–<b>34</b> and intermediates <b>35</b>–<b>55</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_002.csv">CSV</a>)</p></li><li><p class="inline">Homology models of human ICMT built using the crystal structure of Ma-ICMT (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A2N">4A2N</a>), as template (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Homology models of human ICMT built using the crystal structure of Tc-ICMT (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V7P">5V7P</a>), as template (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_004.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_001.pdf">jm9b00145_si_001.pdf (1.31 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_002.csv">jm9b00145_si_002.csv (1.83 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_003.pdb">jm9b00145_si_003.pdb (241.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00145/suppl_file/jm9b00145_si_004.pdb">jm9b00145_si_004.pdb (356.28 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00145%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00145" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a62069dd3d54","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
